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ABSTRACT 
The exposure of skin to ultraviolet (UV) radiation can have serious 
consequences which may include the down-regulation of cutaneous immunity 
and the generation of tumours. This study examined effects of such an 
exposure on the dendritic cells migrating from skin to the draining lymph node 
in a cannulated ovine pseudoafferent lymphatic vessel. These investigations 
have revealed that exposure of skin to UV light increased migration of 
Langerhans cells (LC) from the skin. Exposure of skin to a dose of 8.1 kJ/m 2 
UVB caused a sustained increase in both the number and proportion of LC 
migrating towards the regional lymph node. Higher doses triggered non-
specific effects including increased lymph output and the increased migration of 
other lymphoid cells. This provides strong evidence that the depletion in LC 
numbers in the skin after UV exposure is partially due to the migration of these 
cells to the draining lymph node. In addition, a CD14 + DC population which 
parallels the immunosuppressive macrophages in human and murine models, 
was shown to be increased in ovine afferent lymph after UV exposure of the 
skin. 
Since DC are induced to migrate from UV exposed skin, the functional 
capability of these cells was analysed. Cutaneous exposure to 8.1 kJ/m 2 UVB 
was found to significantly reduce the capacity of migrating DC to present 
antigen to T cells. The same dose significantly impaired mitogen induced 
proliferation of peripheral blood mononuclear cells (PBMC), which were used to 
assess DC function. However, the differing time courses of these two effects 
indicates that the functional capability of both populations were impaired, 
thereby contributing to the overall down regulation of immune function after UV 
light exposure. 
To determine whether altered cytokine production may play a role in these 
events, supernatants from DC:PBMC co-cultures and lymph draining treated 
areas of skin were assayed for the presence of variety of soluble factors. It 
was found that after UV exposure of the skin increased prostaglandin E2 and 
IFNy production in culture supernatants, however the timing of this increase did 
not correlate with the reduced functional capacity of DC. A protein with the 
approximate molecular weight of IL-10 and IL-10-like activity was detected in 
lymph draining the UV exposed skin. This finding may help to explain the 
impaired functional ability of DC migrating from UV exposed skin. In summary, 
this study has shown that DC with impaired functional capacity were induced to 
migrate from UV exposed skin and this effect was associated with increased 
levels of IL-10. 
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FOREWORD 
This study has utilised the cannulation of ovine pseudoafferent lymphatic 
vessels to study the migration and function of cells after UV exposure of the 
skin. The Langerhans cells (LC) are epidermal antigen presenting cells (APC), 
whose migratory and functional properties are thought to play a crucial role in 
tumour immunosurveillance within the skin. Therefore these studies have 
concentrated on the migration kinetics, antigen presenting function of 
cutaneous dendritic cells (DC) and factors which may influence these events. 
Thus providing an insight into altered immunity, which may lead to tumour 
evasion after UV exposure. 
Closely shorn sheep skin was irradiated with a single measured dose of 
UV light. The migration kinetics of lymphoid cells collected from lymphatic 
vessels draining the exposed area of skin was investigated using 
immunofluorescence and flow cytometry. Alterations in the numbers of LC 
which migrated from the UV exposed skin were studied and correlated with the 
reduction of LC noted in other models after UV exposure. 
DC migrating from a defined area of skin were enriched and their capacity 
to present exogenous antigen to primed autologous T cells was assessed using 
in vitro culture assay. Alterations in the APC function of DC after UV exposure 
were compared to the functional capacity of these cells prior to irradiation. The 
dose of UVB used in these studies was one determined to alter the migratory 
properties of DC while having minimal inflammatory effects. 
Since a reduction in the APC capacity of migrating DC was observed after 
UV exposure investigation of costimulatory molecule expression and soluble 
factors secretion which could be associated with this defect were undertaken. 
The effect of UV exposure of skin on the expression of B7 molecules by 
migrating LC was investigated using two-colour immunofluorescence. The 
secretion levels of the cytokines IL-113, IL-5, PGE2, GM-CSF, IFNy and IL-10 in 
culture supernatants was assessed using a combination of enzyme linked 
immunosorbent assays, bioassays and western blotting. 
These investigations revealed that the loss of antigen presenting function 
by migrating DC was not found to be associated with the loss of expression of 
the B7 costimulatory molecules. The loss of functional activity was not 
associated with the loss of IL-113 production or the correlated to the production 
of an immunosuppressive factor in vitro. However, temporary increases were 
noted in the production of IFNy and PGE2 but these changes were not 
correlated with the loss of DC function. A possible correlation was found with 
the in vivo production of the immunosuppressive cytokine, IL-10. Interpretation 
of this data with previously published findings would indicate that in situ 
exposure to ultraviolet light caused the increased migration of LC with aberrant 
functional capabilities. Further it is likely that this is associated with the in vivo 
production of IL-10. 
CHAPTER 1: LITERATURE REVIEW 	 1 
1.1 INTRODUCTION 	 1 
1.2 SKIN STRUCTURE 1 
1.2.1 The Skin Vasculature 	 2 
1.3 THE SKIN IMMUNE SYSTEM 	 3 
1.4 CELLS OF THE SKIN IMMUNE SYSTEM 	 4 
1.4.1.1 Langerhans Cell 	 4 
1.4.2 Keratinocytes 	 21 
1.4.3 y8 T cells 	 24 
1.4.4 Melanocytes 27 
1.4.5 Merkel Cells 	 28 
1.4.6 Monocytes/Macrophages 	 29 
1.4.7 Dermal Dendritic Cells 30 
1.4.8 Mast Cells 	 30 
1.5 ULTRAVIOLET LIGHT 	 31 
1.5.1 Introduction 	 31 
1.5.2 Ultraviolet Light Methodology 	 32 
1.5.3 Inflammatory Response 	 32 
1.5.4 UVA/UVB 	 37 
1.5.5 UV Damage of DNA 	 38 
1.6 IMMUNOLOGICAL EVENTS 	 40 
1.6.1 UV Induced Immunosuppression 	 40 
1.6.2 Genetic Basis for lmmunosuppression 	 43 
1.6.3 Adhesion Molecules 	 45 
1.6.4 Cytokines and Soluble Factors Produced after UV Exposure 	46 
1.6.5 Effects of UV on Langerhans Cells and Antigen Presentation 	54 
1.6.6 UV Induced Macrophages 	 56 
1.6.7 y8 T Cell Changes 	 58 
1.6 SUMMARY 	 59 
CHAPTER 2: MATERIALS AND METHODS 	 60 
2.1 ANIMALS 	 60 
2.2 SURGICAL METHODS 	 60 
2.3 LYMPH COLLECTIONS 60 
2.3.1 Routine Lymph Collections 	 60 
2.3.2 Sterile Collections 	 61 
2.4 UV TREATMENT 	 61 
2.5 IMMUNOFLUORESCENT STAINING 	 63 
2.5.1 Procedure 	 63 
2.5.2 Monoclonal Antibodies 	 64 
2.6 ASSESSMENT OF IMMUNITY TO OVALBUMIN IN SHEEP 	 64 
2.6.1 Preparation of Serum 	 64 
2.6.2 Antigen Coating of Sheep Red Blood Cells 	 64 
2.6.3 Haemagglutination Assay 	 65 
2.7 ANTIGEN PRESENTATION ASSAY 	 65 
2.7.1 Immunisation Procedure 	 65 
2.7.2 Collection Procedure 65 
2.7.3 Assay Procedure 	 65 
2.8 STATISTICAL ANALYSIS 	 67 
2.9 CYTOKINE ELISA'S 	 67 
2.9.1 IL-1# 	 67 
2.9.2 GM-CSF 68 
2.9.3 Prostaglandin E2 EIA 	 69 
2.9.4 IFNy 	 69 
2.10 ISOLATION OF CELLS FROM ALVEOLAR LAVAGE FLUID 	70 
2.10.1 IL-10 macrophage inhibition assay 	 70 
2.11 DETECTION OF IL-10 PROTEIN 	 70 
2.12 IL-5 BIOASSAY 	 72 
2.13 MISCELLANEOUS METHODS 	 73 
2.13.1 Glassware 	 73 
2.13.2 Solutions and reagents 	 73 
2.13.3 Preparation of Media 73 
CHAPTER 3 LANGERHANS CELL MIGRATION AFTER UV EXPOSURE ....75 
3.1 INTRODUCTION 	 75 
3.2 MATERIALS AND METHODS 	 76 
3.2.1 Experimental Plan 	 76 
3.2.2 Statistical Analysis 77 
3.2.3 Presentation of Data 	 77 
3.3 RESULTS 	 78 
3.3.1 Changes in Lymph Flow, Cell Kinetics and Composition after 
Exposure of Skin to 2.7 kJ/m 2 UVB 	 78 
3.3.2 Changes in Lymph Flow, Cell Kinetics and Composition after 
Exposure of Skin to 8.1 kJ/m 2 UVB 	 80 
3.3.3 Changes in Lymph Flow, Cell Kinetics and Composition after 
Exposure of skin to 20.1 kJ/m 2 UVB 	 82 
3.3.4 Changes in Lymph Flow, Cell Kinetics and Composition after 
Exposure of Skin to 40.2 kJ/m 2 UVB 	 84 
3.3.5 Changes in Lymph Flow, Cell Kinetics and Composition after 
Exposure of Skin to 80.4 kJ/m 2 UVB 	 87 
3.4 DISCUSSION 	 90 
3.4.1 The Migration of LC after UV Exposure 	 90 
3.4.2 Lymph Output and Total Cell Output after UV Exposure of the Skin 	 94 
3.4.3 Migration of T cell Subsets after UV Exposure of the Skin 	 95 
3.5 SUMMARY 	 98 
CHAPTER 4: PHENOTYPE OF AFFERENT LYMPHATIC DC AND 
MACROPHAGES 	 99 
4.1 INTRODUCTION 	 99 
4.2 MATERIALS AND METHODS 	 100 
4.2.1 Experimental Plan 	 100 
4.2.2 Presentation of Data 101 
4.3 RESULTS 	 102 
4.3.1 Phenotype of Afferent Lymphatic DC and Alveolar Macrophages 	 102 
4.3.3 Expression of B7 molecules by Afferent lymph DC after UV exposure 
of the skin 	 105 
4.4.1 Macrophage Migration Induced by UV Exposure of the Skin 	107 
4.4.2 Expression of CTLA-4 Ligands by Migrating LC after UV exposure of 
the Skin 	 111 
4.5 SUMMARY 	 113 
CHAPTER 5: EFFECTS OF UVB ON THE FUNCTION OF MIGRATING 
ANTIGEN PRESENTING CELLS 	 114 
5.1 INTRODUCTION 	 114 
5.2 MATERIALS AND METHODS 	 115 
5.2.1 Experimental Plan 	 115 
5.2.2 Presentation of data 116 
5.3 RESULTS 	 116 
5.3.1 Effects of UVB Exposure of Flank Skin on DC Function 	117 
5.3.2 Exposure of flank skin to 8.1 kJ/m 2 	 117 
5.4 DISCUSSION 	 119 
5.5 SUMMARY 122 
CHAPTER 6: ALTERATION OF CYTOKINES AND SOLUBLE FACTORS 
AFTER UV EXPOSURE OF OVINE SKIN 	 123 
6.1 INTRODUCTION 	 123 
6.2 METHODS AND MATERIALS 	 125 
6.2.1 Experimental Plan 	 125 
6.2.2 Cytokine Assays 125 
6.3 RESULTS 	 125 
6.3.1 GM-CSF in lymph and Culture Supernatants 	 126 
6.3.2 IL-110 Detection 	 126 
6.3.3 IL-10-like activity in Lymph after 2.7 kJ/m 2 UVB 	 126 
6.3.4 IL-10-like activity after 8.1 kJ/m 2 UVB 	 127 
6.3.5 IL-10-like activity in Lymph after 20.1 kJ/m2 UVB 	 127 
6.3.6 Detection of IL-10 Protein in Lymph after UV Exposure 	 128 
6.3.7 Prostaglandin E2 in Lymph and Culture Supernatants 129 
6.3.8 IFNy in Culture Supernatants 	 129 
6.3.9 IL-5 in lymph and DC-PBMC Co-Cultures 	 130 
6.4 DISCUSSION 	 131 
6.4.1 GM-CSF 131 
6.4.2 IL-1/3 Production 	 132 
6.4.3 IL-10 production 132 
6.4.4 Prostaglandin E2 Production 	 134 
6.4.5 IRV), 	 135 
6.4.61L-5 136 
6.5 SUMMARY 	 136 
CHAPTER 7: GENERAL DISCUSSION 	 138 
SUMMARY 	 146 
BIBLIOGRAPHY 	 147 
CHAPTER 1: LITERATURE REVIEW 
1.1 INTRODUCTION 
The skin acts as a protective layer reducing the adverse effects of the 
external environment on the body's internal milieu. Exposure of the skin to the 
ultraviolet (UV) rays contained in sunlight is a common occurrence and results 
in the beneficial synthesis of vitamin D and melanin. However, such exposure 
is linked to many harmful effects including inflammation, DNA, cellular and 
protein damage, which result in the down-regulation of the immune system and 
the generation of skin tumours. The interaction between UV light and the 
immune system has been subject of serious study, especially over the last 
three decades during which time decreases in stratospheric ozone have been 
documented. Decreased stratospheric ozone has led to increased levels of UV 
light reaching the earth's surface. This increase may have serious biological 
consequences including further increases in the rates of skin cancer and 
infectious disease throughout the human population. 
The unique physical and biological properties of the skin enable it to act 
as a barrier against various noxious chemical, microbial and physical 
influences, including sunlight, which contains harmful ultraviolet rays. The skin 
possesses unique cell types that afford this protection. These include 
keratinocytes whose differentiation, keratinisation and eventual death make up 
the outer protective physical barrier of skin and melanocytes that produce the 
pigment melanin which provides protection against UV exposure. 
Immunological protection is provided by the Langerhans cell (LC), a dendritic 
antigen presenting cell (APC) found in the epidermis acting as an antigen trap, 
transporting foreign antigens to the lymph node. In turn the LC can present 
these antigens to T cells, resulting in the stimulation of immune responses. The 
keratinocyte and to a lesser extent the melanocyte may contribute to immune 
function by producing a variety of cytokines. These cells constitute the skin 
immune system and their interaction with UV light is the focus of this thesis. 
1.2 SKIN STRUCTURE 
The skin is the external barrier between man and the environment 
protecting man against various noxious agents including microbial, chemical 
and physical insults. The skin is composed of two layers, the epidermis and 
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the dermis, with the epidermis being epithethial in origin, while the dermis is 
mainly connective tissue (Hunter et al., 1989). 
The epidermis contains keratinocytes, a unique cell population, whose 
differentiation and development give rise to the barrier function of the skin. The 
keratinocyte is generated in the basal layer and forced upward into the outer 
cell layers due to mitotic activity. As the keratinocyte moves upward it 
degenerates and keratinisation of the cell increases until eventually the cell 
dies leaving a cytoplasmic shell of keratin. These cells are continuously shed 
in a process termed desquamation. Before their shedding, the dead cells form 
the final layer of the skin, the horny layer whose properties makes the skin an 
effective barrier against water soluble compounds and other various insults. 
Another protective function of keratinocytes is the ability to take up melanin 
produced by ultraviolet light stimulation of melanocytes which reside in the 
basal layer of the epidermis. This pigment is protective against some of the 
harmful effects of ultraviolet light. 
In contrast, the dermis contains mainly connective tissue which is 
composed of collagen and elastin, proteins produced by fibroblasts to give the 
skin its elasticity and strength. Upward projections from the dermis (papillae) 
interlock with downward projections from the epidermis (rete pegs). Such 
projections not only enhance surface area but are also important in epidermal-
dermal adhesion (Hunter et a/., 1989). Blood vessels are richly contained 
throughout the dermis, supplying nutrients to both the dermal and epidermal 
layers of the skin. These vessels together with the cutaneous lymphatics, 
provide a route for cell immigration and emigration from the upper layers of the 
skin. Some cells resident within the dermis have immunological roles. These 
include macrophages, dendritic cells (DC) (including veiled cells) and mast 
cells, which also produce soluble factors with immune function. 
1.2.1 	The Skin Vasculature 
The skin has an abundant blood supply which provides nutrients to both 
the dermal and epidermal layers, as well playing an important role in regulating 
temperature. The vasculature of the skin forms two horizontal layers, the upper 
horizontal plexus and lower horizontal plexus. The lower plexus exists at the 
dermis-subcutis interface while the upper exists at the dermal-epidermal 
interface. The two plexi are connected by vascular channels through which 
blood flows. These vessels supply capillary branches to the hair bulbs and 
sebaceous glands. The vascular channels join the upper horizontal plexus 
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from which branches of intertwining networks of arterioles and post capillary 
venules arise. These ascending loops are contained within the dermal 
papillae, which interdigitate with the epidermis. The post capillary venules are 
readily susceptible to histamine which cause the endothelial cells to contract 
leading to gaps and increased vascular permeability (Majno & Palade 1961, 
Majno et at., 1969, reviewed in Braverman 1983). The post capillary venules 
are also readily permeable to dyes and serve as the site of emigration of 
neutrophils and lymphocytes into the skin with inflammation (Braveman 1983). 
The lymphatic network within the skin parallels the structure of the 
vasculature with an upper and a lower dermal plexus. The cutaneous 
lymphatics contain unique valves which are orientated to prevent back flow of 
lymph fluid (Braverman and Yen 1974). Endothelial cell gaps are common 
throughout the cutaneous lymphatics and provide the route by which fluid and 
cells may be reabsorbed and then transported to the draining lymph node. 
1.3 THE SKIN IMMUNE SYSTEM 
Skin was first proposed as an organ of immune function by Streilein 
(1978). He proposed that LC, keratinocytes, skin specific T cells, endothelial 
cells of the dermal vasculature and lymphatic vessels together with the local 
draining lymph node (DLN) comprised the skin associated lymphoid tissue 
(SALT). The skin was thought to have its own specialised immune function in 
an organ specific manner similar to the gut associated lymphoid tissue (GALT) 
and to the bronchus associated lymphoid tissue (BALT). The cells found within 
the skin were proposed to be specialised and provide the immune protection for 
the skin. SALT however, did not take into account many cell types within the 
dermis which could also influence cutaneous immune responses. 
Bos and Kapensberg (1986) included both the dermis and epidermis in 
their proposal for skin immunity in which they coined the phrase skin immune 
system (S IS), to describe the many cellular and humoral components that could 
influence immune responses in the skin. They also argued that Streilein's 
SALT bore little resemblance to GALT or BALI due to lack of 
compartmentalisation. Furthermore B cells, which are plentiful in these areas 
are absent from the skin (Bos et al., 1987). The same study also found that the 
majority of T cells in the skin were closely associated with the post capillary 
venules of the dermis (90%), with those in the epidermis only accounting for 
2% of the total population (the majority CD' 8+2). Hence little direct T cell 
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keratinocyte interaction could occur. In addition there was a lack of intra-
epidermal T cell differentiation which was proposed as part of SALT (Bos et a/., 
1987). SALT was also proposed to involve the homing and maturation of skin 
specific T cells. However, the majority of T cells in the skin were activated and 
not at rest as would be expected (Bos et al., 1987). More recently the 
expression of E-Selectin (also known as ELAM-1 or CD62E) by endothelial 
cells, has been proposed to act as skin homing molecule for memory T cells in 
response to inflammation (Norris et at., 1991). The LC which Streilein 
proposed as unique cells for carriage of antigen to the draining lymph nodes, 
were proposed by Bos and Kapensberg (1986) to actually form part of a widely 
distributed family of dendritic antigen presenting cells and that their specificity 
for the epidermis did not suggest a skin specific function. 
Recently the dermis has had a greatly emphasised role in immunological 
reactions occurring in the skin. The dermal microvascular unit (DMU) was 
proposed by Sontheimer (1989) to be the center of dermal immunological 
reactions. The DMU is comprised of dermal T cells, mast cells, vascular 
endothelial cells, dermal dendritic cells and monocytes. Nickoloff (1993) 
expanded the idea of the DMU, to include fibroblasts because of their intimate 
relationship with other dermal cells, this he called the dermal immune system 
(DIS). DIS like SIS included humoral components of the dermis, cytokines and 
neuropeptides. 
The SIS theory provides the most complete and comprehensive picture of 
cutaneous immunity as it emphasises both the cellular and humoral 
components of both the epidermis and the dermis. However, Streilein's SALT 
proposal still has merit as it provides a connection between the immunological 
components of the skin and the DLN. 
1.4 CELLS OF THE SKIN IMMUNE SYSTEM 
1.4.1.1 	Langerhans Cell 
In 1868 Paul Langerhans found a group of dendritic cells (DC) in human 
skin which stained with gold chloride. The cells observed under the 
microscope appeared to be in continuity with nerve cells, which also have an 
affinity for the stain. This led Langerhans to conclude that he was looking at an 
intraepidermal nerve cell system. 
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This hypothesis was accepted for nearly a century before it was disproved 
by electron microscopy (EM) which showed the cells had no structural 
similarities with nerve cells (Birbeck et aL, 1961). Birbeck described the 
ultrastructural features of the LC including a unique granule now named after 
its discoverer. The alternate hypothesis that LC were in fact worn out 
melanocytes that had lost their capacity to produce pigment as proposed by 
Masson (1945) and reviewed by Breathnach, (1991) was also disproved by 
Birbeck's study. 
It was suggested by Silberberg et at., (1973) that LC were involved in the 
immune process as antigen presenting cells, as after dinitrochlorobenzene 
(DNCB) sensitisation it was found that LC were apposed to lymphocytes. This 
hypothesis is now accepted as valid, as it has been established that mature LC 
have a capacity to present antigens to T cells with extraordinary efficiency 
(Bergstresser et al., 1992). 
1.4.1.1 	Lineage 
Katz et at., (1979) showed that LC originate from bone marrow. The 
transplantation of parental skin to Fl hybrid mice showed that the majority of 
the LC present in the graft were from recipient origin, whereas the 
keratinocytes were from donor origin. This was supported conclusively by 
Perreault, (1984) who showed that after the transplantation of human bone 
marrow from a male to a female, Y chromosome positive LC were found in the 
skin. 
It is now generally accepted that LC precursors migrate from the bone 
marrow to the skin, via the bloodstream as CD1a+ cells have been found in 
peripheral blood (Wood et al, 1984). Further evidence for the migration of 
precursors into the skin has been provided using a monoclonal antibody (mAb), 
4F7. This labels dendritic cells in the mouse epidermis having phenotypic and 
functional properties in common with the LC yet they lack Birbeck granules. 
When mouse skin was treated with dinitrofluorobenzene (DNFB), an increase 
in the number of these cells (some exhibiting Birbeck granules) was found in 
the epidermis (Kolde et al., 1992). This suggests these cells represent 
immature LC that have migrated via the peripheral blood to the epidermis. 
Indeed it has been demonstrated that DC can be generated from peripheral 
blood mononuclear cells (PBMC)(Romani et al., 1994). Although Katz et al, 
(1979) and Perreault (1984) have shown that LC were continuously replaced in 
the skin from the precursor pool, it has been observed that LC in the skin can 
replicate, albeit slowly (Czernielewski and Demarchez, 1987). The speed at 
which this occurs is approximately half that of keratinocytes. These results are 
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supported by Kanitakis et al., (1993) whose EM studies have shown LC 
undergoing mitosis in human skin. 
It has also been suggested that LC precursors are of monocyte origin 
(Katz etal., 1979), due to similar expression of cell surface markers. However, 
the point at which the lineages of LC, monocytes and other dendritic cells 
diverge is still not clear. It is however possible that that they are cells of the 
same phenotype with the differences being associated with location 
(Bergstresser et al., 1992). This contention is supported by evidence showing 
that various cytokines can induce differentiation of monocytes into DC including 
interleukin (IL)-4 and interferon y (IFNy) (Xu et a/, 1995), IL-4 and 
granulocyte/monocyte-colony stimulating factor (GM-CSF) (Porcelli et al., 
1992). CD34 + progenitor cells can also be induced to become DC after 
stimulation with tumour necrosis factor-a (TNFa) and GM-CSF (Caux et al., 
1992). The resultant DC were shown to express Birbeck granules, 
characteristic of LC. CD4OL (Caux et al., 1994) and stem cell factor (SCF) 
(Young et al., 1995) have also been shown to play a role in DC maturation. 
Hence there are at least two possible sources for DC, from a colony forming 
unit DC within the bone marrow (Young et al., 1995) and the other from a 
monocyte origin. These "mixed" origins mean that DC and macrophages share 
many common markers, and are hard to separate on an individual phenotypic 
marker, reviewed by Peters etal., (1996). 
	
1.4.1.2 	Distribution 
LC are thought to be present in the epidermis of all mammals, while birds 
and reptiles lack them. They have been identified in the epidermis of man, the 
rhesus monkey, lorisidae, mice, guinea pigs, rats, rabbits, hamsters sheep and 
cows. However LC in pigs appear to lack Birbeck granules (reviewed by 
Breathnach et a/., 1991). LC appear in the mammalian stratified squamous 
epithelia, which includes epidermis, oral cavity, oesophagus, nasopharynx, 
conjunctiva and female genital and urinary tracts (Breathnach 1988). 
Furthermore migrating LC are found within the dermis, lymph nodes and 
lymphatic vessels draining the skin (Wolff and Stingl, 1983). 
In sections of skin, LC occupy a suprabasal position in rodents and a 
basal position in the human epidermis. LC make up between 2-4% of 
epidermal cells (Stingi et al., 1978a). LC cells in sheep are restricted to the 
basal layer of the epidermis and constitute about 10% of the cells in this layer 
of the epidermis (Hollis and Lyne, 1972). The density of LC per unit area has 
been reported to differ between species, with LC density in humans 460-1000 
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cells/mm2 (Rowden, 1981), guinea pigs 800-1000 cells/mm 2 (Wolff and 
Winkelmann, 1967b) and in mice the highest density recorded is 800 cells/mm 2 
(Bergstresser et al., 1980). There exists regional variation between different 
areas of the body in the species studied. Examination of human epidermal 
sheets have shown that in general the highest LC density is found on the face 
and neck (976 LC/mm2 ), while the trunk and limbs contain medium levels of LC 
(740 LC/mm2 and 640 LC/mm2 respectively) and relatively low numbers are 
found in palm and sole skin (189 LC/mm 2) (Chen et al., 1985). Ashworth et al. 
(1986) found no significant difference in LC numbers in vertical sections of 
limbs, the face and the trunk skin but found significantly lower numbers of LC in 
the vertical sections of the sole and palm skin. The highest densities of LC in 
mice are found on the back and footpads whilst the lowest is present in the tail 
(Bergstresser et al., 1980). 
The LC count in normal skin may vary widely from individual to individual 
(Horton et al., 1984) and in humans LC density decreases with age (Gilchrest 
et al., 1982). LC enumeration of vertical sections can be expressed in a variety 
of ways such as LC/20 high power fields, LC/mm epidermal surface, LC/mm 
length of basement membrane, LC/200 basal cells, LC/mm2 of epidermal 
section (Bieber etal., 1988). The different enumeration methods and markers 
used to identify LC population in vertical sections leads to variable results and 
these can often be contradictory (Bieber et al., 1988). For these reasons 
epidermal sheets are a more ideal way to enumerate LC in the skin. 
1.4.1.3 	Ultrastructure 
In the skin, LC possess a highly dendritic morphology. Sensitive 
immunolabelling techniques have shown branched dendrites extending in three 
dimensions, allowing one LC to cover a large area. LC are recognisable under 
the electron microscope (EM) they have folded nuclei, lack desmosomes, 
tonofilaments, premelanosomes and melanosomes. The Birbeck granule is a 
unique marker for LC and is regarded as the definitive morphological feature 
seen under the EM (Hanau et al., 1987). 
Birbeck granules appear as rod shaped structures of variable length with 
a central periodically striated lamella. When studied in ultrathin sections the 
rods appear tennis racket shaped due to their opening into a bleb at one side 
(Schuler et al., 1991). The Birbeck granule has been shown to be derived from 
the invagination of the cytomembrane (Takahazi and Hashimoto, 1985, 
Takigawa et al., 1985) and granule is thought to be derived from the 
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endocytosis of the T6 antigen (Hanau et al., 1987). Cells with the same 
characteristics as LC but lacking the Birbeck granule, are named indeterminate 
cells, serial sectioning of these indeterminate cells often reveals the presence 
of the Birbeck granule in cells that would otherwise be classified as 
indeterminate cells (Tamaki etal., 1979). Some indeterminate cells have been 
shown to react with a monoclonal antibody to CD1c (Murphy et al., 1985). It 
has been proposed that these cells are in fact precursors of LC (Breathnach, 
1991). 
The numbers of Birbeck granules appear to bear no reflection on whether 
the LC is undergoing mitosis, as the granules have been found to be common 
(Konrad and Hongismann, 1973) and uncommon (Kanerva et al., 1983) in this 
state. However, LC lose the Birbeck granule when they are cultured and is 
thought to provide evidence for maturation into lymphoid DC (Romani et al., 
1989, Teunissen et al., 1990, Richters et al., 1993). Normally only a small 
percentage of interdigitating cells have the granule (Kamperdijk et al., 1978). 
However, an increase in Birbeck granule positive lymph node has been 
reported after immune stimulation (Kamperdijk et al., 1985). This is thought to 
represent the migration of LC from the skin to the lymph node. 
1.4.1.4 	Phenotype of Resident and Freshly Isolated LC 
The phenotype of LC are varied and often dependant on the state in 
which they are isolated from tissue. They encompass a wide variety of markers 
expressed by other cell populations including B cells, T cells and especially 
those of the monocyte/macrophage lineage. Extensive studies in humans and 
mice and to a lesser extent in rats, rhesus monkeys and sheep reveal that the 
expression of surface molecules on LC varies from species to species. LC 
undergo profound changes in phenotype when cultured (Romani et al., 1989) 
and this is thought to reflect their maturation into interdigitating cells. This is 
discussed in greater detail in the next section. 
Like all bone marrow derived cells, LC express the CD45 common 
leucocyte antigen (Wood et al., 1984). They also express MHC I as do all 
nucleated cells (Bronstein etal., 1983). MHC II is expressed by LC (Rowden 
et al., 1977, Klareskog etal., 1977) including HLA-DR, HLA-DQ and HLA-DP 
(Sonthiemer et al., 1986). LC appear the only cells to constitutively express 
MHC II in normal epidermis. Accordingly MHC II is able to be used as a 
reliable marker for the LC population in skin and expression of MHC II is 
essential in the presentation of antigen to T cells (Unanue et al., 1984). 
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LC are positive for a marker of thymocytes, CD1a (Fithian et al., 1981) 
and given that no other cell type in the epidermis is positive for this marker, it 
has become the most reliable marker for LC (reviewed by Romani et al ., 1991). 
CD1b does not appear to be expressed by LC in the epidermis (Furue etal., 
1992, Meunier et al., 1993, Richters et al., 1995). LC in the epidermis are also 
positive for CD1c, however murine homologues of the CD1 group of antigens 
are less well defined. Possible candidates in the murine system, were the Tla 
group of antigens but data suggests that this is not the case (reviewed by 
Romani etal., 1991). A sheep homologue, which stains LC in epidermis has 
been identified and designated SBU-T6 (Mackay et al., 1985). Another marker 
of T cells that is expressed on human LC is the CD4 molecule (Wood et al., 
1983, Groh et al., 1986) which is up-regulated during inflammatory reactions 
(Groh etal., 1986). CD4 expression is not observed on murine LC (Witmer et 
al., 1988). The functional significance of the expression of this T cell marker by 
LC is not known. CD4 expression by LC renders the cells susceptible to 
infection by HIV (Tschachler etal., 1987). 
The close lineage of monocyte/macrophages and LC is evident by the LC 
expression of many so called macrophage specific adhesion markers, including 
complement binding molecules CD11b (Mac-1 (mouse)) and CD11c (gp 
190,95) and the 13 chain CD18 (De Panfilis et al., 1989). However, while the 
expression of CD11c appears to be substantial, the expression of CD11b is 
very low. LC also appear to be weakly positive/negative for CD11a (LEA-1) 
(Romani et al., 1989). LC are negative for CD14 (Romani et al., 1989) though 
reports suggest that some LC present in the nasal associated lymphoid tissue 
co-express both CD1a and CD14 (Graeme-Cook etal., 1993). LC express the 
cytoplasmic markers non-specific esterase (Romani et al., 1989) and 
myleoperoxidase (Dubertret et al., 1982) which are two typical macrophage 
markers. The only monoclonal antibody so far developed which exhibits 
exclusive specificity to LC, binds to the LAG antigen, which is a glycoprotein 
associated with the Birbeck granule in human LC (Kashihara, etal., 1986). 
LC also express some other enzymatic and protein markers including 
adenosine triphosphatase (ATPase) which was one of the earliest reliable 
markers of LC discovered (Wolff and Winkelmann, 1967) and has been used 
extensively. However, Zelickson and Mottaz (1968), in Zelickson and Mottaz, 
1970) found that keratinocytes and melanocytes may be reactive to ATPase 
staining and that some LC were negative. Sheep LC express 
acetylcholinesterase (AchE) (Lyne and Chase, 1966) and this was confirmed 
9 
by Hollis et al., (1972) and more recently by Townsend et al., (1997). 
Townsend's recent study suggests that in sheep AchE is more sensitive marker 
of LC than either MHC ll or CD1. Another protein marker 8100 is expressed 
intracellularly by LC in the skin however, it is also found in nerve cells, 
melanocytes and dermal dendritic cells within the skin which reduces its use as 
an LC marker (Cocchia etal., 1981). 
LC resident in the epidermis express few adhesion molecules however 
there exist some notable exceptions for example, LC have been shown to 
express the 131 sub unit of the very late antigen (VLA) group of adhesion 
molecules (Le Varlet et al., 1991). The same group have shown that sub-
populations of LC present in the skin express the a chains of the VLA adhesion 
molecules, VLA-1 (40%), VLA-2 (53%), VLA-3 (40%), VLA-4 (67%), VLA-5 
(77%) and VLA-6 (90%). Many of these a chains are receptors for extracellular 
proteins such as collagen (VLA-1, VLA-2, VLA-3) fibronectin (VLA-3, VLA-4 
and VLA-5) and laminin (VLA-6). VLA-2 and VLA-3 may allow the LC to attach 
to neighbouring keratinocytes, while VLA-6 and to a lesser extent VLA-1 may 
permit LC to attach to and migrate through the basal membrane. Furthermore 
VLA- 3 and VLA-5 may facilitate the migration of LC through the fibronectin 
network of the dermis (Le Varlet etal., 1991). 
LC also weakly express sialyl Lewis X which is a ligand for E-selectin 
expressed on endothelial cells (Ross et al., 1994). The mAb HECA-452 which 
recognises a neuraminidase sensitive determinant on sialyl Lewis x has also 
been shown to react with LC (Koszik et al., 1994). The localisation of skin 
specific memory T cells is thought to be mediated by adhesion to E-Selectin 
(Berg et al., 1991, Picker et al., 1993, Norris et al., 1991), suggesting that 
perhaps the migration of LC precursor could also be mediated via this 
interaction. LC are shown to strongly express E-cadherin which has been 
shown in vitro to facilitate LC-keratinocyte binding (Blauvelt etal., 1995). 
While LC express the immunoglobulin receptor FcyRII in both the human 
and murine skin they do not express FcyRI or FCyRIII (Romani et al., 1989). 
LC in normal human skin also express both the high affinity receptor for IgE, 
FceRI (Bieber et al., 1992a, Wang et al., 1992) and the low affinity receptor, 
FceRII (Bieber et al., 1989). However, the latterreceptor is not expressed on 
murine LC even after stimulation with IL-4 a known inducer of FceR expression 
(Hertl et al., 1996). These receptors are thought to play a role in skin disorders 
such as atopic dermatitis. 
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40% of LC within the human epidermis have been shown to weakly 
express the CD40 antigen (Romani et al., 1989) while 100% of HLA-DR 
positive, freshly isolated LC express the CD40 molecule (Peguet-Navarro et al., 
1995). LC have also been shown to express the CD69 molecule which is an 
early activation marker of lymphocytes though the significance of this is 
unknown (Bieber et al., 1992b). 
Freshly isolated LC from both human (Symington etal., 1993) and murine 
(Razi-Wolf et al., 1994) skin appear to lack expression of B7 molecules. 
Supporting this is a study by Yokozeki et al., (1996), who could find no 
evidence in human skin of either CD80 (B7-1) or CD86 (B7-2) expression on 
LC. These molecules are arguably the most important for DC stimulation of T 
cells. This lack of expression suggests that LC within the skin would be poor 
stimulators of T cells via the CD281B7 interaction. Freshly isolated LC also 
only weakly express LFA-3 and ICAM11 which are adhesion molecules that 
play critical roles in APC adhesion to T cells, via CD2 and LFA-1 respectively 
(Teunissen et al., 1990). Low expression of LFA-1 is seen on both human 
(Perry et al., 1992) and murine LC (Simon et al., 1993) in the skin. 
Larrengina et al., (1996) conducted an extensive study of cytokine 
receptor expression by both fresh and cultured LC. This group found that 
freshly isolated LC express various cytokine receptors, including the weak 
expression of IL-1 receptor 1 and strong expression of IL-1 receptor 2 The 
latter has been shown to be non functional and possibly acts as a trap for 
exogenous IL-1 (Colotta et al., 1993). All LC expressed the 75kd receptor for 
TNFa, while none of the cells expressed the 55kd receptor. 67% of LC were 
found to express the IFNy receptor. Although no LC expressed receptors for 
M-CSF, G-CSF, 15% expressed the 3 chain for the GM-CSF receptor and 80% 
expressed the a chain. The expression of the IL-6 receptor was seen in 30% of 
LC while 27% expressed GP 130, the receptor's signal transducing element. 
Fresh LC were negative for the a and 13  chains of the IL-2 receptor, as well as 
IL-4, IL-7 and IL-8 receptors. 
1.4.1.5 Maturation of LC in Culture 
After culturing LC undergo a dramatic change in phenotype until they 
closely resemble lymphoid dendritic cells (Romani et al., 1989, Teunissen et 
al., 1990). This is reflected by a 30 fold increase in their ability to stimulate T 
cells (Schuler and Steinman, 1985). This increased functional capacity is due 
in part to a dramatic increase in MHC ll expression (Romani et al., 1989). A 
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nine fold increase in expression of HLA-DR , a three fold increase for HLA-DQ 
and a five fold increase for HLA-DP have been reported (Teunissen et al., 
1990). B7-1 and B7-2 molecules appear on the surface of cultured LC 
(Yokozeki etal., 1996). The addition of mAbs against these molecules reduces 
the cultured LC ability to stimulate T cells by 81% and 29% respectively and 
87% when combined, thus demonstrating the relative importance of 67 
molecules to antigen presenting cell function. Increases are also seen in MHC 
I expression (Teunissen et a/., 1990). The expression of ICAM-1 by LC 
increases after culturing (Cumberbatch et al., 1992), as does LFA-3 
(Teunissen et al., 1990) which would increase the ability of the LC to bind to 
and therefore, stimulate T cells. 
The expression of various markers of LC have been shown to be 
decreased during culture including the loss of ATPase and non-specific 
esterase activity (Romani etal., 1989). CD1a and CD1c expression have both 
been shown to be markedly decreased or lost after culturing (Teunissen et al., 
1990). Further, the reactivity of LC with various macrophage markers such 
CD11b and CD11c, (Teunissen et al., 1990) is lost as is expression of the 
FCyRII (Romani et al., 1989, Teunissen et al., 1990). As mentioned earlier 
remodelling of the antigenic profile of LC means that they resemble the 
interdigitating cells found within the lymph node. 
E-cadherin which is thought to mediate LC-keratinocyte adherence, is 
also down-regulated during culture which would be expected to facilitate LC 
migration from the epidermis (Borkowski et al., 1994). The contact allergen 
2,4,6-trinitrochlorobenzene (TNCB) and the cytokine TNFa enhance LC 
migration from the epidermis with down-regulation of E-cadherin expression 
(Schwarzenberger and Udey, 1996). This led the authors to propose that down 
modulation of E-cadherin expression occurs as a consequence of local 
cytokine production, facilitating LC emigration and the initiation of immune 
responses against antigens encountered in epidermis. In contrast sialyl Lewis 
X which mediates binding to endothelial cells is up-regulated upon LC culture 
(Ross et al., 1994). This was thought to increase LC binding to L-selectin 
expressed by T cells within the lymph nodes, as well as facilitating the binding 
of LC to the draining lymphatics, which express P-selectin (Ross et al., 1994). 
Changes in cytokine receptors are also seen after the culturing of LC. The 
a and 3 chain of GM-CSF are up-regulated as is IL-1 receptor 2, the a and 13 
chains of IL-2 receptor, the IL-6 receptor and gp130. The IL-1 receptor 1 and 
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the 75 kD TNFa receptor are down-regulated whilst the IFNy receptor 
expression was unaltered (Larregina etal., 1996). 
1.4.1.6 	LC Function 
Silberberg-Sinakin et al., (1976) noted that increased numbers of LC with 
bound ferritin appeared in the draining lymph node (DLN) in sensitised animals. 
The LC were seen in direct apposition to the T cells, which led the authors to 
conclude that LC were presenting antigen to the T cells. Stingl etal., (1978b) 
showed the LC like monocytes/macrophages were able to induce a proliferative 
response in immune T cells. They were also able to act as effective stimulators 
of the mixed leucocyte reaction (MLR). The LC was the only cell in the 
epidermis able to mediate this function. 
LC are also able to act as antigen presenting cells for chemical haptens 
(Nishioka, 1985, Shimada etal., 1987). Furthermore the ability of LC to present 
nickel has also been shown (Braathen et al., 1980). In addition to stimulating T 
cells hapten modified LC are able to induce cytotoxic T lymphocytes (CTL) 
(Pehamberger et al., 1983, Tsuchida et al., 1984). MHC II expression by LC 
was a requirement for this to happen. However, Shimada and Katz, (1988) 
found that trinitrophenol (TNP) modified epidermal cells, depleted of LC were 
able to induce equal proliferative responses in TNP specific CTL, a secondary 
immune response. Since CTL are CD8 positive and need antigens expressed 
in association with MHC I this was an expected result. 
Schuler and Steinman (1985), and Inaba et a/., (1986) were also able to 
show that cultured LC were far more efficient at stimulating MLR than fresh LC. 
This once again shows the importance of the phenotypic changes LC undergo 
during culture. Fresh LC were found to be good stimulators of secondary MLR 
but not of primary MLR's. This may reflect the lack of expression of the B7-2 
molecule, which appears to be important for the generation of primary T cell 
responses (reviewed by Lenschow et a/., 1996). The culture of LC with 
allogeneic T cells results in the generation of MHC II restricted T helper cells 
(Inaba et al., 1986). However, this can also result in the generation of CTL 
(Faure etal., 1984). LC can act as accessory cells for CD4 (MHC II restricted) 
T cells which, in turn, can stimulate a T cell dependent antibody response 
(Inaba etal., 1986). 
As well as being able to present haptens and alloantigens to T cells, LC 
can present antigens such as haptens, alloantigens, microbial antigens and 
tumour antigens, which can be derived from other epidermal cells such as 
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keratinocytes and melanocytes (reviewed by Stingl and Shevach, 1991). LC 
have been shown to present cellular antigens such as xenogenic red blood 
cells (Halliday and Muller, 1987) and are also capable of presenting viral 
antigens, including HIV (Girolomoni et al., 1996). LC are primarily active in 
capturing foreign antigenic material present in the skin and presenting it to 
MHC II restricted T cells resulting in clonal expansion of the relevant T cells 
(Kapensberg et al., 1989). For example it has been demonstrated that LC in 
mouse skin can internalise Leishmania major, transport it to the lymph node 
and generate a specific T cell response including activation of unprimed T cells 
(Moll et al., 1993). LC can also induce contrasuppression which overcomes 
suppressor cell activity (Flood etal., 1991). 
Efficient antigen presentation, via MHC ll on LC requires efficient 
ingestion, processing and re-expression of the antigen. LC, DC and veiled 
cells were until recently thought to be non-phagocytic although there existed 
various contradictory reports. A definitive study has shown LC can 
phagocytose particles from 0.5-6 p.m, including zymosan particles, latex beads, 
microbes including S. aures and C. parvum (Sousa et al., 1993) albeit the 
phagocytosis of complement and immunoglobulin (Ig) coated sheep red blood 
cells (SRBC) was not seen. However the ability to ingest C. pan/urn was 
markedly increased after incubation with mouse serum, thus suggesting that Fc 
or complement receptors play a role. The uptake of zymosan was partially 
mediated by mannose receptors on LC and these appear to concentrate macro-
molecules in MHC II compartments and maximise the capacity of DC to present 
non-self antigens (Sallusto et al., 1995). The majority of antigen is thought to 
be taken in by macropinocytosis, which occurs during the formation of ruffles in 
the membrane. Although it was thought that DC projections and veils were used 
to contact T cells they may also be used for macropinocytosis (Steinman and 
Swanson, 1995). 
Sousa etal., (1993) also demonstrated that cultured LC were not able to 
phagocytose and during culture LC lose the ability to process soluble antigens 
(Steinman et al., 1991). The rate of MHC ll synthesis drops, as does 
expression of the invariant chain which is required for efficient processing of 
exogenous antigen for re-expression in association with MHC ll (Pure et al., 
1990). In addition the loss of acidic organelles which are required for efficient 
antigen processing also occurs (Stoessel., etal., 1990). This loss of the ability 
to process fresh antigen after culture is thought to represent the LC changing 
role from acting as a sentinel in the epidermis, were it is able to process 
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antigens in the environment, to that of an antigen presenting role, were they 
can present antigens they have gathered before being induced to migrate, to T 
cells within the draining lymph node (Ibrahim et a/., 1995). 
The presence of MHC II alone is not sufficient to induce sustained 
proliferation of T cells (Dalme et al., 1992) and lack of further co-stimulatory 
signals may lead to the generation of T cell unresponsiveness (Weaver and 
Unanue, 1990). The cytokine IL-1 was originally proposed as the co-stimulator 
molecule and with the finding that IL-1 was present in enriched LC culture 
suggesting that the LC were able to provide co-stimulation (Sauder et al., 
1984). Since this result LC have been shown to produce IL-18 (Enk and Katz et 
a/., 1992). The presence of the interleukin 1 converting enzyme (ICE) has also 
been demonstrated in murine LC, which is essential for the production of 
functional IL-1p, and LC are the primary source of this cytokine within the 
epidermis (Ariizumi etal., 1995). The production of IL-113 by LC is thought to 
play an essential role in the generation of immune responses in the skin (Enk 
et a/., 1993). TCR stimulation together with the addition of IL-1 has been 
known to induce the proliferation of Th2 clones which has been shown to be 
independent of IL-4. This finding suggested that APC might be able to directly 
stimulate Th2 type responses (Huber et al., 1996). 
The cytokine IL-12 has recently been shown to play an important role in 
the generation of Th1 responses (Seder et al., 1993) and is produced by 
activated macrophages, B cells (D'Andrea et al., 1992), DC (Macatonia et al., 
1995, Heufler etal., 1996) and most recently, by LC (Kang etal., 1996). CD1a 
positive dendritic lymph cells, which are derived from LC, are also capable IL-
12 of production (Yawalkar etal., 1996a). IL-12 is able to stimulate the T cells 
to secrete IFNy and thus leads to the generation of Th1 responses (Seder et 
al., 1993). IL-12 is also thought to induce proliferation of the Th1 cells but not 
that of Th2 or Th0 (Kennedy et al., 1994) and inhibit differentiation of T cells 
into the Th2 subtype (McKnight etal., 1994). The ability of LC to produce IL-12 
and therefore direct T cells to produce IFNy without addition of exogenous IL-
12, anti-IL-4 or microbes, suggests that stimulation of Th1 responses is a major 
role for this cell (Heufler et al., 1996). 
The interaction between T cells and DC is not in one direction as MHC II 
interaction with the TCR and CD40 ligation on the dendritic cell causes 
increased production of IL-12 by the DC, in turn resulting in the induction of 
additional IFNy production by T cells (Koch et al., 1996, Cella et al., 1996). 
CD40 ligation on DC also up-regulates the production of MHC II, B7-1, B7-2, 
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and LFA-3 (Caux et al., 1994). It has been shown to also enhance DC viability 
and in contrast to the above results, up-regulated ICAM-1 and B7-2 but not 
HLA-DR, CD1a, CD58, and B7-1 (Peguet-Navarro etal., 1995). Accordingly it 
is important to remember that LC/DC-T cell interaction is one where both cell 
types derive signals from each other which influence their functional 
capabilities. 
LC express adhesion molecules, some of which are thought to provide co-
stimulatory signals, which increase T cell proliferation. These include ICAM-1, 
LFA-3 members of the VCAM family (Dalme et al., 1992). The most important 
co-stimulatory signal provided by a cell surface molecule, apart from 
MHCiTCR engagement, is that provided the B7 family of molecules. The B7 
family binds to both the CD28 receptor and the CTLA-4 receptor on T cells and 
the interaction between B7-1 (CD80), B7-2 (CD86) and CD28 is thought to be a 
crucial event in T cell stimulation. A third molecule has also been identified, 
B7-3 (Boussiotis et al., 1993) although its role is clear. As previously 
discussed LC are negative for B7-1 and B7-2 when freshly isolated from skin 
but are able to dramatically up-regulate this after culture or by the addition of 
cytokines (Chang et al., 1995). 
CD28 and CTLA-4, are two counter receptors which are expressed by T 
cells and showed only 31% homology, although CTLA-4 is highly conserved 
between species (>70% homology) (Lindsten etal., 1993). CD28 is expressed 
by the majority of T cells, whilst CTLA-4 is expressed by activated T cells 
(Freeman etal., 1992). The distinct cytoplasmic domains of these receptors as 
well as their distribution suggests that they have non-overlapping roles in 
signal transduction. It is likely that B7-1, or B7-2 binding to CD28, may be the 
essential T cell co-stimulatory signal (reviewed by June et al., 1994). T cells 
lacking CD28 could initiate but not sustain an in vitro antigen specific response 
(Lucas et al., 1995). CTLA-4 crosslinking seems to inhibit T cell proliferation 
and IL-2 secretion which are strongly induced by the B71CD28 interaction 
(Krummel et al., 1995). CTLA-4 has also been shown to induce antigen 
specific apoptosis in T cells (Gribben et al., 1995). B7/CTLA-4 and B7/CD28 
interactions have been shown to enhance T cell proliferation and are key 
control points in the activation of T cells (Lindsey et al., 1995). The interaction 
of B7/CD28 has been shown to protect T cells from apoptosis (Boise et al., 
1995). B7-2 expression by LC has been shown to play a potent role in the 
induction of contact hypersensitivity (CHS) and was found to be specifically up-
regulated after antigen stimulation, (Nuriya et al., 1996) while treatment with 
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anti-B7-2 mAb resulted in contact allergen specific unresponsiveness. 87-1 
was shown not to play a role in the induction of CHS, while neither molecule 
influenced the effector phase of such responses. 
The two co-stimulatory pathways of the B7 family and IL-12 do not act in 
total isolation from one another, with IL-12 shown to act synergistically with 
CD281B7 interaction, inducing efficient cytokine production and proliferation of 
T cells (Kubin et al., 1994, Murphy et a/., 1994). The proliferation of Th1 cells 
seems to require both B7/CD28 and IL-12 to be present (Macatonia et al., 
1995). 
Janeway, (1992) expanded theories describing how the immune system 
discriminates between self and non-self to include details of how the innate 
immune system has developed broad spectrum receptors against molecules 
expressed by pathogenic agents, including lipopolysaccharide (LPS), mannans 
and glycans, which induce the APC to express signals (co-stimulators) to 
activate T cells. Thus the LC in the skin is acting as a sentinel waiting for such 
an interaction to stimulate it to migrate to the DLN. This idea of DC acting as 
an immunosurveillance mechanism has been further expanded by Ibrahim et 
al., (1995) who proposed that APC are also stimulated by microenvironmental 
tissue damage, stating that the signals may include free radicals, cytokines, 
complement and extracellular matrix degradation products. Release of these 
products by necrotic cells would stimulate the APC whereas cell death by 
apoptotis would limit this response. The response of DC to cellular damage is 
similar to that of "danger" stimulating APC proposed by Matzinger (1994) who 
argued against self and non-self discrimination by the immune system and 
proposes instead a "danger" signal. 
The LC has many abilities which allow it to become an efficient initiator 
and stimulator of immune responses. These include; expression of MHC II, 
complement and Fc receptors, the ability to ingest and process antigen and to 
subsequently migrate to the DLN carrying the processed antigens. Importantly 
on arrival in the DLN, the LC undergoes a maturation step, with up-regulation 
of B7-1, B7-2 and various adhesion/co-stimulatory molecules. This taken 
together with the LC ability to secrete the potent T cell stimulatory cytokines IL-
113 and IL-12, gives the LC the ability to act as a supremely efficient 
"professional" antigen presenting cell. 
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1.4.1.7 	Migration and Relationship Between LC, Afferent Lymph DC, 
Veiled Cells and Lymph Node DC 
The presence of microfilaments and a prominent system of microtubules 
in LC suggest that these cells are capable of movement. Tissue culture 
experiments have shown that LC are capable of active pseudopodial movement 
using dendrites that are capable of extending and contracting (Thorbecke et al., 
1980). It has been postulated that LC act upon a "signal" where they are 
induced to migrate from the epidermis via the dermis into the draining 
lymphatics and from there to the lymph node. Three main methods have been 
used to study LC migrating from the skin, cannulation of lymphatics, the use of 
dyes painted on the skin to track LC in the lymph nodes and the use of skin 
explants. The direct cannulation of lymphatics is generally not practicable due 
to their small size. However the generation and cannulation of pseudoafferent 
lymphatics has been used in ruminants allowing the collection of large numbers 
of DC (Hopkins et al., 1985). The cellular composition of these vessels is 
similar to true afferent lymph and contains 1-10% MHC II + DC (Hopkins et al., 
1985, Hein et al., 1987, Bujdoso etal., 1989). A small number of studies have 
been performed by cannulation of human lymphatics vessels. The use of 
fluorescent dyes such as fluorescein isothiocyanate (FITC) have been used to 
track LC from the skin to the lymph node particularly in the murine model. In 
addition a number of studies have used human skin explants, were LC residing 
in the epidermis are seen to migrate via the dermis into culture media in the 
skin. This has been used to study the phenotypic changes that occur during 
this process (Richters etal., 1993, Richters etal., 1995). 
Interdigitating cells are found in the T cell areas of the lymph node, and 
are the classical antigen-presenting cells of MHC restricted responses. Human 
LC and interdigitating cells have very similar phenotypes, including CD4 and 
CD1 expression (Ralfkiaer etal., 1984). lmmunostaining experiments using the 
monoclonal antibody NLDC-145, which reacts with LC, veiled cells and 
interdigitating cells but not other follicular DC (Kraal et aL, 1986), have been 
used to suggest that interdigitating cells are derived from veiled cells 
(Breathnach, 1991). The presence of the Birbeck granule is also seen in these 
two cell types (Silberberg-Sinakin et al., 1976). The presence of the Birbeck 
granule (Hoefsmit, 1982) and E-Cadherin (Borkowski et al., 1994), which are 
both expressed on LC, is only seen in lymph node dendritic cells (LNDC) 
draining the skin. Afferent lymph veiled cells and LNDC have been shown to 
be associated with antigen after cutaneous sensitisation (Lens et a/., 1983, 
Macatonia et al., 1987). The application of antigen increases the number of 
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DC in the draining lymph node in a dose dependent manner (Macatonia et al., 
1986). It has also been shown that pseudoafferent lymph DC migrating from 
the site of an intradermal injection of antigen are able to stimulate a significant 
proliferative response in antigen specific T cells when compared to control cells 
(Bujdoso et al., 1989). Furthermore, through the use of the pseudoafferent 
model in sheep, enhanced migration of LC from the skin has been seen after 
application of the contact sensitiser TNCB as well as in response to chemical 
carcinogens such as 7,12 dimethylbenz(a)anthracene (DMBA), (Dandie et al., 
1994) benzo(a)pyrene (BP) and to the tumour promoter 
12-o-tetradecanoylphorbol-13-acetate (TPA) (Ragg et al., 1994). Increased 
numbers of Birbeck granule positive LNDC are also evident after antigen 
treatment of the skin (Silberberg-Sinakin et al., 1976). The treatment of the 
skin with ultraviolet light has been shown to cause increased migration of LC to 
the draining lymph node (Moodycliffe et al., 1994) (see section 1.4.6.5) 
Increased numbers of LC are also seen in lymph from human skin after 
application of the irritant, sodium lauryl sulphate (SLS) (Brand et al., 1995). In 
an in vitro model, using a reconstituted basement membrane invasion assay, 
the treatment of LC with hapten (TNBS or FITC) was able to induce migration 
through the membrane to a dermal fibroblast culture medium (Kobayashi et al., 
1994). However, in contrast to the in vivo studies of Brand et al., (1995), SLS 
did not appear to induce migration. This was possibly due to the lack of a local 
release of cytokines by keratinocytes which are absent from this in vitro model. 
Indeed some cytokines have been proposed as stimulators of LC migration with 
the most likely candidates being TNFa (Cumberbatch and Kimber, 1992) and 
IL-10 (Cumberbatch et al., 1997) though their exact role is not yet fully 
understood. 
Chemokines are a family of pro-inflammatory and chemotactile cytokines 
with characteristic four cysteine residues. They are divided into two sub-
families, C-C (which have two linked cysteine bonds) and C-X-C (which have 
two linked cysteine bonds separated by an amino acid) (Tizard, 1995). DC 
have been recently shown to migrate in response to a set of chemokines 
distinct from that of monocytes/macrophages. Exposure of DC to the C-C 
chemokines, monocyte chemotactic protein (MCP)-3, macrophage inflammatory 
protein-1a and RANTES (an acronym for a protein which is, regulated upon 
activation, normal T cell expressed and secreted) caused a chemotactic 
response and a rise in the intracellular calcium levels. In contrast, the C-X-C 
chemokines, IL-8 and IP-10 and the C-C chemokines, MCP-1 and MCP-2 were 
inactive as chemoattractants for DC (Sozzani et al., 1995). Nakamura et al.-, 
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(1995) found that using a transgenic mouse model in which keratinocytes 
expressed MCP-1, the epidermis did not contain substantially more LC, 
suggesting that sites for LC in the epidermis were near saturated normally. 
Although Sozzani's study would suggest that perhaps LC are unresponsive to 
MCP-1. Accordingly the role of chemokines in the migration of LC remains 
uncertain. 
The signal for LC migration from the epidermis seems to be mediated by 
protein kinase C (PKC) as the addition of an analogue of diacylglycerol, L-a-
dioctanoyl glycerol (a physiological activator of PKC) applied on the skin of 
mice, depleted le cells from the epidermis and increased the numbers of FITC 
positive cells in the lymph node after topical treatment with FITC(Halliday and 
Lucas, 1993). Further evidence supporting the hypothesis that PKC is the 
mediator of the migration signals comes from experiments where the addition of 
the PKC inhibitors, palmitoyl-DL-carnitine chloride or D-sphingosine were 
shown to block LC migration in response to TNCB (Halliday and Lucas, 1993). 
In summary, LC are a population of cells that migrate carrying antigen 
from the skin to the draining lymph node via the dermis. They can be 
visualised in transit as veiled cells and in the lymph node as interdigitating 
cells. A variety of stimuli includes haptens, antigens, UV light which induce 
inflammation producing cytokines and perhaps chemokines. These signals 
subsequently induce the LC to migrate to the DLN. 
1.4.1.8 	Summary 
The LC is a bone marrow derived cell which forms a network in the 
epidermis. LC express a wide variety of immunological markers many of which 
are in common with cells of the myeloid lineage. However under normal 
circumstances, it is the only MHC II or CD1 expressing cell in the epidermis. 
LC can take up and process antigens in the skin and re-expresses them in 
association with MHC II. The LC can be stimulated to migrate to the draining 
lymph node by stimuli such as inflammation. Once in the lymph node the LC 
undergoes dramatic phenotypic changes to resemble a interdigitating cell, 
including up-regulation of expression of co-stimulator and adhesion molecules, 
thus enabling the stimulation of naive and immune T cells. In turn primary and 
secondary immune responses are stimulated. This process results ultimately in 
the production of effector cells including Th1 cells, Th2 cells, cytotoxic T cells 
or antibody producing plasma cells. These cells can then respond to foreign 
antigens present within the skin. Further, the ability of LC to induce and 
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stimulate CHS and delayed type hypersensitivity (DTH) responses antigens, 
reflects the LC crucial role in cutaneous immunity and immunosurveillance. 
1.4.2 	Keratinocytes 
Keratinocytes make up the majority of cells in the epidermis. They have 
tonofilaments which are joined to form tonofibrils and desmosomes, which are 
small interlocking cytoplasmic processes which maintain continuity between the 
keratinocytes. The major function of these cells is to produce the protein 
keratin which is found in the skin, nails and hair. The keratin produced is 
visible as granules which fill the cytoplasm of the keratinocyte, giving rise to a 
horny cell. These form the external protective layer of the epidermis. 
Keratinocytes also synthesise Vitamin D from sunlight and its pre-cursor 7- 
dehydrocholesterol (Hunter et al. 1989). 
Keratinocytes have been shown to play a role in lymphocyte maturation. 
Co-culture of keratinocytes with bone marrow cells has been shown to induce 
early markers of T cell maturation, including the Thy-1 antigen (Rubenfield et 
al., 1981). Similarly co-culture was able to induce increase maturation of 
human thymocytes and the induction of CD1, a thymocyte antigen in a mature 
leukemic cells lines (Chu et al., 1987). This antigen is normally expressed in 
the epidermis by LC and the induced expression may therefore be a reflection 
of the environment and not the maturity of the T cell. Generally, however, it 
appears the keratinocytes are able to induce further maturation of immature T 
cells in vitro. 
Keratinocytes secrete numerous cytokines constitutively, including IL-la, 
IL-113, IL-3, natural killer (NK) cell augmenting factor, IL-6, monocyte 
chemotaxis and activating factor, GM-CSF, macrophage-colony stimulating 
factor, hepatocyte stimulating factor, lymphocyte differentiating factor, 
thymopotein-like-factor and IFNa. Keratinocytes may be induced to secrete 
other cytokines such as IL-8 (stimulated by IL-1a and TNFa) and TNFa, which 
is expressed in response to UVB exposure and LPS (Matsue et al., 1992). 
Other cytokines secreted are transforming growth factor (TGF)-a, TGF-13 and 
platelet-derived growth factor (Ansel et al., 1990). The immunomodulatory 
cytokines produced by keratinocytes are thought to play a role in regulating the 
antigen presentation by LC (Grabbe et at, 1992) as well as other 
immunological events in the epidermis such as inflammation (Matsue et al., 
1992). 
Keratinocytes have been shown to constitutively express mRNA for both 
the p35 subunit of IL-12 and the p40 subunit (Aragane et al., 1994). Previously 
mRNA encoding the p40 subunit could only be detected in the epidermis after 
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skin was treated with contact allergen (but not irritants or tolerogens) (Muller et 
al., 1994). Importantly up-regulation by UVB of both has been shown in vitro 
and in vivo (Enk etal., 1996). 
Keratinocytes have been shown to express the MHC II molecule in 
disease states (Lampert etal., 1981) and may be induced to express MHC II 
on their surface by exposure to the cytokine IFNy (Gaspari et al., 1988a). 
Combined with the constitutive secretion of IL-1 (Ansel et al., 1990) this is 
suggestive of an involvement in antigen presentation, albeit this has not been 
conclusively demOnstrated. Gaspari et al., (1988a) has shown that MHC II + 
keratinocytes in mice were able to induce antigen specific unresponsiveness in 
hapten specific T helper 1 clones. The mice used were treated with 50,000 
units of IFNy per day for six days to induce MHC II expression by the 
keratinocytes (Gaspari et al., 1988b), possibly reflecting induction of MHC II 
expression induced by inflammation. MHC II expressing keratinocytes are able 
to support T cell proliferation following the stimulation of the T cells with 
superantigens or with CD3 monoclonal antibodies (Dalme et al., 1992). The 
cytokines produced by superantigen/keratinocyte stimulated T cells were IL-4, 
IL-5 and IL-10 but not IFNy (Goodman et al., 1994) suggestive of a Th2 like 
response as it is proposed the generation of a Th1 response requires the 
presence of the B7 group of co-stimulatory molecules (Nickoloff and Turka et 
al., 1994). 
Keratinocytes have been shown to react with the BB1 mAb (Nickloff et al., 
1993, Fleming et al., 1993), but not with mAbs, against B7-1 or the CTLA-4 
fusion protein which binds both B7-1 and B7-2 (Nickloff et al., 1993). The 
epitope recognised by this mAb has been designated B7-3 and appears to be a 
ligand for CD28. However the effects of this interaction are at this time 
unknown. B7/BB1 expression is found focally on keratinocytes in allergic 
contact dermatitis and lichen planus (Simon etal., 1993). The regulation of the 
expression of BB1 by keratinocytes is found to be mediated via a unique 
calcium mediated event in vitro. Furthermore, loss of BB-1 expression is 
triggered by increasing calcium (Nasir et al., 1995) but what this means in vivo 
is unknown. However the addition of mAb's against BB-1 did not reduce T cell 
proliferation and this is suggested to operate through other mechanisms such 
as the heat stable antigen or the invariant chain (Nickloff and Turka, 1994). 
Keratinocytes cannot therefore stimulate an allogeneic immune response 
normally. It has been hypothesised that this may be due to the lack of 
expression of the invariant chain and therefore alteration of antigen 
presentation by MHC II (Nickoloff and Turka, 1994). B7-1 transfected 
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keratinocytes have also been shown to stimulate an allogeneic immune 
response, albeit this was observed not to be very potent (Nick°loff etal., 1995). 
Contradicting the suggestion that lack of stimulation was due to lack of 
invariant chain expression, IFNy treated transfected keratinocytes, expressing 
B7-1 and B7-2, were able to generate a vigorous primary allogeneic T cell 
response (Vercauteren et al., 1995). Further the ability of keratinocytes to 
present mycobacterium leprae antigens to T cells (Mutis et a/., 1993), shows 
that MHC ll expressed on keratinocytes is functional. Therefore the inability to 
induce allogeneic responses is due to the lack of B7 expression (Otten et al., 
1996). The considerable weight of evidence is strongly suggestive that 
keratinocytes are "non professional" antigen presenting cells. 
Keratinocytes have been shown to mediate antigen specific tolerance 
(Gaspari etal., 1988), possibly through their lack of expression of B7-1 or B7-2 
(Nickoloff etal., 1995). Transgenic mice with B7-1 expression by keratinocytes 
were able to amplify the primary immune response to oxalozone (Williams et 
al., 1994). The ability of B7-1 transfected keratinocytes to stimulate an immune 
response is also supported by Nasir etal., (1994). 
Constitutive expression of another adhesion/co-stimulatory molecule, 
ICAM-1 is observed on keratinocytes in normal human skin (Lontani et al., 
1996) Higher levels of ICAM-1 can be induced in inflammatory disease (Singer 
et al., 1989) and its expression is increased by TNFa (Krutmann et al., 1990, 
Barker et al., 1990), IFNy treatment (Dustin et a/., 1988) or UV treatment 
(Krutmann etal., 1990). The ability of keratinocytes to respond to IFNIy by up-
regulation of ICAM-1 is progressively lost during differentiation (Little et al., 
1996). The ability of ICAM-1 to be induced by TNFa and UVR is highly 
variable from individual to individual (Middleton and Norris, 1995). 
Keratinocytes can also be induced to express the Fas antigen by IFNy 
treatment (Sayama etal., 1994). Addition of mAb against Fas, led to apoptosis 
in 32% of keratinocytes. 
Keratinocytes play an important role in the skin immune system due to 
their secretion of numerous cytokines and expression of immunological cell 
surface proteins, including adhesion and co-stimulatory molecules. This gives 
the keratinocyte the ability to influence the outcomes of immune responses in 
the skin. The keratinocyte acts as a "non-professional" antigen presenting cell 
due to its lack of expression of essential co-stimulators such as B7-1 or B7-2 
needed to induce primary immune responses. However, the production of both 
IL-12 and IL-10 indicates that the keratinocyte can directly influence the nature 
of the immune responses generated within the skin, thus determining whether it 
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is driven towards a Th1 or Th2 like response. Nickoloff and Turka, (1994) 
propose that the keratinocyte is able to induce active responses of the Th2 type 
which can be mistaken for anergy if Th1 functions are only examined. 
1.4.3 	yo T cells 
A population of dendritic cells, that were found to form a network within 
the murine epidermis were shown to express the Thy1 antigen. The Thy1 
antigen is mainly expressed in lymphocytes in the thymus (Bergstresser et al., 
1983, Tschaler etal., 1983). It was shown by Tschaler etal., (1983) that these 
Thy1 + dendritic cells contained a lobulated nucleus, dense cytoplasm, and 
abundant filaments, but did not contain keratin filaments, desmosomes, 
melanosomes, Birbeck granules or Merkel cell granules which separated them 
from other epidermal cells. It was proposed by Bergstresser etal., 1983) that 
these cells may be a population of intra-epidermal T cells and it was later 
shown by Breathnach etal., (1984) that these cells were derived from the bone 
marrow. Thy1 is thought to act as a signal transducing molecule and is shown 
to trigger a rise in intracellular calcium in transfected B cells and T cells 
(Kroczek et a/., 1986). Thy1 + dendritic cells were shown to express the y6 T 
cell receptor (TCR 1) Kuziel etal., 1987 as well as CD3, which is required for 
effective TCR signalling (Shimada et al., 1990b). Dendritic epidermal T cells 
(DETC) were found to express the V73/Jy1-Cy1 and Vo1/D.51/J62-Co genes 
almost exclusively, suggesting a limited repertoire of antigen recognition 
(Kuziel et al., 1987, Asarnow et al., 1988 Asarnow et al., 1989, Havran and 
Allison, 1990). Other subsets, such as V74, are present (Ota et al., 1992) and 
TCR ar3+ DETC have been identified in chimera studies and were found to be 
Thy1 + (Shiohara etal., 1993). DETC were shown not to express either CD4 or 
CD8 but did express CD45, reviewed by Bergstresser etal., (1993). y5 T cells 
in the intraepithelial cells of the intestine of the mouse (Goodman and Le 
Francois, 1988) and sheep (Gyorffy et al., 1992) and in human splenic 
sinuosoids have been shown to express CD8. The network of DETC which 
appear in the mouse epidermis appear not to be present in humans (Cooper et 
a/., 1985a). However, y6 T cells seem to be associated with the pathogenesis 
of various human diseases, including some that involve skin (reviewed by 
Bergstresser et al., 1993) and they also show a strong preference for the 
epidermis and papillary dermis in various disease sates (Horn and Farmer, 
1990). 
One of the major functional capabilities of y6 T cells appears to be 
cytotoxcity as they have been shown to act as non-MHC restricted killer cells 
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similar to that of LAK cells and NK cells (Bensussan etal., 1989). Koide etal., 
(1990) demonstrated that some y8 T cells are positive for CD57, an NK cell 
marker. They have also been shown to contain cytoplasmic granules similar to 
that of af3 CTL and NK cells as well as perforin and serine esterase mRNA, 
which is also typical of cytotoxic cells (reviewed by Taylor and Cohen, 1992). y8 
T cells have been shown to kill numerous tumour cell lines including YAC-1, a 
leukemia cell line (Nixon-Fulton et at, 1988), UV light transformed 
fibrosarcoma cells (Okamoto et al., 1988) and K562, a natural killer cell target 
(Koide et al., 1989). DETC have the ability to recognise and lyse transformed 
keratinocytes and melanocytes (Kaminski etal., 1992). This suggests that one 
of the roles of DETC is to eliminate transformed cells in vivo. y8 T cells may 
also play a role in recognising and lysing virus infected cells as they have been 
shown to lyse virus infected cells in the rhesus monkey (Malkovsky et al., 
1992). In addition, human y8 T cells have been shown to recognise and destroy 
herpes simplex virus (HSV)-1 and HSV-2 infected cells (Maccario et al., 1993). 
The expansion of y5 T cells in response to viral infection is seen in vivo (De 
Paoli et al ., 1991, De Maria etal., 1992). Murine y8 T cells have also been 
shown to lyse xenogenic rat cells (Okumura et al., 1995). Freshly isolated 
DETC fail to exhibit cytotoxic activity but it acquire it in culture after mitogen 
stimulation in the presence of IL-2 (Nixon-Fulton etal., 1988). Freshly isolated 
yS T cells from the murine intestine did exhibit cytotoxicity (Goodman and Le 
Francois, 1989). However DETC, which are freshly isolated from the skin 
express the mRNA for perforin (Kobata et al., 1990) suggesting that once 
activated DETC can act as killer cell. Hence their role in the skin may be to 
"eliminate stressed, damaged or transformed cells" (Bergstresser et al., 1993). 
yo T cells play a protective role in various infections, accumulating in 
disease lesions (Modlin et al., 1989). In addition y5 T cells have been shown to 
play a protective role in Listeria monocytogenes infection in both primary and 
secondary infections albeit, they appear to be less important than a13 T cells 
(Mombaerts et al., 1993). A unique lesion was found in the liver of 75 T cell 
deficient mice in response to this pathogen. Rakhmilevich, (1994) found that 
neither y8 T cells or a43 T cells were required in resolving a primary infection but 
both contributed to a secondary response, although y5 T cells were of less 
importance. y5 T cells are activated in vitro by Mycobacterium tuberculosis 
(Janis et al., 1989, 0' Brien et al., 1989) and appear to accumulate at sites of 
infection in vivo (Griffin etal., 1991). This activation of y5 T cells results in their 
secretion of large amounts of IL-2, however a lesser proliferative response than 
that with CD4+ cells was observed. The response by these two cell types to the 
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same infection despite differences in activation produces similar effects such 
as IFNy secretion and cytotoxicity. y5 T cells have also been shown to play a 
role in resistance to Toxoplasma gondii and have role mediating the expression 
of the 65kD heat shock protein (HSP) on macrophages, an important resistance 
factor (Nagasawa et al., 1994). L. monocytogenes induces Th1 cytokine 
secretion in y5 T cells (IFNy) and Nippostrongulus brasilensis induces Th2 
cytokine secretion (IL-4), the same response as CD4 + a13 T cells, showing that 
y8 T cells may contribute to the overall direction of the immune response. 
Freshly isolated DETC express mRNA for IFNy, and upon concanavalin A (Con 
A) stimulation express mRNA for IL-2 and when expanded by further addition of 
IL-2 expressed mRNA for IL-4, IL-2, IFNy, IL-la, IL-3, IL-6, IL-7, TNFa, TNFI3 
and GM-CSF (Matsue et al., 1993). This wide variety of cytokines that DETC 
produce suggest y5 T cells may influence the pathogenesis of various 
diseases, including intracellular bacteria, protozoan and viral infections. A 
clear role of DETC and y8 T cells in immune responses to pathogens is 
unknown as the ligands y8 T cells recognise are not yet clearly defined. 
The lack of diversity in TCR expressed by DETC suggests that the ligands 
recognised are restricted, thus Bergstresser et al., (1993) propose that they 
may recognise a set of molecules expressed commonly in the epidermal micro-
environment. Some candidates include heat shock proteins (Asarnow et al., 
1988), MHC II (Matis et al, 1989), MHC I (Spits et al., 1990) and non classical 
MHC I, including TL antigens in mice (Van Kaer et al., 1991), CD1 (Porcelli et 
al., 1992) and T22 (Weintraub et al., 1994) in humans and indeed DETC can 
be activated by self antigens (Huber et al., 1995a). Unlike conventional ar3 T 
cells, transgenic yo T cells were able to be preferentially stimulated by a8 T 
cells rather than dendritic cells (Spaner et al., 1995). This also illustrates that 
y5 T cells appear to utilise a different co-stimulatory pathway which is 
independent of CD281B7 interactions in allogeneic reactions (Penninger et al., 
1995). Although both c43 T cell and y8 T cell alloreactivity is mediated by 
foreign MHC bound peptides. 
y5 T cells are also involved in autoimmune disease with increased 
numbers seen in the CSF and peripheral blood of multiple sclerosis. 43% of 
these cells reacted with 70 kD HSP compared to 7% of controls (Stinissen et 
al., 1995). y5 T cells have also been isolated from the synovial fluid from 
patients with rheumatoid arthritis. Bergstresser et al., (1993) proposes that 
DETC play a suppressive role by competing with a8 T cells that act as effector 
cells in autoimmunity. 
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The suppressive role of y8 T cells in other immune responses has been 
shown, with hapten coupled DETC able to induce hapten specific 
unresponsiveness (Sullivan et al., 1986) and infusion of allogeneic DETC 
leads to recipients failing to respond to subsequent alloantigen challenge 
(reviewed by Bergstresser et al., 1993). This is in direct contrast to LC which . 
also form a network in nnurine skin and are potent inducers of CHS and DTH. 
The DETC density in the epidermis of various mouse strains has been shown 
to inversely correlate with the capacity of the animals to mount a CHS response 
(Bigby et al., 1987). Cytokines produced by keratinocytes after contact 
sensitiser treatment have been shown to activate y5 T cells (Huber et al., 
1995b), and it appears that DETC migrate into the epidermis in response to 
TNFa, possibly produced by keratinocytes (Tamaki etal., 1994). This provides 
further evidence of their importance in skin immune responses. 
It was proposed recently by Love-Schimenti and Kripke (1994), from 
evidence gathered in vitro during a CHS response that DETC are activated by 
IL-2 and then eliminate autologous hapten specific T cells in the skin. This 
would limit the effector phase and the destruction of hapten modified cells. The 
authors suggested that this cytotoxic activity against antigen reactive cE8 T cells 
may able to account for the ability of DETC to induce tolerance in vivo. While 
LC appear to induce immune responses within the skin, DETC appear to down-
regulate skin immune responses. The y6 T cell has also been proposed to play 
a role in the control of inflammation and tissue necrosis, prevent exaggerated 
inflammatory responses that may be harmful to the host by interacting with 
neutrophils or other inflammatory cells (Fu etal., 1994). 
The role of the y8 T cells in immune responses is still not clear. They 
appear to be important for providing immune protection against intracellular 
pathogens, including bacteria, protozoa and viruses. Cytotoxicity appears to 
be an important functional role, as does the production of cytokines. DETC in 
mice have been shown to be important in skin immune responses, possibly 
playing a down-regulatory role in CHS responses and inflammation. While a 
similar network appears not to be present in human skin, the y8 T cells 
association with disease occurring within the skin suggests that y8 T cells may 
still partially influence skin immune responses. 
1.4.4 	Melanocytes 
Melanocytes are the only cells in the body that can produce the pigment 
melanin. They are dendritic in nature and are closely associated with 
27 
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may able to account for the ability of DETC to induce tolerance in vivo. While 
LC appear to induce immune responses within the skin, DETC appear to down-
regulate skin immune responses. The y5 T cell has also been proposed to play 
a role in the control of inflammation and tissue necrosis, prevent exaggerated 
inflammatory responses that may be harmful to the host by interacting with 
neutrophils or other inflammatory cells (Fu etal., 1994). 
The role of the y6 T cells in immune responses is still not clear. They 
appear to be important for providing immune protection against intracellular 
pathogens, including bacteria, protozoa and viruses. Cytotoxicity appears to 
be an important functional role, as does the production of cytokines. DETC in 
mice have been shown to be important in skin immune responses, possibly 
playing a down-regulatory role in CHS responses and inflammation. While a 
similar network appears not to be present in human skin, the 75 T cells 
association with disease occurring within the skin suggests that y8 T cells may 
still partially influence skin immune responses. 
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Melanocytes are the only cells in the body that can produce the pigment 
melanin. They are dendritic in nature and are closely, associated with 
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keratinocytes in the epidermis. Melanocytes contain unique organelles, the 
melanosomes, in which tyrosine is converted to Dopa and then dopaquinone by 
the enzyme tyrosinase. The eumelanins, which are black/brown pigments are 
formed by the polymerisation of dopaquinone. This compound can also react 
with cysteine groups to give rise to the phaeomelains which are reddish 
pigments (ie red hair). Fully melanised organelles are passed via the dendritic 
processes into the surrounding keratinocytes where they become distributed 
throughout the keratinocytes cytoplasm (Hunter et al., 1989). 
Melanogenesis is controlled by a variety of stimuli, including hormones, 
however, the most important stimulator of this process is UV light. After 
exposure to UVA (320-400nm) tanning was shown to occur in two stages 
immediate and delayed tanning. Immediate tanning is due to the oxidation of 
pre-formed melanin, while delayed tanning is due to the synthesis of new 
pigment (Pathak etal., 1962 in Kaidbey and Kligman, 1979). Melanin migrates 
upwards from the epidermis within the keratinocytes were it is shed during the 
process of desquamation. 
Negroes have dispersed melanosomes and are more intensely 
pigmented, where as in Caucasians they are aggregated and are degraded 
more readily by lysosomes. This results in higher concentrations of melanin in 
Negro skin (Olson etal., 1970 in Olson etal., 1973). Olson etal., (1973) found 
that dark Negro skin was 33 times less susceptible to erythema than Caucasian 
and this was due to the size and density of the individually dispersed 
melanosomes. These authors proposed that the resistance to UV light induced 
erythema, may be due to the ability of melanosomes to absorb free radicals 
which, even today are believed to be a mediator of UV damage. 
Melanocytes are also able to produce a variety of cytokines including IL-1, 
IL-6, GM-CSF and PDGF (Ansel et al., 1990). However, production of these 
factors by the more numerous keratinocytes, means that melanocytes provide 
only a minor contribution to the cytokine milieu in the epidermis. 
1.4.5 	Merkel Cells 
Merkel cells are neuroendocrine cells found in the epidermis. They 
contain spherical granules and sparse desmosomes by which they are 
connected to keratinocytes They are also found adjacent to non-myelinated 
nerve endings (Hunter et al., 1989). These cells have been shown to secrete 
the neurotransmitter, vasoactive intestinal peptide (VIP) (Ansel et al., 1990) 
which is found in the granules within the cell. VIP alters immune functions, 
28 
including inhibition of lymphocyte proliferation in peyers patches (Roitt et a/., 
1991). Infusion into the afferent lymphatics of sheep, reduced the output of 
small and blast lymphocytes via the efferent lymphatic (Moore et al., 1988). 
Further the neurotransmitter calcitonin gene-related peptide (CGRP) has been 
shown to play a role in inflammation where it is found in association with nerve 
fibres and Merkel cells. CGRP causes vasodilation and inhibits antigen 
presentation by LC (Hosoi et a/., 1993). LC were shown in Hosoi's study to be 
intimately associated with the nerves containing this peptide. 
CGRP together with nitric oxide have been demonstrated to be released 
by sensory nerve fibres after UV exposure. This occurs when the levels of 
other epidermal cell derived mediators have returned to normal (Gillardon et 
a/., 1992, Benrath et a/., 1995). The topical administration of the CGRP 
receptor antagonist restored the capability of the immune system to respond to 
haptens applied through UV exposed skin (Benrath et al., 1995). The soluble 
factors produced by cells of neuroendocrine origin in the skin may play a role in 
the inflammatory and possibly immunological responses within the skin 
microenvironment, especially after UV exposure. However, the exact role of 
the Merkel cell and its interaction with the skin immune system is not fully 
understood. 
14.6 	Monocytes/Macrophages 
Cells of the monocyte/macrophage lineage are known to occur in the 
human dermis at around 30% of the density of LC in the epidermis, though if 
total numbers are compared the macrophages of the upper dermis clearly 
outnumber the LC (Weber-Matthiesen and Strerry, 1990). These authors have 
shown that the dermal macrophage population is heterogenous with the 
morphology varying from moderately dendritic, to flat cells, to large 
intravascular cells. The phenotype of these macrophage populations studied 
using mAbs, revealed that the cells had the characteristic phenotype of 
phagocytic macrophages and lacked features of immune macrophages, of 
which only the LC was phenotypically similar (Weber-Matthiesen and Strerry, 
1990). OKM5+ cells were identified as occurring at the dermal/epidermal 
junction but were not found to be MHC II + and were not of the phagocytic 
phenotype. After UV exposure a population of OKM5 + macrophages appears in 
the epidermis which are proposed to originate from the dermis (Baadsgaard et 
a/., 1987). The role of dermal macrophages in the skin immune system is not 
clear but with multiple phenotypes they are likely to have multiple roles. 
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	1.4.7 	Dermal Dendritic Cells 
A population of dermal dendritic cells has been shown to express MHC II 
antigens in both mouse (Sonthiemer et al., 1989) and human skin (Cerio et al., 
1989). Dendritic cells in the murine skin that were Factor XIII- and Thy1.2- 
were capable of providing accessory cell function in Con A stimulated T cells. 
They were able to present alloantigens, process and present large protein 
antigens (Cooper et al., 1987); initiated DTH responses (Tse and Cooper, 
1990). Further characterisation by Duriswamy et al., (1994) showed that the 
LC like APC function of dermal DC was due to a population of interstitial DC 
that were MHC II + CD11 b-. These cells, due to their position adjacent to the 
vasculature are likely to be the first APC which T cells emigrating into the skin 
would come in contact. Optimal sensitisation studies by Kurimoto and Streilein 
(1993) demonstrated that excess hapten painted on the skin was taken up by 
both LC in the epidermis and dermal DC, both of which could then initiate CHS. 
Further, the dermal DC from UV irradiated CHS resistant mice were able to 
stimulate CHS responses, while those from CHS sensitive mice induced 
tolerance (Kurimoto et al., 1994). This suggest that DC from the dermis are 
capable of acting in a similar manner to LC in the skin immune system. 
To reach the lymph node, LC must migrate through the dermis. Therefore 
is likely that a portion of APC function provided by the dermis may be due to 
these migrating cells. Richters et al., (1995) found a population of cells 
migrating from human skin explants that expressed CD1b. The kinetics of the 
migration suggests this marker may be induced transiently in dermis in LC 
migrating from the epidermis to the DLN. 
1.4.8 	Mast Cells 
Mast cells are bone marrow derived cells that are found in the loose 
connective tissue of the dermis as well as many other tissues within the body. 
mast cells upon activation release a variety of preformed mediators including 
histamine, serotonin, neutral proteases, acid proteases, proteoglycans (eg 
heparin) and cytokines including TNFa (reviewed by Van Loveren et al., 1997). 
After receiving an appropriate stimulus, mast cells synthesise prostaglandins 
D2, E2 and 1 2 , as well as various leukotrienes and platelet activating factor. 
Mast cells in vitro have been shown to increase mRNA levels or secrete de 
novo synthesised IL-1, 3, 4, 5, 6, 10, 13, TGFp, stem cell factor, GM-CSF, 
IFNy, MIP-1 a and 13, T-cell activation factor 3 and TNFa. Stimuli that lead to 
mast cell activation include complement proteins (C5a and C3a), neuropeptides 
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including substance P and CGRP, UV light and the binding of immunoglobulins 
such as IgE and IgG (reviewed by Van Loveren et aL, 1997). The same 
reviewers also highlighted the ability of mast cells to influence inflammatory 
responses occurring within the skin including immediate and delayed 
hypersensitivity reactions. 
1.5 ULTRAVIOLET LIGHT 
1.5.1 	Introduction 
Ultraviolet light forms part of the electromagnetic spectrum with 
wavelengths between 200-400nm. Ultraviolet light is broken into three parts 
UVA (320-400nm), UVB (290-320nm) and UVC (200-290nm)(Kochevar, 1983, 
Spikes, 1983). Solar UVC is absorbed by ozone in the stratosphere and is not 
relevant in biological systems. The division between UVC and UVB was 
established at 290nm for this reason. Discussion of UVC effects on the skin 
therefore, are kept to a minimum is this review. The energy carried by each 
portion of the spectrum is inversely related to its wavelength so 
UVC>UVB>UVA. The depth of penetration of ultraviolet light into the skin 
increases with increasing wavelength. 
The skin is the organ most susceptible to damage by UV light as it is 
directly exposed. UV exposure of the skin has a number of biological effects, 
many of which are detrimental. The following sections deal with the effects of 
UV light on the skin and its constituents, concentrating on immununological 
changes in a variety of animal, human and cellular models. 
The peak of UV induced carcinogenicity has been shown to lie within the 
UVB portion of the UV spectrum (reviewed by de Gruji., 1996). The primary 
consequence of ozone depletion is the increased amount of UVB on the earths 
surface, it may, in turn lead to increased incidence of skin cancer and eye 
damage (Lloyd et a/., 1993). Combined with the possibility that UVB also alters 
immune responses to infectious agents (reviewed by Ward et al., 1995), this 
has brought the detrimental effects of ultraviolet exposure to the forefront of 
scientific discussion. This is especially relevant in Australia, where the highest 
incidence of any single cancer, a skin cancer (basal cell carcinoma), is 
reported (Green et a/., 1997). Australia also lies within or near the "hole in the 
ozone layer", perhaps, further increasing the risk of developing such cancers in 
this country (Osterberg and Szarfmen, 1996). 
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1.5.2 	Ultraviolet Light Methodology 
A variety of light sources has been used to study the effect of UV light on 
skin. These light sources vary considerably in their emission spectra, 
advantages and disadvantages relative to each experimental model used. A 
summary of different UV sources used in research, is presented in Table 1. 
Generally most groups currently use sunlamps in studying the effects of UV 
light on the immune system. However, this and the way they are used often 
varies from laboratory to laboratory. The use of sunlamps is widespread due to 
their relatively low cost and high UVB output. It has been suggested that the 
UVC output (non solar UV) by FS40 sunlamps is sufficient to affect MLR's and 
epidermal cell-lymphocyte reaction (ELR) experiments (Hurks et al., 1995) 
However, Cooper et al., (1996) have shown that the immunosuppression 
arising from 4 minimal erythema! doses (MED) of both FS40 sunlamps and 
solar simulator lamps are identical, thus validating the extensive use of 
sunlamps in research. 
Usually UV treatment is given as a dose per unit area. However, this is 
often referred to in terms of minimal erythema! dose (MED), with little or no 
reference to the actual dose received. Urbach and Stern (1972) stated that" 
Furthermore it is not always clear that "minimal" refers to the shade of erythema 
produced or to the least amount in energy in one of series of increasing doses 
that produces erythema". Urbach subsequently stated that variables such as 
time to generate MED was rarely mentioned or spectral output of the light 
source used. Recent publications have begun to correct these oversights, 
allowing easier comparison between different studies. In humans the 
dose/exposure time to reach MED varies from individual to individual due to 
genetic differences reflected in the amount of melanin produced and stored. 
Table 2 gives a brief summary illustrating the varying doses required to 
generate MED in a variety of species and different sources of UV irradiation. 
1.5.3 	Inflammatory Response 
1.5.3.1 	Vascular Events 
One of the earliest observed inflammatory responses of the skin to 
ultraviolet irradiation was vasodilatation of cutaneous blood vessels (Finsen, 
1899) resulting in the production of erythema. He postulated this was caused 
by exerting a direct effect on the vessels. An alternate theory by Partington, 
(1954) was that this effect was produced by soluble vasoactive mediators, 
although no direct evidence was provided for either hypothesis. The time 
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Table 1.1 	Ultraviolet light sources used for research 
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Table 1.2 	Minimal Erythemal Dose for a Variety of UV sources and 
species 
900 UVB Guinea pigs Monochromatic 
295nm 
Eaglstein et al., 1979 
Guinea pigs 260 	I UVC Monochromatic 
250nm 
Eaglstein etal., 1979 
Guinea pigs 246 	I UVB Sunlamp Morison etal., 1981 










Cornelius etal., 1994 
Gilchrest etal., 1983 
5.15x105 I UVA Humans Parrish et a/, 1981 
Humans 5. 52x105 I UVA Xenon arc(ss) 
(335 filter) 




6.6x105 I UVA 
8.6x105 I UVA 








Paul and Parrish, 1982 
Kumakiri etal., 1977 
Baadsgaard etal., 1987 
Humans 184 	I UVB Sunlamp Kaidbey and Kig man, 
1979 
Humans 200 	I UVB Monochromatic 
300nm 
Olson etal., 1966 
Humans 220 	I UVB Sunlamp Paul and Parrish, 1982 
Humans 200-300 I UVB Monochromatic 
300nm 
Norris et a/.,1991 
Humans 264 	I UVB Hot Quartz Tanenbaum etal., 1976 
Humans 264 	I UVB Xenon arc(ss) 
(345 filter)  
Kaibey and Kligman, 
1975 
Humans 291-327 I UVB Sunlamps Cooper etal., 1992 
Humans 300 	I UVB Sunlamp Cornelius etal., 1994 
400 	I UVB Humans Parrish et a/, 1981 
Humans 437 	I  UVB Sunlamp Arbabi etal., 1983 
Humans 450 	UVB Hot Quartz Gilchrest etal., 1981 
Humans 975 	I UVB T12(307nm filter) Baadsgaard etal., 1987 
Humans 992 	I UVC TUV(286nm filter) Baadsgaard etal., 1987 
C3H Mice 1600 I UVB TL20 El-Ghorr etal., 1995 
course seen for the production of erythema is biphasic with an initial erythema 
observed before the completion of the treatment. This is followed by a further 
increase usually of greater magnitude occurring an hour later and lasting for 
24-48 hours. The reddening that occurs at this stage is also believed due to an 
increase in vasodilation (Logan and Wilhelm, 1963, Kaidbey and Kilgman, 
1979). Later studies made used more sensitive instruments that measured 
reflectance, were able to show that vasodilation preceded visually perceptible 
erythema (Diffey and Oakley, 1987). The degree of erythema observed after 
treatment with UV light increases proportionally with dose until at least 15 MED 
(Farr and Diffey 1984). Eventually, at higher doses blistering, and other signs 
of gross damage are seen. Erythemal responses are also influenced by 
environmental factors, including heat, wind, humidity and water immersion 
(Freeman and Knox, 1964, Owens et al., 1974 Owens et al., 1975). 
Logan and Wilhelm (1966a) also investigated the erythemal reaction in a 
variety of animal models including rats, rabbits and guinea pigs. They looked 
at various aspects, including vascular permeability, tissue leucocytosis and the 
production of erythema and found variation in the exposure times needed to 
provoke erythema in the different species. 
Adaptive changes are also observed in the skin after exposure to UV light. 
These include epidermal thickening (hyperplasia) and melanogenesis 
(tanning)(Rosario et al., 1979) which provide some degree of protection against 
further UV insult. Increased melanin production provides increased protection 
against the harmful effects of UVR (Shono et al., 1985), to the extent that 
Negroes with a high melanin content, have a MED 33 times higher than their 
Caucasian counterparts (Olson et al., 1973). Increases in melanin production 
correlating with increasing UV dose are also observed in some human 
populations (Shono et at., 1985). 
Many factors have been suggested as potential mediators for the 
erythemal response of skin to UV light however, most of these have been found 
to have no or only a minor effect. Logan and Wilhelm (1966a) thought the 
early erythemal response to UV light was similar to that of thermal injury which 
had been shown to be mediated by histamine. However, the addition of anti-
histamines did not effect the induction of erythema in either the guinea pig or 
rabbit models used. The early response seen in rats was mediated by 
serotonin (5-HT) as the addition of an antagonist (BOL-148) blocked the 
induction of erythema, while the addition of anti-histamines had no effect. 
Greaves and Sondergaard (1970) have shown UVB erythema in humans is 
33 
linked with the action of a smooth muscle contracting agent. This agent was 
clearly different from histamine, bradykinin, serotonin or acetyl choline and was 
shown to be a fatty acid, possibly a prostaglandin. Indeed, an increase in the 
production of the prostaglandins PGE2 and PGF2a and their precursor 
arachidonate was evident 24 hours after UVB exposure of the skin (Black, et 
al., 1978). Inhibitors of prostaglandin synthesis including aspirin (Miller etal., 
1967) and indomethacin (Snyder and Eaglstein, 1974, Greenberg et al., 1975, 
Kaidbey and Kurban, 1976, Eaglstein and Marsico, 1975) had been previously 
noted to decrease the erythemal response but not eliminate it, providing 
indirect evidence for the involvement of prostaglandins. The presence of 
increased amounts of prostaglandins could not, however, be demonstrated at 
48 hours post-treatment thus suggesting that these compounds are only 
responsible for the early erythemal response. The application of indomethacin 
topically, intradermally or orally, has been shown not to effect UVA or PUVA 
induced erythema (Morison et al., 1977) Thus UVA induced erythema is not 
due to a prostaglandin mediated event. 
Recently, nitric oxide (NO) has been shown to be produced by 
keratinocytes after UVB irradiation. This NO release is dose dependent and 
the enzyme required to synthesise NO is constitutively expressed by these 
cells (Deliconstantinos et al., 1995). The same authors demonstrated that in, 
the guinea pig, an inhibitor of NO synthetase (L-NMMA) was shown to have a 
UV protection factor (PF) of 8.71. The authors concluded that this may be a 
major part of the integrated inflammatory response to UV light leading to 
vasodilation and erythema. Current evidence suggests that DNA is the 
chromophore for erythema, as the action spectrum for the frequency of 
pyrimidine dimers in vivo closely matches the action spectrum for erythema up 
to 334nm (Freeman etal., 1989). 
The vasodilation and subsequent erythema produced after exposure of 
the skin to ultraviolet light, is not due to the production of any one substance 
but is multifactorial with NO and prostaglandins possibly playing key roles. 
Other inflammatory substances including inflammatory cytokines may play 
minor but still important roles in the complicated reaction to UV light. The 
inflammatory response and its mediators cannot be considered in isolation. 
These, in turn, effect the immune response that may be generated from the 
affected area by altering adhesion molecule and cytokine expression of 
resident cell populations and the induction of non-resident cell types to migrate 
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into the area, resulting in the generation of an "inflammatory" linked immune 
response. 
1.5.3.2 	Morphology and Ultrastructural Changes 
One consequence of UV exposure of the skin is damage to epidermal 
cells (Logan and Wilhelm, 1966a, Daniels etal., 1961). This becomes evident 
as early as two hours after UV exposure. The earliest indicator of damage is a 
decrease in keratinosomes which results in the formation of dyskeratotic cells 
(Wilgram etal., 1970). 16-18 hours after exposure intracellular oedema can be 
seen, followed at 30-48 hours by intercellular oedema which develops in the 
spaces around damaged keratinocytes. Sunburn cells (damaged 
keratinocytes) appear shortly before the presence of oedema is observed 
(Logan and Wilhelm, 1966a, Daniels et al., 1961, Woodcock and Magnus, 
1976, Obata and Tagami, 1985). 
The sunburn cell was proposed as one of the early examples of apoptosis 
(Kerr etal., 1972). UV induced apoptotic cells are rapidly phagocytised by the 
surrounding keratinocytes (Olson and Everett, 1975). Macrophages are also 
known to bind to and phagocytose apoptotic cells (Duvall etal., 1985) and are 
known to increase dramatically after UVB treatment (Cooper et al., 1992). All 
wavelengths of the UV spectrum including UVC are able to induce apoptosis 
rather than necrosis in Ly-5 murine lymphoma cells (Godar et al., 1994). There 
appears to be two types of UV induced apoptosis, an immediate type apoptosis 
and a more classical delayed apoptosis (Godar et al., 1995). The delayed 
apoptosis is thought to be induced by UV-induced damage of DNA rather than 
free radical damage (Godar et al., 1995). Furthermore it was found that 
immediate apoptosis was due to constitutive factors which did not require 
protein synthesis, while the delayed type (inducible) apoptosis does require 
protein synthesis (Godar etal., 1996). 
Similar apoptotic changes are noted in epidermal LC. Which are 
especially sensitive to the effects of UV light (Aberer et al., 1981, Obata and 
Tagami, 1985), with damage observed at lower doses than that observed in 
keratinocytes. LC are more sensitive to UV induced damage in comparison to 
keratinocytes for both UVA and UVB wavelengths (Aberer et al., 1981). The 
degenerative changes for LC and keratinocytes include mitochondrial swelling 
and rupture, condensation of the cytoplasm and the appearance of pyknotic 
nuclei and nuclear fragments (Aberer et al., 1981, Obata and Tagami, 1985, 
Daniels et al., 1961, Nix et al., 1965). The cellular damage is maximal at 48-72 
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hours for the total UV range (Rosario, 1979). In vitro exposure of an epidermal 
derived cell line to both UVA and UVB, has been shown to induce cytoskeletal 
blebbing, this being a characteristic of oxidative stress (Malorni et al., 1994). 
Another consequence of ultraviolet irradiation is the infiltration of 
leucocytes, predominantly neutrophils, into the damaged area. This becomes 
apparent 1/2 to one hour after treatment, with peak infiltration at 4-6 hours and 
this response concluded after 48 hours (Logan and Wilhelm, 1963). These 
studies conducted using guinea pigs showed that the peak in dermal 
leucocytosis occurred before both maximum erythema and vascular 
permeability, suggesting a cause and effect relationship. Later studies by the 
same authors in the rat and rabbit (Logan and Wilhelm, 1966a) suggested that 
lymphocyte infiltration was not as important in these animal models and peaked 
after both maximum erythema and vascular permeability. Eaglstein et al., 
(1979) suggested that leucocytes have a role in UVB induced inflammation in 
guinea pigs but not that of UVA or UVC. The presence of neutrophils is seen in 
dermal inflammation due to UVB irradiation in humans. These cells were 
observed to be present a short time after irradiation increasing in number 
gradually until at least 48 hours post treatment (Hawk et al., 1988). The onset 
was observed to be more gradual and less marked than other acute 
inflammatory responses. Neutrophils have the potential to add to the physical 
damage caused by UV light, as they are capable of releasing a variety of 
substances, including reactive oxygen intermediates which are damaging to 
cells and structures of the body (Darr and Fridovich, 1994). However, the role 
of neutrophils in UVB inflammatory responses is unclear (Strickland et al., 
1997), although they may have a role in "repair" processes such as increased 
elastin production (Starcher and Conrad, 1995). 
The mast cell is a resident cell which has a role in UV induced 
inflammation. Physical changes in mast cells have been noted after UVB 
exposure, including the presence of hypogranulated and degranulated cells 
and the presence of extracellular granules in the surrounding tissue (Walsh et 
al., 1995). It was also noted that a decrease in mast cell numbers occurred. In 
contrast mast cells in the lower dermis have been shown to increase in number 
after chronic UVB exposure of hairless mice though whether this a protective 
event is unknown (Kligman and Murphy, 1996). 
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1.5.4 	UVA/UVB 
The erythemal responses of both UVA and UVB are thought to act 
through similar mechanisms, however the differences seen in skin changes 
which result are thought to be due to the variation in the depth of penetration 
associated with the different wavelengths through skin. Energy from UVB 
irradiation is absorbed over a short distance of the skin (mainly the epidermis), 
while greater amounts of light in the UVA region can penetrate to the dermis 
and beyond and so can disperse their energy over a greater depth (reviewed 
by Anderson, 1993 
The wavelength of ultraviolet light influences the cytotoxicity seen, with 
UVB>UVA. Generally UVB acts mainly in the epidermis, while UVA injury 
tends to cause necrosis of the endothelial cells thus damaging the dermal 
blood vessels (Willis and Cylus, 1977, Rosario et al., 1979, Zheng and 
Kligman, 1993). However, it should be noted that 10-15% of UVB penetrates to 
the dermis and hence it is possible for UVB to have a direct affect on 
microvascular endothelial cells (Everett etal., 1966, Strickland eta!, 1997). In 
vitro studies by Cornelius et al., (1994) also support a direct effect of UVB on 
endothelial cells. 
Direct cytotoxic effects on cells in the skin are evident after UV exposure. 
Sunburn cells are visible in the epidermis after UVA irradiation, though fewer in 
number than the equivalent dose of UVB (Woodcock and Magnus, 1976, 
Kumakiri etal., 1977). In contrast, a study using erythemal doses of UVA only, 
showed that while sunburn cells were absent from the epidermis perinuclear 
vacuoles were present in LC (Gilchrest et al., 1983). The same study 
demonstrated the recruitment of neutrophils into the UVA irradiated skin. UVB 
doses that cause similar amounts of erythema, did not appear to induce this 
change (Gilchrest et al., 1981), although this has been reported from rodent 
based experiments (Eaglstein et al., 1979). Detailed studies by Hawk et al., 
(1988) were also in direct contrast to those of Gilchrest et al., (1981); the 
authors suggested that the lack of similar findings previously was due to 
"failure to obtain biopsy material at times of significant nbutrophil infiltration". 
However, it must be noted that this study used a sunlamp which does contain 
approximately a third UVA. 
A study by Tyrell and Pidoux (1987) suggests that UVA induced 
cytotoxicity may be just as, if not more important than UVB. When the sun is at 
its zenith (10am-2pm) and UVB maximal, UVA still makes up 50-60% of the 
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phototoxic wavelengths found and this is increased at other times. UVA 
induced changes also include elastic fibre proliferation, randomly deposited 
microfibrils and duplication of vascular basement membrane, while after UVB 
some degradation of fibres is present. Microfibrils are also increased but the 
organisation remains; some collagen degradation also occurs (Zheng and 
Kligman, 1993). 
1.5.5 	UV Damage of DNA 
The heterocyclic bases of nuclear deoxyribonucleic acid (DNA) have been 
shown to be a major UV absorbing chromophore in the skin (Ely and Ross, 
1949). The absorption (which is maximal between 260-265nm) leads to 
damage of the DNA which may result in the generation of tumours. DNA 
strongly absorbs energy in the UVB region of the spectra. The main lesions 
induced are pyrimidine dimers and pyrimidine-pyrimidone photoproducts, which 
make up 65% (Mitchell et al., 1992) and 35% (Lippke et al., 1981) of UVB 
induced DNA lesions respectively. Of the pyrimidine dimers formed 50% are 
thymine-thymine dimers (Vink et al., 1993). These lesions have been shown to 
occur in the basal and suprabasal layers and can be found in Langerhans cells 
(Vink et al., 1994). Pyrimidine dimers are proposed as an initiation step in 
mutagenesis and tumour formation (Hart et al., 1977). Mutations in the ras 
oncogene were mostly found opposite dipyrimidine sequences (Pierceall et al., 
1992) providing more evidence for the role of pyrimidine dimers in tumour 
genesis. The exposure of skin to ultraviolet radiation also increases the proto-
oncogene c-fos (Roddey et al., 1994). 
Exposure of human skin to two MED UVB induces keratinocyte and 
fibroblast induction of metallothionein genes in vivo (Anstey et a/., 1996). The 
metallothionein proteins are proposed to play a possible role in protecting the 
skin against photo-oxidative stress (Hanada et al., 1992), which has been 
shown to induce strand breaks in DNA (Ghosh etal., 1993). Thus expression of 
high levels of metallothioneins by basal keratinocytes may protect cells from 
UV induced DNA damage (Anstey etal., 1996). 
UVB light has been shown to induce nuclear factor a (NFKE3), although 
without the need for chromosomal DNA damage (Simon et al., 1994). The 
gene is associated with IL-6 promoter region. Also found recently are two 
proteins, 40 kD and 68 kD in size, which bind, specific ultraviolet responsive 
elements on DNA, with the 40 kD protein playing a role in DNA replication 
(Yang et al., 1993). The exact function of these proteins is unknown. 
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Ultraviolet light induces mutations in p53, an anti-oncogene (Brash et al., 
1991, Kanjilal et al., 1993). This has been demonstrated in squamous cell 
carcinoma (Brash et al., 1991). However mutations in p53 seem to be absent 
from melanomas (Lubbe et al., 1994). p53 stops progression of cells through 
the normal cell cycle after UV exposure, thus allowing time for the cell to repair 
DNA damage. As p53 can also lead to the induction of apoptosis, it is not 
surprising that in p53 knockout mice, the formation of sunburn cells is an order 
of magnitude lower (Pierceall et al., 1991). The heterozygote in this study 
displayed an intermediate phenotype suggesting that the alteration of one p53 
gene in a cell is enough to cause an effect. Therefore sunlight may, by 
mutating a p53 gene, cause tumour initiation (DNA mutation) and by further 
exposure delete the normal cells (which undergo programmed cell death), 
allowing the p53 mutant to dominate leading to tumour promotion (reviewed by 
Ziegler etal., 1996). 
DNA damage (pyrimidine dimer formation) has also been proposed as a 
chromophore for the initiation of systemic immunosuppression in mice after UV 
irradiation (Kripke et al., 1992). Photorepair of DNA damage is seen in the 
marsupial Mondelphis domestica. This animal contains photo-repair enzymes 
which are activated by visible light and prevent the induction of UV induced 
immunosuppression (Applegate et al., 1989). Treatment of the skin with 
liposomes containing the excision repair enzyme T4 endonuclease V (T4N5), 
increases the rate of thymine dimer repair (Yarosh etal., 1990) thus preventing 
the UV induced immunosuppression of DTH and CHS (Kripke et al., 1992). 
Kripke et al., proposes that DNA damage leads to the release of 
immunoregulatory cytokines. Indeed preliminary unpublished data by this 
group found that down-regulation of IL-10 production by a UV damaged 
keratinocyte cell line (PAM212) was seen to occur after treatment with T4N5 
liposomes thereby providing a role for DNA damage in UV induced systemic 
immunosuppression (reviewed by Vink eta!, 1996). Local immunosuppression 
is also manipulated by T4N5 treatment and prevents LC loss from the 
epidermis and partially reduces local immunosuppression (Wolf et a/., 1995). 
Normally, cells with UV damaged DNA can be observed in the DLN after UV 
treatment of the skin. Treatment of these UV damaged cells with the 
photolyase photorepair enzyme is able to restore the ability of these cells to 
induce a normal immune response. This treatment also prevents the induction 
of suppressor cells (reviewed by Vink etal., 1996) 
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UV light is capable of directly damaging DNA causing mutation which may 
give rise to tumours, especially as mutations in oncogene and anti-oncogenes 
are shown to occur. DNA damage is the primary change required for the 
initiation of tumours, however for the tumour to become established a tumour 
promotion step is required. This secondary change may be provided by 
alteration of immune function and immunosurveillance within the skin after 
subsequent exposure to UV light. 
1.6 IMMUNOLOGICAL EVENTS 
1.6.1 	UV Induced Immunosuppression 
Hanisko and Suskind (1963), observed that the contact hypersensitivity 
response seen in skin sensitised to DNCB was reduced if skin was previously 
exposed to sub-erythemal doses of UVB. Kripke (1974) investigated the 
antigenicity of UV induced tumours and showed that the induced tumours were 
highly immunogenic and were only transplantable to immunosuppressed hosts. 
Kripke and Fisher (1976) found that UV induced tumours were able to grow in 
the primary host due to a systemic alteration in the hosts immune response to 
the tumour. This was due to the UV exposure received, as UV irradiated 
recipients were unable to reject the tumours. UVB exposure has been shown 
to result in suppression of many immune parameters including lymphocyte 
function (Morison et al., 1979), CHS responses (Haniszko and Suskind, 1963, 
Greene et al., 1979, Toews et al., 1980, Morison et al., 1981a, Noonan et al., 
1981, De Fabo and Noonan, 1983, Elmets etal., 1985, Elmets et al., 1988) and 
DTH responses (Morison etal., 1981b, Ullrich etal., 1986, Glass etal., 1989). 
However, little effect was shown on antibody production (Kripke et al., 1977, 
Spellman et al., 1984, Ullrich et al., 1986, Chen et al., 1997). Suppression of 
cellular immune responses was transferable with T lymphocytes and was 
specific for syngeneic tumours induced by UV irradiation (Fisher and Kripke, 
1978). UVA exposure appears less immunosuppressive (De Fabo and Kripke, 
1980). While UVB wavelengths greater than 315nm are also weakly 
immunosuppressive. (Noonan et al., 1992). The contrasting effects of UVA and 
UVB have recently been confirmed by a study, in which human skin was 
exposed to equivalent erythemal doses, UVB was shown to depress 
sensitisation to the contact allergen diphenylcyclopropenone while UVA did not 
result in decreased immunisation rates (Skov etal., 1997). 
Many investigations have been undertaken since the early discovery of 
UV induced suppressor cell activity, aimed at identification and characterisation 
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of these cells. CD8+ cells increased in the circulation of humans exposed to 1 
hours sunlight per day, while CD4 levels decreased and suppressor cell activity 
was seen in T and B pokeweed mitogen stimulated cells (Hersey etal., 1983). 
Thy 1.2+ cells have been shown to abrogate suppressive activity after UVB 
exposure. This was found to be specific for the hapten applied through the 
irradiated skin (Elmets et al., 1983). Treatment with Lyt1 + antibodies was shown 
to remove suppression and allow rejection of tumours, suggesting these cells 
are required for immune suppression (Ullrich and Kripke, 1984). However, 
Schwarz etal., (1987) showed that serum from UVB irradiated mice was able to 
induce systemic suppression and this suppression was due to the generation of 
suppressor cells. This indicates a role for cytokines in UV induced 
immunosuppression. 
The ability of UVB exposure, followed by hapten painting to induce 
specific suppressors, was assessed on strains of UV resistant and UV sensitive 
mice and it was found that suppressor cells were induced regardless of UV-
CHS phenotype. This indicated that the difference was due to interruption of 
effector mechanisms (Glass etal., 1989). This hypothesis is supported by the 
fact that UVB exposure converts LC from an immunologically potent APC, to a 
tolerogenic APC; were stimulation of Th1 cells is reduced while the ability to 
stimulate a Th2 response remains intact (Simon et al., 1990). Clonal anergy 
appears also induced in the Th1 cells in response to UV exposed LC (Simon et 
al., 1991). This provides a mechanism where by a "suppressor" cell is induced 
(Th2 cell) and the effector cell (Th1) is eliminated or anergized. Simon etal., 
(1994) demonstrated that draining lymph nodes cells from normal and hapten 
treated murine skin, IL-2 and IFNy were able to be produced by Th1 cells. 
However, after UVB exposure and hapten treatment of the skin these cytokines 
could not be detected. This implies that the UV irradiated skin immune system 
would lose immunosurveillance against tumours or infectious agents requiring 
a cellular response (Simon et al ., 1992). This alteration of the immune 
response may be due to the action of IL-10 which has been shown to alter the 
immune response after UV exposure (Rivas and Ullrich, 1992). 
Brown et al., (1995) investigated the effect of UV treatment on the 
Th1/Th2 balance using the murine antibody response to Borreilia burgdorferi as 
a model. Brown et al., (1995) showed that Th1 and Th2 cells differentially 
regulate antibody isotype production. Following UV exposure and by 
immunisation with B. burgdorferi, IgG2a and IgG2b isotypes were down-
regulated (Th1 isotypes) while IgG1 was unaffected (Th2 isotype). There was 
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also a loss of DTH response to the organism, in comparison to immunisation 
without UV exposure. Injection of an anti IL-10 antibody into UV irradiated, 
immunised animals restored the IgG2a and IgG2b antibody responses and 
DTH to normal, providing further evidence of the role of IL-10 in altering the 
balance of the immune response. 
Yagi et al., (1996) was able to generate a line of Th2 cells expressing 
CD3+CD4+CD8-V137 +, from the spleens of UVB pre-irradiated, 
tetracholorosalicylanilide photosensitised mice that had been subjected to 
repeated antigenic stimulation. These cells were shown to suppress contact 
photosensitivity, both in vivo and in vitro. This was neutralised by anti IL-10 
mAb's as these cells produce IL-10, but not by anti-IL-4 mAb which they also 
produce. However, the author found amount of IL-4 produced by 
CD3+CD4+CD8-V37 + cells is sufficient to provide a microenvironment for Th2 
cell generation, which in turn further suppresses Th1 cells. 
The importance of UV induced immunosuppression can be seen by 
lowering of immunity to many microbes as evident by decreased DTH 
responses to M. bovis (Jeevan and Kripke, 1990), M. leprae (Cestari et al., 
1995), L. monoctyogenes (Goettsch et al., 1996) and Candida albicans 
(Denkins et al,. 1989), as well as reducing the T cell proliferation response to 
tetanus toxoid (PreteII etal., 1984). 
Anti-viral immunity has a heavy reliance on the cellular arm of the immune 
system. The UV induced immunosuppression of this aspect of immunity has 
serious consequences for viral infection. In mice infected with murine leukemia 
virus, after UV exposure, mitogen induced proliferation was decreased, as were 
responses to SRBC and MLR's with more liver pathology, being seen due to 
infection (Brozek etal., 1992). Infection of rats with RCMV, following exposure 
to 5 x 0.5 MED UVB exposure, resulted in an increased viral load and more 
frequent necrosis and inflammation (Goettsch et al., 1994). The severity of 
herpes simplex virus (HSV) -2 infection was been shown to be increased after 
HSV-2 infects a site previously exposed to 4 suberythemal doses of UV 
(Yasumoto et al., 1987). This study demonstrated that antigen specific T cells 
were generated and that these cells were able to suppress DTH and lymphoid 
cell proliferation in response to HSV-2 in transfer studies. The same decrease 
in immune- responses to HSV-1 was observed after suberythemal doses of UVB 
(Howie et al., 1986). For this suppression of immune responses to occur, the 
infection must occur within 2-14 days after irradiation (Ross et a/., 1988). 
Rooney etal., (1991) found that 71% of patients with a history of herpes labilis 
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developed lesions with a 4 MED UVB exposure, while only 3% of patients 
whose skin was protected by sunscreen, had virus shedding and none formed 
lesions. However, Rooney etal., (1991) suggests that increased infection after 
UV exposure may also be due, in part, to activation of the virus. After UV 
treatment of psoriasis patients it was found that ability of LC to present HSV 
was severely depressed. Antibody levels, lymphocyte proliferation and the 
ability of blood DC to present HSV were unaltered (Gilmour etal., 1993). From 
these studies it is evident that decreased cellular immunity observed after UVB 
exposure of the skin can lead to alterations in the body's ability to respond to 
variety of viral and intracellular microbes. 
While evolutionary advantage of immunosuppression remains unknown, 
one possibility is that the alteration of the skin by UV exposure alters the 
antigen profile of the cells, which in the absence of immunosuppression may 
lead to rejection (as suggested by Dr. George Klein, Koralinska Institute, 
Stockholm, reviewed by Nishigori et W., 1996). Nishigori et al., (1996) 
suggested that UV induced immunosuppression was a side-effect of the 
cytokines produced to restore damaged skin resulting in a temporary gap in 
the immune response. 
UV induced immunosuppression is a serious complication arising from the 
bodies natural responses to UV exposure of the skin. Evidence at this time 
suggests that it may result from the generation of T suppressor cells, (Th2) 
which may inhibit the effector cells of Thl type. It appears that UV induced 
immunosuppression depresses the function of Thl cells and enhances the 
activity of Th2 cells via cytokines (reviewed by Ullrich, 1996) and via cell 
mediated immunosuppression (reviewed by Cooper, 1996). The combination 
of these events and others, shifts the normal cutaneous immune response 
away from cell mediated immunity. Which, in turn, causes decreased immunity 
to intracellular pathogens including bacteria and viruses. This loss of cellular 
immunity may lead to a loss of immunosurveillance to tumours, possibly arising 
perhaps from the direct action of UV on the skin, as it appears that individuals 
that are susceptible to UV-induced immunosuppression are more susceptible to 
skin cancer (Yoshikawa etal., 1990). 
1.6.2 	Genetic Basis for immunosuppression 
It is clear that genetic background, especially genes which regulate skin 
pigmentation, affect the susceptibility of an individual to skin cancer. However, 
other genes, which can be detected before cancers arise (reviewed by Streilein 
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,1996) play a role in UVB induced immunosuppression. Using CHS as a test of 
cutaneous immune response, there are distinct phenotypes within the human 
population, UVB resistant and UVB sensitive (UVB-R and UVB-S) (Yoshikawa 
et al., 1990). This does not correlate with skin pigmentation as 40% of dark 
skinned individuals display the UVB-S phenotype (Vermeer et al., 1991). 
Providing further evidence that UV induced immunosuppression has a role skin 
cancer, is the study by Yoshikawa (1990), which found that in basal cell and 
squamous cell carcinoma patients, 90% were of the UVB-S phenotype. 
Streilein and Bergstresser (1988) originally demonstrated that the 
C3h/HeN and C57BI strains of mice were UVB-S, while Balb/c was UVB-R. Fl 
hybrids of UVB-R and UVB-S strains were UVB-S, suggesting that this 
phenotype is the dominant one. C3H/HeJ were found to be UVB-R, despite 
differing from C3H/eN at only the LPS locus, suggestion that polymorphisms at 
this locus are important in producing the phenotype (Streilein and Bergstresser, 
1988). This loci regulates the production of the pro-inflammatory cytokines IL-
1, IL-6 and TNFa (Streilein and Bergstresser, 1980). The TNFa Loci is 
considered important, as there is a 100% correlation between the INFad allele 
and the UVB-R phenotype (Vincek et al., 1993) 
Noonan and Hoffman (1994a) also investigated the control of UVB 
immunosuppression in a wide variety of mouse strains and found a more 
complex system of genetic control. Three distinct phenotypes with differing 
susceptibilities to UV immunosuppression were found. These being LO, (low 
susceptibility 50% immunosuppression with 9-12.3 kJ/m 2 UV) HI (High 
susceptibility 50% immunosuppression with 0.7-2.3 kJ/m 2 UV) and intermediate 
phenotype (intermediate susceptibility 50% immunosuppression with 4.7-6.9 
kJ/m2 UV). To relate this to the work of Streilein, Balb/c were classified as LO, 
C3H/eN intermediate and C57BL as HI. These phenotypes do not correlate 
with the MHC haplotype and the findings of Noonan and Hoffman, are in 
disagreement with Streilein's findings, as by their definition C3H/eN and 
C3H/eJ strains did not differ in their susceptibility, despite the differences at the 
LPS loci. Also, as the TNFa loci is located within the MHC loci, differences in 
these genes likewise failed to affect the UVB immunosuppressive phenotype 
seen. Noonan and Hoffman (1994b) did, however, find that the control UVB 
induced immunosuppression was controlled by at least three separate loci 
(Uvs1, Uvs2 and Uvs3), one of which was sex linked, while the other two were 
autosomal. None of these genes were linked to either pigment loci. 
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From these studies in experimental inbred animals it is clear that the 
genetic control of the UVB immunosuppressive phenotype is complex. This is 
likely to be even more so in the outbred human population and it may be some 
time before it is fully understood. 
1.6.3 	Adhesion Molecules 
A wide variety of adhesion molecules are expressed by cells of the skin 
and the blood vessels in the dermis, including integrins, selectins, addressins 
and those of the immunoglobulin super family. Many of these adhesion 
molecules play a role in inflammatory responses triggered by a variety of 
factors, such as ultraviolet light. E-Selectin (ELAM-1) is expressed at high 
levels at sites of acute UVB inflammation and act as a vascular homing 
molecule for neutrophils and memory T lymphocytes, (Norris etal., 1991) Also 
thought to act in a similar way during immune responses are the ICAM and 
VCAM families of adhesion molecules. 
E-selectin is up-regulated on dermal post capillary venules during 
inflammatory responses (Waldorf et al., 1991) including up-regulation on 
vascular endothelium and polymorphonuclear cells after UV exposure (Norris et 
al., 1991). This group also looked at VCAM-1 and ICAM-1 expression in 
human skin after a DTH response and after skin was exposed to 2 or 8 MED 
dose of UVB. The group found that there was no significant induction of either 
adhesin during the 72 hours post UV treatment. Slight up-regulation of ICAM-1 
occurred on endothelial cells. This is supported by Cornelius etal., (1994) who 
demonstrated up-regulation of ICAM-1 on microvascular endothelial cells of the 
dermis in vitro after UVB irradiation. A UV irradiated keratinocyte cell line has 
been shown to have a biphasic expression of ICAM-1 with an initial inhibition at 
24 hours followed by induction at 48,72 and 96 hours (Norris etal., 1990). 
UVB treatment of melanocytes or a melanoma cell line shows a similar 
effect of UVB on ICAM-1(Kirnbauer etal., 1992), although a variety of cytokines 
in the same study were seen to up-regulate this molecule (IFNy, IL-1, IL-6, IL-7 
and TN93). ICAM-1 has also been shown to be down-regulated on cultured 
monocytes after UV exposure, thereby reducing their ability to act as accessory 
cells for T cell activation (Krutmann et al., 1990). 
ICAM-1 is an important adhesion molecule in the skin as it mediates the 
binding of T cells to keratinocytes (Dustin etal., 1988) and is one of the major 
adhesion molecules involved in the interaction of T cells and antigen 
presenting cells. LC, constitutively express this molecule (De Panfilis et al., 
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1990) and hence, down-regulation of this molecule could affect the ability of LC 
to stimulate T cells. Tang and Udey (1991) suggested that doses of UV light 
which are sufficient to cause down-regulation of ICAM-1 are ultimately cytotoxic 
for the LC. 
Alterations in adhesion molecule interaction between DC and T cells do 
occur after UV exposure of the skin as shown by the reduced ability of FITC + 
APC from UV irradiated mice to cluster to T cells. Also observed was an 
increase in the numbers of CD8+ T cells in the clusters (Muller et a/., 1994). 
The alteration in T cell subsets may mean different adhesins or a different 
combination of adhesion molecules is being expressed by the LC. 
More recently the decreased expression of E and P cadherins have been 
shown to be induced in melanocytes following UV irradiation (Seline et al., 
1996), which may alter melanoma binding to keratinocytes. This may increase 
the metastatic potential of transformed cells and has an inverse relationship 
with disease progression in melanoma (Seline et a/., 1996). This demonstrates 
how UV induced alteration of adhesion molecules can have profound effects 
1.6.4 	Cytokines and Soluble Factors Produced after UV 
Exposure 
1.6.4.1 	Urocanic Acid 
De Fabo and Noonan (1983) proposed that urocanic acid (UCA) a 
compound found within the epidermis was the chromophore for UV-induced 
immunosuppression. This substance is produced by the deamination of 
histidine by the enzyme histidine ammonia lyase (histidase). The enzyme is 
present in high amounts in only two tissues, the skin and liver (Noonan and De 
Fabo, 1981). UCA accumulates in the skin due to the lack of the catabolic 
enzyme urocanase (Noonan and De Fabo, 1981). UCA absorbs light in the 
ultraviolet region, undergoing photoisomerization from the trans to the cis 
isomer (reviewed by Noonan and Defabo 1992). 
UCA was proposed as the photoreceptor mediating UV induced 
immunosuppression due to UCA's absorption spectra closely matching that of 
the immunosuppression action spectrum (more so than DNA) together with its 
superficial location in the stratum corneum and photochemical properties (De 
Fabo and Noonan, 1983). The administration of UV irradiated urocanic acid 
(UV-UCA) to mouse skin suppresses DTH to herpes simplex virus (Ross et ai., 
1986) as well as increasing UV induced tumour yield and malignancy in the 
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hairless mouse (Reeve et al., 1989). In addition cis-UCA impairs induction of 
CHS and induces tolerance (Kurimoto and Streilein, 1992). Cis-UCA treatment 
also inhibits alloantigen presentation by LC enriched epidermal cells in MLR 
experiments (Beissert et al., 1995). UCA also increases keratinocyte 
production of PGE in the presence of histamine and induces weak ICAM-1 
expression, which is increased when combined with TNFa (Mitra etal., 1993). 
UV-UCA induces defects in antigen presentation by splenic DC (Noonan 
et a/., 1988) as well as reducing the numbers, and altering the morphology of 
LC in mouse skin (Kurimoto and Streilein, 1992) in a manner similar to the 
observed effects of cutaneous UVB treatment. In contrast to these results, 
topical application of cis-urocanic acid had no effect on the number of dendritic 
cells within the draining lymph node (Moodycliffe et al., 1992). The addition of 
anti-TNFa antibodies was able to stop the decrease in LC from the epidermis 
but this did not eliminate the changes in morphology as seen by Kurimoto and 
Streilein (1992). Moreover, the suppression of contact hypersensitivity by UV-
UCA appears to be mediated via TNFa, although the induction of tolerance or 
DTH was not mediated via this cytokine (Shimizu and Streilein, 1994). 
However, treatment with antibodies against UV-UCA were able to restore DTH 
responses (EI-Ghorr and Norval 1995). UCA therefore remains a strong 
contender for a major role in UV induced immunosuppression. However, this 
does not seem to exclude DNA damage also being important as both UCA and 
DNA mediate effects associated with immunosuppression (Reeve etal., 1996). 
1.6.4.2 	Cytokines 
UV light exposure of the skin induces many changes to the skin 
microenvironment, including the production of cytokines, which immunological 
effects (reviewed by Ansel et al., 1990, Luger and Schwarz, 1990, Takashima 
and Bergstresser, 1996). In the epidermis the main secretor of cytokines are 
keratinocytes, with the changes in cytokine profile of this cell being the subject 
of intensive study (reviewed by Takashima and Bergstresser, 1996, See Table 
3). LC production of cytokines after UV exposure of skin, while undoubtedly' 
important has not been extensively investigated. Further investigations on 
many of these cytokines are required to define if they have role in altering the 
skin immune system. 
1.6.4.2.1 	Interleukin 1 
IL-1 system consists of interaction between IL-la, IL-1t3, the IL-1 receptor 
antagonist (IL-1 RA) and the IL-1 receptors, type 1 and type 2. Exposure of the 
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C.ytoki  erenC .e0le 
Luger et al., 1981, Ansel et al., 1983, Kupper et al., 
1987, Gahring etal., 1984 
Human IL-1 a/13 
Mouse Ansel etal., 1988, Ansel etal., 1983 IL-1a 
Mouse Gallo etal., 1983 IL-3 
Human Urbanski etal., 1990, de Vos etal., 1994 IL-6 
Human Kondo eta!, 1988 IL-8 
Human Grewe etal., 1995, Enk etal., 1995 IL-10 
IL-10 Mouse Rivas and Ullrich etal., 1992 
Human Mohamadzadeh et al., 1995 
Mouse Gallo et al ., 1991 
Human Kock et al., 1990 
Mouse de Kossodo et al., 1995 
Mouse Iron et al., 1990 NGF 






Table 1.3 Keratinocyte derived cytokines up-regulated by UVB radiation 
(From Takashima and Bergstresser, 1996) 
skin to UV light may alter the natural balance of this complex cytokine system. 
Ansel et al., (1983) found that exposure of cultured keratinocytes to UVB 
resulted in increased production of IL-1 both intra and extracellularly. Also UVB 
exposure of murine skin in vivo caused epidermal cells to produce IL-1. IL-1 
production has been detected in the skin, post UVR in humans (Kupper et al., 
1987, Oxholm et al., 1988). While LC production of IL-1 appears to be 
unaltered by UV exposure (Rasanen et al., 1989), the production of a specific 
inhibitor of IL-1 is also observed after UV exposure of epidermal cells and 
keratinocytes (Schwarz etal., 1987). The inhibitor was termed contra IL-1 and 
was found in the serum of UVB irradiated mice (Schwarz et at., 1988). A 
possible candidate is IL-1 RA, which binds to the IL-1 receptor but produces no 
activation (Dripps et al., 1991). Hirao et al., (1996) demonstrated that a 
hundred fold excess of IL-1 RA is needed to inhibit the biological function of IL-1 
and that in human skin unexposed to UV IL-la dominates. However, in UV 
exposed skin IL-1RA is dominant (Hirao etal., 1996). Furthermore in the same 
study, exposure to 2 MED was shown to dramatically up-regulate IL-1 RA in the 
stratum corneum of human volunteers, leading to the suggestion that this may 
inhibit excessive inflammation and may account for some of the UVB induced 
immunosuppression. 
Studies using the HeCAT keratinocyte cell line, have demonstrated that 
TGFa, TGFP, IFNy IL-6 and TNFa increase IL-la production, while no effect on 
mRNA of IL-1RA was evident. This suggests that the balance between IL-la 
and IL-1RA is due to the levels of IL-la, not IL-IRA, which remains constant 
(Phillips etal., 1995) which is in direct contrast to Hirao's hypothesis. 
Interestingly while proposed as antagonistic in inflammation, 
immunosuppressive effects of both IL-1RA and IL-la have been demonstrated. 
IL-IRA injection into the skin prior to sensitisation with DNFB inhibits ear 
swelling by 36-43% (Kondo et al., 1995). IL-1a has been shown to suppress 
the ability of LC to present tumour antigens to CD4 + T cells (Grabbe et al., 
1994), as well reducing CHS (Robertson et al., 1987). Enk et al., (1993a) 
demonstrated that LC from IL-la injected mice have reduced capacity to 
stimulate anti-CD3 treated T cells. It appears that IL-la and IL-10, which is 
only produced by LC in the epidermis, have different roles in CHS responses, 
with IL-113 being crucial in the induction of CHS (Enk et al., 1993a). IL-10 
expression has been shown to increase LC after the contact sensitiser 
application to the skin (Enk et at., 1992) but, as yet, no evidence has been 
forthcoming about IL-10 production after UV exposure. 
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In the skin, interactions between IL-la, IL-10 and IL-1 receptor type 1 all 
induce inflammatory reactions; IL-1 RA and IL-1 receptor type 2 appear to 
down-regulate these responses (Kupper and Groves 1995). Further studies of 
the interaction of this system after UV exposure of the skin, should reveal in 
detail more on the role of the IL-1 family in the suppression of cutaneous 
immune responses. 
1.6.4.2.2 	Interleukin 10 
Schwarz et a/., (1987) showed that serum from UVB irradiated mice was 
able to induce systemic suppression. Furthermore, UVB exposure of cultured 
human keratinocytes resulted in the production of IL-10 in vitro, which caused 
systemic immunosuppression when the supernatant's were injected into mice 
(Rivas and Ullrich, 1992). Further evidence of UV induced IL-10 production by 
human keratinocytes was shown both in vitro and in vivo by Enk et a/., (1995). 
UVB strongly stimulates IL-10 production, however, UVA-1 (340-400nm 
wavelengths) were most stimulatory (Grewe etal., 1995). However, Teunissen 
etal., (1994) reported that human keratinocytes were unable to produce IL-10. 
This was supported by Jackson et al., (1996) who were unable to detect IL-10 
secretion from a transformed keratinocyte cell line. Higher doses of UV were 
required to produce barely detectable, IL-10 mRNA production and this 
required more extensive PCR than Grewe's study and no protein was detected. 
In reply Grewe et al., (1996) suggested that the reverse transcriptase-
polymerase chain reaction method used by Jackson may have lacked the 
sensitivity of their system. Grewe et a!, (1996) also argued that the use of non-
neutralising antibodies in their ELISA's increased sensitivity. 
Although keratinocyte production of IL-10 is controversial, this may be 
irrelevant as Kang et al., (1994) only detected slight increases in keratinocyte 
IL-10 mRNA after UVB exposure whereas large amounts of IL-10 were 
produced by CD111D+ macrophages, which infiltrate the epidermis after UVB 
exposure (Cooper etal., 1992). Kang etal., (1994) demonstrated that the skin 
infiltrating macrophages production of IL-10, far outweighed that of the 
keratinocytes, suggesting that infiltrating macrophages were the major source 
of IL-10 in the epidermis after UVB exposure. 
IL-10 has been shown to down-regulate many aspects of the skin immune 
system including inhibition of CHS (Fergusson etal., 1994, Peguet-Navarro et 
a/., 1994). Such inhibition of CHS was seen to occur at the effector phase of 
CHS and not during the induction of CHS (Schwarz etal., 1994). However, the 
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same study showed that IL-10 inhibited both the initiation of DTH and its 
effector phase. This is supported by Rivas and Ul!rich, (1994) who found that 
the systemic administration of anti-IL-10 antibodies to mice blocks the ability of 
UV suppressor cells to DTH but not the suppressor cells which suppress CHS. 
CD4+ Th2 cells isolated from spleens of UV irradiated mice produce IL-10 
inhibit Th1 cells (Yagi etal., 1996), hence inhibiting DTH and CHS responses. 
Local IL-10 production in the skin, by infiltrating macrophages restricts the 
ability of LC to stimulate an effective Th1 cell response, instead anergy of Th1 
cells occurs, but the ability to stimulate a Th2 response is unaltered (Enk et a/., 
1993b). This is supported by Ullrich, (1994) who found that adding IL-10 from 
UV irradiated cultured keratinocytes to splenic APC caused inhibition of antigen 
presentation to Th1 cells and enhanced stimulation of Th2 responses. LC also 
lose their ability to stimulate a primary allogeneic response when incubated 
with IL-10 (Peguet-Navarro etal., 1994). This may be due to loss of important 
co-stimulators such as down-regulation of B7-2 which occurs after addition of 
IL-10 to human peripheral blood DC (Buelens et al., 1995). The ability of LC to 
present tumour antigens is also down-regulated by incubation with IL-10, which 
overcomes the GM-CSF induced maturation of normal LC APC function. 
Ullrich, 1996 showed that in vitro and in vivo administration of anti-IL-10 mAb 
restores the lost antigen presenting function of splenic DC 
The many down-regulatory effects of IL-10 on CHS, DTH, antigen 
presenting function of LC and its ability to stimulate Th2 cells while inhibiting 
Th1 cells has resulted in IL-10 being regarded as "the primary mediator of UVB 
induced local as well as systemic suppression" (Takashima and Bergstresser, 
1996). 
1.6.4.2.3 	Other Interleukins 
The production of a number of other interleukins have been shown after 
UV light exposure of the epidermis (See Table 3). While IL-3 is produced in 
mice after irradiation it does not appear to be generated by human 
keratinocytes and "IL-3 like activity "in human skin can be inhibited by 
antibodies to GM-CSF and IL-6 (Kondo et al., 1995). 
IL-6 is a pro-inflammatory cytokine which has been shown to be produced 
in the skin of humans; the peak serum levels occurs 12 hours after severe 
sunburning, correlating with fever production (Urbanski et a/., 1990). It was 
shown by Kirnbauer etal., (1991) that keratinocytes were able to produce IL-6 
and increased serum levels were proposed to arise from this confirming the 
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hypothesis developed by Urbanski et al., (1990). IL-6 is involved with the 
production of acute phase responses but its role, in the skin immune system is 
unknown. 
IL-8 is a pro-inflammatory cytokine produced in the epidermis and causes 
neutrophil chemotaxis to sites of inflammation. Furthermore, IL-8 production is 
greatly increased after UV exposure (reviewed by Luger and Schwarz, 1990); 
IL-8 production is seen within an hour and the levels of mRNA expression 
increased 11-13 fold (Kondo et al., 1993). The accumulation of neutrophils in 
sunburned skin (Logan and Wilhelm, 1963, Hawk et al., 1988) correlates with 
the production of this cytokine (Strickland et al., 1997). 
The induction of IL-15 has been noted after UV exposure and found to be 
produced by keratinocytes and dermal fibroblasts (Mohamadzadeh et a/., 
1995). Blauvelt et a/., (1996) reported that freshly isolated keratinocytes and 
cultured keratinocytes expressed IL-15 mRNA in vitro which was down-
regulated by UV exposure in a time and dose dependant manner. Blauvelt et 
al., (1996) were unable to explain their contrasting results with those of 
Mohamadzadeh et al., (1995). Blauvelt et al., (1996) also showed that IL-15 
mRNA was expressed by LC and blood dendritic cells, and proposed that IL-15 
may contribute to the enhancement of Th1 like responses, thus down-
regulation of its production after UVB exposure, may contribute to UV induced 
reduction of Th1 like responses. Before the role of this cytokine can be 
established in the immune alterations following UV exposure, further studies 
are required on whether its production is enhanced or suppressed by UV light. 
While there is no evidence for IL-4 production by cells of the skin after UV 
light, CD4+ Th2 cells isolated from the spleen of UV irradiated mice produce IL-
4 (Yagi etal., 1996). Further, antibodies to IL-4 are able to reduce the ability of 
UV induced suppressor cells to suppress DTH responses but no reduction for 
CHS responses was observed (Rivas and Ullrich, 1994). This suggests that 
the suppression of these responses involve different mediators, recent studies 
in IL-4 deficient mice confirm these findings (El-Ghorr and Norval, 1997). 
1.6.4.3 	TNFa 
Tumour necrosis factor a (TNFa) is a pro-inflammatory cytokine that is 
produced by a number of different cell types in the skin. These include pre-
formed storage in mast cells (Gordon et a/., 1990) and induced expression in 
keratinocytes (Koch et al., 1990), activated Langerhans cells (Larrick et al., 
1989) and dermal dendritic cells (Nickoloff etal., 1991). Two TNFa receptors 
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are described; TR60 (Type I, 55kD) and TR80 (type II, 75kD), with lymphoid 
cells expressing type ll and cells of epithelial origin express type I (Grell et 
a/.,1994). The expression of this cytokine has been shown to be dramatically 
increased after exposure of the skin to UVB irradiation (Oxholm et al., 1988). 
TNFa is considered to have major role in UVB induced changes in 
inflammatory and immune reactions, including down-regulation of CHS 
responses (Yoshikawa and Streilein, 1990). Cis-UCA generated by the UV 
exposure of the epidermis appears to mediate its effects on CHS via TNFa 
(Kurimoto and Streilein, 1992). 
TNFa affects inflammatory and immunological responses in the body. 
These include the induction of other cytokines, including IL-la, but not its 
receptor antagonist (Phillips et al., 1995). It also has a role in the recruitment 
of cells to areas of inflammation by affecting adhesion molecule expression in 
the surrounding environment (Strickland et al., 1997). Intradermal injection of 
recombinant human TNFa up-regulates ICAM-1, VCAM-1 and E-Selectin in 
vivo (Groves et al., 1995). E-Selectin was found to up-regulated on dermal 
microvascular endothelial cells after release of TNFa by dermal mast cells 
(Waldorf et al., 1991). CD44 also appears to be up-regulated, which appears 
to be involved with increased binding of leucocytes to the endothelial surfaces. 
(Osada et al., 1995) The increased expression of CD44 and E-Selectin is 
thought to be involved with increased infiltrates of neutrophils and mononuclear 
cells seen after UV light exposure (Norris et al., 1991, Osada et al., 1995, 
Strickland et al., 1997). 
Further evidence of the importance of TNFa comes from the study by 
Walsh, (1995) who found that UVB irradiation in vitro and in vivo resulted in 
TNFa release from mast cells which, in turn, leads to increases in ICAM-1 and 
E-Selectin expression on endothelium, within 2 hours of UVB exposure. This 
was found to be independent of the epidermis, suggesting that keratinocytes 
only make a small contribution to the acute release of TNFa. However due to 
the extent of the epidermis and the fact that keratinocytes produce this cytokine 
after UVB irradiation, it seems likely that TNFa release by keratinocytes may 
contribute to the later stages of the UVB inflammatory process. 
TNFa was originally named because of its ability to kill tumour cell lines. 
Today it is a cytokine known to be involved with the induction of apoptosis 
(Grell etal., 1994). TCR mediated TNFa induced apoptosis has been shown 
for mature T cells via the TR-80 receptor. This was found to be more important 
in mediating CD8+ T cell apoptosis than CD4+ T cell apoptosis, which was 
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mediated mostly via Fas and Fas Ligand interaction (Zheng et al., 1995). The 
55kD version of the TNF receptor is expressed by keratinocytes and has a 
"death domain" homologous to that of Fos and this has been implicated in the 
induction of apoptosis in non-lymphoid cells (Grell etal., 1994). TNFa has been 
recently shown to be involved in the formation of sunburn cells (Schwarz et al., 
1995), as injection of anti-TNFa reduced UV induced sunburn cell formation, 
although the cytokine by itself was not sufficient to induce sunburn cell 
formation. 
TNFa also has a role in regulating the survival and migration of dendritic 
cells found in the skin. TNFa has been shown to support the survival of LC in 
the murine system but this did not result in the acquisition of accessory cell 
function (Koch et al., 1990). In the ovine system TNFa supports survival of 
afferent lymph DC, whereas GM-CSF does not (Haig etal., 1995). 
TNFa has been proposed to stimulate LC migration from skin to the 
draining lymph node (Cumberbatch and Kimber, 1992). This group injected 
increasing doses of TNFa intradermally into Balb/c mice and found that DC 
accumulation in the lymph node was increased after just two hours. This 
group subsequently found that TNFa was required for both migration and 
optimal contact sensitisation (Cumberbatch et al., 1995). In contrast 
Yoshikawa et al., (1992) found that injection of 5Ong INFa (identical in amount 
and activity to that used by the previous group) intradermally, followed by 
cutaneously applied hapten, led to the retention of LC within the epidermis. 
However, previous studies by the Streilein had shown that there was indeed a 
30% reduction of la + (LC) within the epidermis after 2 hours but LC numbers 
returned to normal within 24 hours (Vermeer & Streilein, 1990). This data 
suggests, that the differing time courses of the experiments may have lead to 
differing results for these two groups. Further evidence for the DC depleting 
effect of TNFa comes from systemic administration of the cytokine where DC 
were depleted from heart, kidney and skin (Roake et al., 1995). Zanella et al., 
(1995) recently found using skin organ culture that low doses of TNFa (50- 
100U/m1) enhanced LC emigration by 167%. However high doses >1000 U/ml 
suppressed emigration, possibly due to toxicity. At this time it is still unknown 
whether TNFa acts on DC directly or via cytokine cascade. 
1.6.4.4 	Prostaglandins 
Increases in prostaglandin (PG) production after UV exposure of the skin 
have been demonstrated (Imokawa and Tejima, 1989) and the prostaglandins 
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produced were PGE2, PGF2 c, and PG 6-oxo-F ia. Treatment of the skin with 
indomethacin, (an inhibitor of PG synthesis) after UV exposure leads to a 
decrease in erythema (Lim et al., 1983, Farr and Diffey, 1986) but did not 
prevent decreases in the density of LC (Lim et al., 1983). However, 
administration prior to UV exposure was shown to stop LC depletion but this 
was found to be due to the ability of indomethacin to absorb light in both the 
UVA and UVB portions of the spectra, as oral administration of indomethacin 
did not stop LC depletion. However, oral administration of indomethacin has 
been shown to partially reduce the depression of CHS by UV exposure (Chung 
et a/., 1986, Jun et al., 1988). The production of PG after UV exposure may 
have immunodulatory effects on the skin immune system. However, it is likely 
that these effects are minor compared to that of IL-10 and TNFa. Interestingly 
both TNFa and IL-la, which are produced in the skin after UV light exposure, 
up-regulate keratinocyte synthesis of PGE 2 (Grewe etal., 1993). 
1.6.5 	Effects of UV on Langerhans Cells and Antigen 
Presentation 
LC are the only constituent antigen presenting cell type found within the 
epidermis and, after exposure to UV alterations in LC morphology and kinetics 
have been observed (Aberer et al., 1981, Obata and Tagami 1985). LC are 
considered to be an important cell type in the lowering of immune function and 
the induction of tolerance after UV exposure (Simon et al., 1990 and Simon et 
al., 1991). 
Alterations in LC where first shown by Fan et al., (1959) who examined 
high, clear level cells (Langerhans cells) of the epidermis and found they were 
difficult to demonstrate in human epidermis after exposure to UV light In 1967 
Wolff and Winkelmann exposed guinea pig skin to ultraviolet light which 
revealed no changes in LC distribution. In this study, while the exposure times 
were identical to those used in the previous study, however, no treatment dose 
was given in either study. In contrast to this, a histochemical study of the 
human epidermis after a single exposure to 6 MED of sunlight, undertaken by 
Zelickson and Mottaz (1970) revealed that the number of LC present in the 
epidermis was decreased. Repeated daily exposure for two weeks showed an 
absence of LC from the epidermis. Additional studies have revealed that LC 
are depleted from the human epidermis after UV treatment (Aberer et al., 1981, 
Cooper et al., 1992). This has also been demonstrated for other animal models 
including that the guinea pig (Lim etal., 1983) and a variety of murine models 
(Aberer etal., 1981, Obata and Tagami, 1985). Recently, UV damaged LC 
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expressing thymine dimers have been shown to migrate to the lymph node one 
hour after UV exposure (Sontag etal., 1995), indicating that the depletion of LC 
from the skin from UV irradiated skin may be associated with an increase in 
migration. 
While the depletion of LC from the skin would reduce the immunological 
ability of the epidermis to respond to foreign antigens this is not the only effect 
UV light has on LC. It has also been demonstrated extensively that UV light 
exposure affects APC function. Levis etal., (1978) found that the ability of UV 
treated APC to stimulate hapten (DNCB) specific autologous lymphocytes in 
primary culture was abrogated and the ability of APC to stimulate blast cells in 
secondary culture was diminished but not eliminated. They suggested that this 
may be due to the alteration of cell surface markers, as well DNA by UV light. 
The effects of UV light in APC function, was also studied in vivo by Greene et 
al., (1979) who reported that TNP derivatised APC from UV irradiated mice 
failed to induce an immune response in UV irradiated syngenic mice, when 
compared to normal APC. This failure to induce immunity was associated with 
suppressor T cells. In vitro studies by Stingi et a/., (1981) have also shown that 
the ability of epidermal cells to stimulate T cells was reduced in a dose 
.dependent fashion after exposure to UV. No epidermal cell death was 
observed, however as LC made up only 3-5% of epidermal cells, specific 
cytotoxic effects on these cells could not be ruled out, although similar 
percentages of LC were found in epidermal cells preparations, both before and 
after irradiation. The loss of cell surface markers was put forward as the most 
likely explanation for these events. This suggestion was consistent with data 
showing exposure of LC to UV light lowers ATPase activity in vivo (Toews et 
al., 1980). A reduction in the expression of MHC ll was seen by Aberer et al., 
(1981) using 600-800 J/m2 UV, although this is a topic of debate as this may 
have been due to the loss of the cells expressing this marker. Exposure to 
milder doses of UV light in vitro (200J/m2) had little effect on the retention of la 
(murine MHC II) antigen or the 16 antigen (Czernielewski et a/., 1984). Recent 
work suggests that no reduction in MHC II expression is seen in FITC + DC 
migrating after a dose of 2 kJ/m 2 (Muller etal., 1994). 
The loss of important co-stimulator expression may, in turn, provide at 
least a partial explanation for the reduction in LC function observed after UV 
exposure. This has been shown as a reduced T cell proliferative response 
(Stingl etal., 1981) and by a loss of DTH response (Perry and Green et al., 
1982). Loss of CHS response after UV irradiation is also associated with 
55 
deficient antigen presentation (Noonan etal., 1981). It should also be noted 
that splenic APC function is down-regulated after UV exposure (Kripke, 1984) 
which may be mediated by UV-UCA (Noonan et al., 1988), suggesting a 
systemic reduction in APC function after UV exposure of the skin. 
The reduction in the ability of enriched T6+ LC to induce an ELR was 
shown to be reduced immediately after exposure of the skin to UV, when 
compared to non-irradiated controls (Cooper et al., 1985b). Further, this 
reduction in allostimulatory activity was not reversed by the addition of 
indomethacin or IL-1 to the culture system. It can be speculated that the 
production of IL-10 by keratinocytes or UV induced macrophages may be able 
to down-regulate the co-stimulator B7-2 on LC, as has been shown to occur 
after addition of IL-10 to human peripheral blood DC (Buelens et al., 1995). IL-
10 is proposed to mediate the systemic suppression of APC function observed 
after UVB exposure (Ullrich, 1996). LC can be induced to express the B7-1 
and B7-2 co-stimulatory molecules after culture, however, UVB exposure of 
epidermal cell suspensions, with doses ranging from 100-200 J/m 2 , reduce 
functional B7-1 and B7-2 expression in a dose dependant manner. This could 
be partially restored with sub-mitogenic doses of anti-CD28 mAbs (Weiss et al., 
1995). Since LC could not be returned to their full allostimulatory capacity. 
Weiss et al., (1995) suggests that this may be due to the presence of an 
inhibitory cytokine, with possible candidates being PGE, IL-1, IL-10 or TNFa 
produced after UVB exposure. Any loss of B7 expression would render the LC 
less able to stimulate T cells, as the interaction without B7, may lead to anergy 
reviewed by Linsley and Ledbetter (1993) and possibly to specific down-
regulation of Th1 responses (reviewed by Constant and Bottomly, 1997). In 
support of this hypothesis is crucial evidence presented by Simon et al., 1990 
which shows that LC from UV irradiated skin are able to stimulate Th2 cells but 
not Th1 cells. Furthermore LC from UV treated skin can induce anergy in Th1 
cells (Simon et al., 1991) which appear to be essential for cellular immune 
responses such as DTH and CHS. Thus generating Th2 "suppressor cells" and 
reducing or eliminating Th1 "effector cells", both of which are required for UV 
immunosuppression. 
1.6.6 	UV Induced Macrophages 
UV irradiation reduces allostimulatory capacity of DC isolated from the 
epidermis immediately after treatment, however, three days later an increase 
in the allostimulatory capacity was noted. This increased allostimulatory 
capacity was shown to be due to T6- DC, which were seen to infiltrate the 
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epidermis at this time (Cooper et al., 1985b). These infiltrating DC, expressed 
the monocyte specific marker, OKM5 (CD36) (Cooper et al., 1985b). 
Suggesting that the cells were of the monocyte/macrophage lineage. These 
cells were shown to be capable of inducing T cell proliferation and were able to 
act as stimulators of an autologous ELR (Cooper et al., 1985b) and were 
subsequently shown to express MHC II (Baadsgaard, 1987). 
A later study by Cooper et al., (1992) showed a sub-population of the 
infiltrating cells were non-dendritic neutrophils which is consistent with data 
obtained from studies on other species (Logan and Wilhelm, 1963, Logan and 
Wilhelm, 1966b) including humans (Hawk etal., 1988). Another sub-population 
of infiltrating DC expressed high levels of the macrophage marker, CD11 b and 
co-expressed high levels of MHC II. Timing of the peak infiltration of this sub-
population coincided with the return of UVB epidermal APC function from 21% 
to 59% at three days and the maximal depletion of LC. Hammerberg et al., 
(1994) demonstrated this sub-population of infiltrating cells when isolated from 
UVB exposed, hapten treated skin led to re-sensitisation, rather than tolerance. 
These were also shown to stimulate suppressor inducer cells (Th2) and CD8 
cells with the addition of IL-2 (Baadsgaard, 1988 and Baadsgaard 1990). 
It has also been shown that the UV induced macrophages are a major 
source of IL-10 secreted in the epidermis post irradiation (Kang etal., 1994. As 
IL-10 is a potent down-regulator of Thl (cellular) immune responses (Del Prete 
et al., 1992), this provides a mechanism by which the infiltrating macrophage 
population can suppress cellular immune responses generated by LC. Recent 
work has found that infiltrating UV-induced macrophages appear to come from 
the expansion of a subset of dermal macrophages (Meunier et al., 1995) which 
are CD36+ CD11b+CD1-. 
One study by Kurimoto etal., (1994) using mice, has produced data which 
contradict Cooper's theory that macrophages mediate the down-regulation of 
immune function after UV exposure. This investigation used liposomes which 
contained dichloromethylene diphosphonate, which selectively kills phagocytic 
macrophages and showed that these cells play a role in generating CHS 
responses in UV resistant mice, but had no effect on tolerance induction in UV 
resistant mice. Although they were trying to compare their results to those of 
Cooper's group, the UV irradiation consisted of four treatments, whereas 
Coopers group used a single dose. No immunohistochemical studies were 
performed to show that macrophages were depleted the skin, which may be 
important as Weber-Matthiesen and Strerry, (1990) found that OKM5 + 
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macrophages are non-phagocytic, so they may not have ingested the 
liposomes. 
While strong evidence exists in humans for the infiltration of macrophages 
after UV, less is known about this in animal models. After UVB exposure of the 
skin, macrophages do appear in the lymph nodes of mice (Tang et al., 1992). 
Evidence in mice shows an increased proportion of DC expressing CD11 b 
(Mac-1) binding to CD4 and CD8 positive cells (Muller et al., 1994). It should 
be noted that epidermal LC in the human (De Panfilis et al., 1989) and cultured 
murine LC (Tang etal., 1992) also express CD11 b and therefore it cannot be 
taken as a specific marker of macrophages. 
The timing of the maximum migration of UV induced macrophages into the 
skin coincides with the maximal depletion of LC as they secrete IL-10 (Kang et 
a/., 1994) and stimulate suppressor inducer T cells (Baadsgaard, 1988 and 
1990), both which result in down-regulation of Thl immune responses. It would 
therefore appear that the infiltrating macrophages may contribute to UV 
induced immunosuppression. 
1.6.7 	yg T Cell Changes 
UVB exposure of murine skin can completely deplete DETC from the 
epidermis (Aberer et a/., 1986 and Alcalay et al., 1989). This depletion was 
sustained and Thy-1 DEC did not reappear until 14-22 weeks following 
exposure of the skin, whereas as influx of LC was continuous (Aberer et a/., 
1986). The doses used were 4 exposures to 700 J/m 2 or a single exposure of 
1000 J/m2. Chronic exposure, such as that used by Alcalay et al., (1989) 
consisting of 8 kJ/m 2 three times a week until the mice became moribund from 
the tumours induced, resulted in these cells being consistently absent, after 43 
weeks post treatment. LC were observed to return to the skin and infiltrate 
tumours (Alcalay et al., 1989). This suggested to the authors that the tumours 
persisted, because of the lack of Thy-1 DEC and their cytotoxic potential. 
Love-Schmenti and Kripke (1994) found that DETC incubated in the presence 
of IL-2, were capable of deleting hapten specific autologous T cells. The lack of 
DETC network in the human and ovine systems suggests that the relevance of 
these cells may be limited to the murine system. 
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1.6 SUMMARY 
As well as acting as a physical barrier, the skin is an immunological 
barrier due to the interaction of many cells in the skin. LC have an extremely 
important role in initiating and stimulating immune response by migrating to the 
draining lymph node and presenting antigens to T cells, in a manner which 
induces efficient proliferation and generation of effector cells. The keratinocyte 
is able to secrete a vast array of cytokines and soluble mediators, which in turn 
affect LC and attract other cells into the skin. Other minor skin cell populations 
may also play a role in the skin immune system. 
Human skin is often exposed to ultraviolet light in sunlight. The exposure 
of the skin to UV down-regulates the skin immune system by inducing a number 
of cellular changes. The trigger(s) for these effects are thought to be direct 
DNA damage of cells or photoisomerization of trans to cis-UCA and its 
subsequent interaction with cells in the skin. These alterations induce changes 
in the cytokine profile of keratinocytes. Further, LC antigen presenting function 
appears to be altered so the Th1/Th2 balance is tipped in favour of Th2 cell 
function. Further, population of macrophages which secrete IL-10, thereby 
suppressing Th1 responses, migrates into the epidermis. These events 
combine, leading to the generation of suppressor T cells, which would appear 
to produce Th2 cytokines, thus further disrupting cell mediated immune 
responses by inhibiting effectors of the Th1 subtype. The induction of specific 
suppression of CHS and DTH responses is evident and is believed mediated 
by TNFa and IL-10 respectively. IL-10 suppresses the effector phase of both, 
possibly by inhibiting APC production of IL-12 via down-regulation of co-
stimulators. These changes in the cellular arm of the skin immune system 
would increase susceptibilty to viral infection and greatly reduce any effective 
immune response to tumour which may arise in the skin as a result of UV 
induced mutation. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1 ANIMALS 
Outbred Polwarth/Comeback sheep, 6-12 months old, were obtained from 
the University of Tasmania Farm at Cambridge, Tasmania via the Central 
Animal House, University of Tasmania. The sheep were obtained and used 
with the permission of the University Ethics Committee (Animal 
experimentation). Sheep were kept in individual metabolism cages and had 
free access to lucerne chaff stock pellets (Gibson Stock feed, Cambridge, 
Tasmania), water and salt lick. 
2.2 SURGICAL METHODS 
All Surgery was performed by Dr. Geoffrey W. Dandie, Division of 
Pathology, University of Tasmania. "Pseudoafferent" prefemoral lymphatic 
vessels were generated by removing prefemoral lymph nodes 8-12 weeks prior 
to cannulation by the method described by Hopkins et al., (1985). This allowed 
the afferent lymphatic vessels to re-anastomose with the remaining efferent 
lymphatic vessels. The prior intradermal injection of patent blue dye into the 
flank skin was used to identify during surgery which pseudoafferent vessels 
were cannulated by the method of Hall and Morris (1962). 
2.3 LYMPH COLLECTIONS 
2.3.1 	Routine Lymph Collections 
Lymph draining from the cannulated pseudoafferent vessel was 
continuously collected in 100 ml bottles (Nalgene, Nalge Labwear, Rochester, 
New York, USA) containing 500 units of sodium heparin (Commonwealth 
Serum Laboratories (CSL), Parkville, Victoria, Australia) and 100 units 
penicillin (David Bull Laboratories (DBL), Mulgrave, Victoria, Australia). 
Collection bottles were changed at intervals of 8-16 hours. The cell 
concentration in the lymph was determined either using a model DN Coulter 
cell counter (Coulter Electronics Ltd., Harpenden, England) or by cell counts 
under a light microscope using an improved Neubauer counting chamber. Cell 
viability was assessed but uptake of 0.25% trypan blue stain (Sigma, St Louis, 
MO, USA). 
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2.3.2 	Sterile Collections 
Collection of lymph under aseptic conditions was undertaken when cells 
were required for culture or when lymph supernatants were required for 
analysis. Clean bottles were autoclaved at 121°C for 15 minutes with a piece of 
autoclave indicator tape placed over the nipple top. The bottle was opened 
under sterile conditions and 500IU of heparin (CSL) and 10000IU of gentamicin 
sulphate (DBL) was added and the lid replaced. When the bottle was tied onto 
the side of the sheep the cannula was wiped with 0.5% chlorohexidine 
(Hibitane, ICI Pharmaceuticals, Melbourne, Australia) in 70% ethanol (CSL), 
the tape removed from the nipple and the cannula placed inside the bottle 
avoiding contact with contaminated surfaces. A piece of Hibitane soaked 
cotton surgical gauze was then wrapped tightly round the cannula and the 
nipple top of the bottle and secured by two wire ties to minimise contamination. 
2.4 UV TREATMENT 
The flank to be treated was shaved, exposing an area of approximately 
200 cm2 of the skin. The sheep was placed in a smaller metabolism cage to 
restrict its movement. The remainder of the body was protected by an 
aluminium backed reflective blanket. The bottles were removed from the sheep 
to prevent direct irradiation of the lymph. The sheep flank was then exposed to 
a bank of 6 pre-warmed (15 minutes) FS40 UVB emitting fluorescent lights 
(UVS, Ultraviolet Pty. Ltd., Scoresby Victoria, Australia) until the required UVB 
dose was reached (See Table 2.1). This dose was measured using an IL-1700 
research radiometer (International Light, USA) fitted with an SED240 detector 
with diffuser and UVB-1 filter. Due to the nature, shape and texture of the flank 
skin of individual sheep this dose is approximate only. The spectral stability 
and total irradiance of the lamps was monitored at intervals using a SR9910 
spectroradiometer (Figure 2.1). After the UV treatment new bottles were 
attached and collections recommenced. 
61 
Table 2.1 UV dose regime 
60 120 kJ/m2 80.4 kJ/m2 
30 60 kJ/m2 40.2 kJ/m2 
15 30 kJ/m2 20.1 kJ/m2 
6 12 kJ/m2 8.1 kJ/m2 




Spectral Output of Sunlamps at 15cm from source 
Total output 240-420nm = 36.60 w'm 2 
Total UV output 240-400nm 4.88 w'm 2 
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2.5 IMMUNOFLUORESCENT STAINING 
2.5.1 	Procedure 
Lymph was centrifuged at 800g for 5 minutes in 50 ml tubes (Corning, 
Corning, New York, USA). The supernatant was collected and stored at -80°C 
until cytokine assays were performed. The cell pellet was washed twice by 
centrifugation at 800g in phosphate buffered saline (PBS), which was prepared 
by a 1/20 dilution of PBS stock solution in Milli-Q water. This stock solution 
was prepared by dissolving 170 g NaCI (anhydrous) (BDH Chemicals, Australia 
Pty. Ltd. Kilsyth, Victoria), 21.4 g Na2HPO4 (anhydrous) (BDH) and 7.8 g 
NaH2 PO4.2H20 (BDH) in one litre of Milli-Q water. The centrifuged cells were 
resuspended in sterile PBS+2% bovine serum albumin (CSL) and 0.1% 
NaN3(BDH) (PBS-BSA-AZIDE) at a concentration of 2x107 cells per ml. 100p1 
of the washed cells were added to wells in a 96 well "v" bottom plate (Nunc, 
Roskilde, Denmark). The plate was centrifuged again at 800g, the supernatant 
discarded and the pellet resuspended in 50p1 of the appropriate monoclonal 
antibody and incubated for 30 minutes at room temperature. The cells were 
then washed three times by centrifugation in PBS-BSA-AZIDE and 
resuspended in 50p1 of sheep anti-mouse Ig F(ab') 2 fluorescein isothiocyanate 
(FITC) conjugate (Silenus Laboratories (Silenus), Hawthorn, Victoria, 
Australia). The CTLA-4 and MCD40 fusion proteins were detected using 50m1 
anti-human FITC conjugate (Silenus) and 50p1 of sheep anti-mouse Ig F(abi)2 
phycoerytherin conjugate (Silenus) was used to identify SBU-T6 positive DC. 
Labelled cells were washed three times by centrifugation in PBS-BSA-AZIDE 
before being resuspended in 150p1 of 500m1 PBS with the following additions 
13m1 40% Formaldehyde (BDH), 10g D-glucose (Ajax Chemicals Ltd. Sydney 
Australia) and 1.09 ml 15% NaN3 in PBS (BDH)(FACS FIX). The plate 
containing the fixed cells was covered in aluminium foil and stored at 4°C until 
analysed by flow cytometry. The above staining procedures were also 
performed on macrophages isolated from bronchial lavage fluid. 
Flow cytometric analysis in Chapter 3 was performed with the assistance 
of Mr Mark Cozens, Department of Pathology, University of Tasmania using an 
EPICS 741 flow cytometer (Coulter), who also asssisted in later studies in 
Chapter 4, which a detailed analysis of dendritic cell populations were carried 
out on either a FACSCAN (Becton Dickenson (BD), Immunocytometry systems, 
San Jose, USA) or Elite ESP flow cytometer (Coulter). Langerhans cells were 
identified by their forward and 90° scatter profiles and intensity of fluorescence. 
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	2.5.2 	Monoclonal Antibodies 
The mAb secreting cell lines producing anti-sheep CD4 (SBU-T4, Maddox 
et at, 1985) and T19 (y5 T-cells, McClure, et al., 1989) were used to produce 
specific monoclonal antibodies and were supplied by Dr C. Mackay (Basel, 
Switzerland) . Lyophilised supernatants against sheep MHC I (SBU 41-19, 
Gogolin-Ewens etal., 1985), MHCII (SBU 49.1- Pan MHC II, Puri etal., 1987a), 
CD1w1 (SBU-T6, Mackay et al., 1985), CD8 (SBU-T8, Maddox et al., 1985), 
CD4 (SBU-T4, Maddox etal., 1985) and T19 (y5 T-cells, McClure, et al., 1989) 
were obtained from Dr M. Brandon (Centre for Animal Biotechnology, School of 
Veterinary Science, University of Melbourne). The °M1, 0M2 and 0M3 mAbs 
were provided in the form of ascites fluid by Dr. J. Rothel (Centre for Animal 
Biotechnology, School of Veterinary Science, University of Melbourne) and 
were used with permission of Dr M. Pepin. These mAbs have been shown to 
react with ovine macrophages (Pepin et a/., 1992). A mAb against bovine 
CD14 (CC-G33) was also used and this was provided by (Dr. C. Howard, 
Institute of Animal Health, Compton, U.K.). Monoclonal antibodies were 
visualised using indirect immunofluorescence. The second layer antibody used 
was a fluorescein conjugated sheep F(ab) 2 portion of antibody specific for 
mouse immunoglobulin. Both fluorescein conjugated antibodies were obtained 
from Silenus Laboratories and were used at a 1/80 dilution in PBS-BSA-AZIDE. 
A summary of the monoclonal antibodies used in flow cytometric studies is 
presented in Table 2.2 
2.6 ASSESSMENT OF IMMUNITY TO OVALBUMIN IN SHEEP 
2.6.1 	Preparation of Serum 
10 ml of ovine peripheral blood was collected into a 10 ml sterile container 
(Disposable Products) and incubated at 37°C for one hour. The clot that 
formed was detached from the side of the bottle and stored at 4°C overnight. 
The serum was poured into a tube and centrifuged for 10 minutes at 2000g to 
remove cells. The complement in the serum was inactivated by incubating at 
56°C for 30 minutes. 
2.6.2 	Antigen Coating of Sheep Red Blood Cells 
400pg of ovalbumin (OVA) (Sigma) was added to 10 ml of a 5% solution 
of washed (3 times in normal saline) sheep red blood cells containing 450p1 of 
0.1% chromic chloride (BDH), in normal saline. Following a 10 minute 
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Table 2.2 Monoclonal Antibodies for Immunofluorescence 
ciono;:w Antigen piloo: : : : : :: : : ,::::•:: : ::: : , ; : :40#04-::: ,:::::::::::::::::::.::::::::::::::::::::::::::::.:::::::: :::.Reference/Remarks' 
SBU-I 
(41.19) 
WIC I undiluted 
supernatant 






M. Brandon and C. 
Mackay 





M. Brandon and C. 
Mackay 
Mackay etal., 1985 
*Reclassified as CD1w1 by 





M. Brandon and C. 
Mackay 





M. Brandon and C. 
Mackay 
Mackay etal., 1986 
Mackay etal., 1989 
SBU-II 
(49.1) 
MHC II undiluted 
supernatant 
M. Brandon Puri et al., 1985a 
0M1 CD11c* 1:80 acites J. Rothel 	. Pepin etal., 1992 
*Reclassified, as CD11c by 
Nassens etal., 1997 
0M2 Macrophage 
subset 
1:40 acites J. Rothe! Pepin etal., 1992 
0M3 Macrophage 
subset 
1:40 acites J. Rothel Pepin etal., 1992 





K. Shortman Linsley et al., 1991 
MCD4O-Hy1 B7 control undiluted 
supernatant 
K.Shortman Linsley etal., 1991 
DDAF mouse Ig 1:80 Silenus FITC congated F(ab')2 
HDF Human Ig 1:80 Silenus FITC congated F(abl2 
DDAPE mouse 1g 1:80 Silenus PE congated F(ab')2 
incubation at room temperature, coated erythrocytes were washed three times 
in PBS and made up to 10 ml with PBS. 
	
2.6.3 	Haemagglutination Assay 
25 pl samples of sheep serum (as prepared above) were diluted using 
serial 2 fold dilution in PBS across wells 1-11 of a 96 well round bottom 
microtitre plate (Nunc). Wells in column 12 contained only 25 pl of PBS and 
served as a negative control. 25 pl of a 2.5% suspension of OVA coupled 
sheep red blood cells (SRBC) was added to each well and mixed gently. The 
plate was then sealed with adhesive tape and incubated at 37°C for 1 hour. 
Antibody titre was determined by the reciprocal of the highest dilution giving 
50% agglutination of SRBC. 
2.7 ANTIGEN PRESENTATION ASSAY 
2.7.1 	Immunisation Procedure 
Alum precipitated OVA was prepared by the addition of 4.5 ml of 1 M 
NaHCO3 (BDH) to a 10 ml solution of 2 mg/ml of OVA (Sigma) in PBS. This 
was followed by the slow addition of 10 ml of 0.2 M AIK(SO 4 )2 .12H 20 (BDH) 
while stirring. The solution was left for 15 minutes at room temperature, then 
washed three times in PBS by centrifugation (300g for 15 minutes) and 
resuspended at the concentration required (method from Hudson and Hay, 
1980). 
Sheep were immunised twice over a 48 hour period by subcutaneous 
injection between the scapulae with a suspension of alum precipitated OVA (2 
mg/ml). This was repeated eight weeks later and serum antibody levels were 
determined by haemagglutination as detailed above. Re-immunisation was 
performed if the titres were low. 
2.7.2 	Collection Procedure 
Lymph from a cannulated pseudoafferent lymphatic vessel was collected 
under sterile conditions (see 2.2.2). 5-10 ml of peripheral blood from the same 
sheep was collected into a syringe containing heparin (CSL) at the same time 
as lymph was collected. 
2.7.3 	Assay Procedure 
This procedure was adapted from the method of Bujdoso et al., (1989) by 
Ragg et a/., (1995). Cells from sterile lymph were collected by centrifugation (5 
65 
minutes at 850g) washed twice in PBS and resuspended in 5 ml of RPM! 1640 
and gentamicin (100 units/mil) (RPMI-Wash media). This was layered over a 
14.5% metrizamide (Nycomed, Oslo, Norway)/15% FCS (CSL) gradient. The 
peripheral blood was diluted 1:1 with PBS and was underlayed with 5m1 
Histopaque 1077 (Sigma). The blood and washed cells were centrifuged at 
850g for 30 minutes. 
The peripheral blood mononuclear cells (PBMC) were collected from the 
Histopaque/serum interface and placed in a 10 ml tube. The DC were collected 
from the interface of the metrizamide gradient and placed in a 10 ml tube. The 
cells were washed twice in PBS and counted using an improved Neubauer 
counting chamber or DN coulter counter. PBMC were resuspended in RPMI 
1640 (HyClone), 2mM L-glutamine (CSL), 5x10-5 M 2-mercaptoethanol 
(Sigma), 100U/m1 gentamicin (DBL) and 5% FCS (RPMI+Supplements) and 
incubated at 37°C/5% CO 2 until required. The DC were resuspended at 2x106 
cells/ml in RPM1+100U/m1 gentamicin (DBL) (WASH MEDIA). The resulting 
suspension was divided into two tubes. To one tube, 10 mg/ml OVA in PBS 
was added to give a final concentration of lmg/ml, both cell suspensions were 
the incubated for 1 hour at 37°C. After incubation DC, were washed once with 
PBS and resuspended at 1x10 7 cells/ml in PBS. DC were then incubated in a 
25 pg/ml solution of Mitomycin C (Kogyo Co. Ltd., Kyowa, Haako, Tokyo 
Japan) for 20 minutes at 37°C. The suspension was made up to 10 ml and 
mixed by inversion and left to stand for 5 minutes allowing clumped dead cells 
to settle out. All but a small fraction of the suspension which contained 
clumped dead cells was removed and placed in a fresh 10 ml tube. This was 
washed twice by centrifugation in PBS and resuspended at 1x10 6 in 
RPMI+supplements. Assays were performed in triplicate using a 96 well round 
bottomed plate (Greiner, Frickenhausen, Germany). 100p1 of OVA pulsed DC 
were added to the first three wells and a 2 fold serial dilution was performed to 
1:16 dilution, 100p1 of PBMC were then added to each well. The same 
procedure was followed for unpulsed DC. Controls were used to assess 
proliferation of the separate cell populations which including pulsed DC, 
unpulsed DC or PBMC The cells were then incubated at 37°C/5% CO 2 for five 
days. 
All wells were pulsed with 10p1 tritiated ([ 3H]) thymidine (Amersham Life 
Science, Amersham, U.K.) 16 hours prior to harvesting. The cells were 
harvested on to glass filter paper (ICN Biomedicals, Aurora, Ohio, USA) using 
a cell harvester (Skatron, Australia) and counted in 0.5 ml of scintillation fluid 
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for one minute in a Rackbeta scintillation counter (LKB Wallac, Turku, 
Finland).The result was expressed as the stimulation index as shown below 
which has been used as a measure of antigen specific proliferation. 
Stimulation index = 3H-thymidine incorporation by PBMC+antigen pulsed DC 
3H- thymidine incorporation by PBMC+unpulsed DC 
2.8 STATISTICAL ANALYSIS 
The use of outbred sheep and the nature of the surgery involved, 
prevents direct comparison of the number of cells migrating from the skin of 
each sheep. Accordingly, only changes in the trend of cell migration 
associated with each treatment protocol have been compared. 
The normal range of lymphoid cell migration for individual sheep was 
calculated as twice the standard deviation of the mean of at least 4 collection 
points prior to the UV treatment. This represents >90% confidence interval 
(Zar et a/., 1984). This was used as a guide to determine the normal range 
migration of cell populations or the normal range of stimulation indices. This 
method was also used to assess the normal range of B7 expression on 
migrating LC and levels of cytokines prior to UV exposure of the skin. Where 
only two background points were used +/- 4.4 times the standard deviation from 
the mean was applied to set confidence limits of >90% (Zar et al., 1984). The 
stimulation indices for the functional studies were plotted showing the mean 
stimulation index +/- the error accumulated by the division of CPM of 
quadruplicate samples of PBMC cultured with antigen pulsed DC by mean CPM 
values of quadruplicate samples of PBMC cultured with unpulsed DC. 
2.9 CYTOKINE ELISA'S 
2.9.1 	IL-116 
This assay was based on the method described in Egan et al., (1994). 
The antibodies used in this assay were provided by G. Barcham, Centre for 
Biotechnology, University of Melbourne, Australia. The mAb directed against 
ovine IL-1f3 (Clone 3.41, ascites) was diluted 1:250 in 0.05M 
carbonate/bicarbonate buffer pH 9.6. This buffer was prepared immediately 
prior to use by the addition of 16 ml of 0.2M sodium bicarbonate to 34 ml of 0.2 
M sodium hydrogen carbonate and made up to 200 ml with Milli-Q water. 100 
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JAI of the antibody/buffer solution was added to each well of a 96 well ELISA 
plate (Disposable products, Sydney, Australia). Plates were incubated 
overnight at room temperature to allow coating of the plate with antibody. 
Plates were washed three times with PBS-TWEEN (PBS + 0.05% Tween (Bio-
Rad)) and non-specific binding sites blocked by the addition of 200 p.I PBS-
TWEEN+3%-FC. The plate was then incubated for one hour at 37°C and was 
then washed twice with PBS-TWEEN, before the addition of 1001.11 of duplicate 
samples and standards occurred. Re-incubation for one hour at 37°C was 
followed by four washes in PBS-TWEEN and a further two hour incubation in 
1000 polyclonal rabbit anti-sheep IL-113 antibody. A further five washes in 
PBS-TWEEN were performed followed by a one hour incubation at 37°C five 
washes in PBS-TWEEN, 100p1 of sheep anti-rabbit-horse radish peroxidase 
conjugate was added prior to re-incubation. After the final incubation the plate 
was washed six times in PBS-TWEEN before 100p1 of 3,3',5,5' 
tetramethylbenzidine (TMB) (Kirkegaard & Perry Laboratories (KPL), USA) per 
well was added. The reaction was stopped by the addition of 100p.I of 0.18M 
H 2 SO4 (BDH) to each well. The absorbance of each well was measured using 
a Bio-Rad 3550 plate reader at a wavelength of 450 nm 
2.9.2 	GM-CSF 
The components for the GM-CSF immunoassay were obtained from Dr. 
Haig (Moredun Institute, Edinburgh, UK). ELISA plates (Disposable Products) 
were coated overnight at 4°C with 50p1 per well of 8D8 affinity purified mAb 
(8D8) at 1 pg/m1 in freshly prepared 0.1 M carbonate buffer, pH 9.6 (see 
previous section). The wells were washed six times with PBS-TWEEN and 
then blocked with PBS-TWEEN+3%-BSA- for 1 hour. The wells were 
subsequently washed twice in PBS-TWEEN. 50111 of samples and standards 
were added, in duplicate, to wells. Lymph and culture supernatants were 
added after being diluted 1:3 in in PBS-3%-BSA-TWEEN. The plate was then 
incubated for one and half hours at room temperature. This was followed by a 
further six washes with PBS-TWEEN. 50111 of affinity purified, peroxidase 
conjugated, monoclonal (3C2) was added to each well and incubated for one 
hour at room temperature. After this incubation the wells were washed a further 
six times in PBS-TWEEN. 1000 of TMB (KPL) was added to each well and 
once the colour change had occurred 100p1 of 0.18M H 2SO4 (BDH) was added 
to halt the reaction. The absorbance of each well was measured using a Bio-
Rad 3550 plate reader at a wavelength of 450 nm 
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2.9.3 	Prostaglandin E2 EIA 
Supernatants from DC:PBMC co-cultures were assayed for PGE2 levels 
using a PGE2 competitive enzyme immunoassay kit supplied by Cayman 
Chemical Co. (USA). This assay system measures PGE2 levels by the 
competition between varying amounts of PGE2 contained in samples and a 
known amount of PGE2 tracer for a limited amount of a mouse anti-PGE 2 mAb. 
The mAb-PGE2  complex binds to the goat anti-mouse polyclonal antibody that 
was previously attached to the well. The tracer, sample and monoclonal 
antibody were incubated 18 hours at room temperature. Following this 
incubation the plate was washed five times in a 1/500 dilution of the wash 
buffer provided. The activity of the acetylcholinesterase linked tracer was 
detected by incubation for 90 minutes in Ellman's reagent. The absorbance 
(ABS) was measured using a Bio-Rad 3550 plate reader at a wavelength of 
415 nm. Thus the amount of tracer remaining is inversely proportional to the 
amount of PGE2 in the sample. Standards were supplied with the kit and a 1/10 
dilution was performed followed by doubling dilutions to give a range of 8-1000 
pg/ml. Samples were used at a 1/5 dilution in EIA buffer (both the EIA buffer 
and Wash buffer concentrates were supplied as part of the kit and required 
dilution in Milli-Q water before use). Non specific binding (NSB) was assessed 
by the addition of the tracer without the addition of the monoclonal antibody, 
while the maximum binding was assessed by adding tracer and monoclonal 
antibody only. The total activity (TA) of the tracer was assessed by adding the 
51_11 of tracer to the wells together with the El!man's reagent. The percentage 
sample bound/maximum bound (B%/B0) was calculated for samples and 
standards using the following formula. 
%B/BO = [(Abssampie - AbsNsB) / (AbsBo - AbSNsB) x100 
A curve was constructed by graphing %B/B0 vs PGE2 concentration for 
each standard and this was used to quantitate the levels of PGE 2 in samples. 
The detection limits for this kit were between 80% and 20% of the maximum 
bound. Samples outside this range were reassessed at a different dilution. 
2.9.4 	IFNy 
The supernatants from DC:PBMC co-cultures were assayed using the 
BOVIGAMTm, commercial bovine interferon y ELISA from CSL, Veterinary 
Division (Parkville, Victoria, Australia). This kit has been shown to react with 
ovine IFNy (Rothel et al, 1990). 501.11 of diluent was added to wells which were 
pre-coated with an IFNy specific mAb. To these wells 50 of samples and 
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supplied standards and controls were added. This was incubated for one hour 
at room temperature followed by six washes in the diluted wash media 
provided. After which 100 RI of conjugated anti-IFNy was added, followed by a 
further one hour incubation at room temperature. The plate was then washed a 
further six times, followed by the addition of 100 RI of the supplied chromogen, 
which was incubated for 30 minutes. The reaction was stopped by the addition 
of 50m1 of 0.25 M H2SO4 (BDH). The absorbance of each well was measured 
using a Bio-Rad 3550 plate reader at a wavelength of 450 nm. 
2.10 ISOLATION OF CELLS FROM ALVEOLAR LAVAGE FLUID 
The lungs and trachea were removed intact from a euthanised sheep, 1-2 
years old, and flushed with 400-800 ml of sterile PBS. The lavage fluid was 
passed through a sterile stainless steel fine sieve to remove debris. The cells 
were gathered by centrifugation (800g) for 10 mins. The cells were washed 
twice in WASH MEDIA before being resuspend at 4x10 6 cells/ml in 
RPM I+Supplements. 
2.10.1 	IL-10 macrophage inhibition assay 
The ovine assay for IL-10-like activity was based on the method described 
by Hein (1997) and by Martin et al., (1995). Test samples were dispensed in 
0.5m1 aliquots to 24 well culture plates (Corning) and 0.5 ml of macrophage 
suspension was added. LPS (Sigma, #L2360) was added to a final 
concentration of 10 ng/ml. Control cultures included macrophages incubated 
with and without LPS. The cells were cultured for 24 hours at 37°C and 5% 
CO2. The cultures were centrifuged at 10,000 rpm for 2 mins to remove cells 
and debris, the resulting supernatants were aliquoted and stored at -80°C. The 
supernatants were thawed when required and analysed for IL-10 concentration 
(see section 2.9.1). 
2.11 DETECTION OF IL-10 PROTEIN 
2.11.1 SDS -Polyacrylamide Gel Electrophoresis 
A 15% SDS (sodium dodecyl sulphate)-polyacrylamide mini gel was 
prepared to perform electrophoresis on lymph samples which were found to be 
positive for IL-10-like activity from the IL-10 bioassay. A Mini-PROTEAN II 
electrophoresis cell (Bio-Rad) was used for both the preparation and running of 
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the gel. The gel was formed by adding 5m1 of 30% Acrylamide/bis-acrylamide 
solution (Bio-Rad) to 2.4 ml distilled water, followed by 2.5 ml of 1.5 M Tris-HCI 
(pH 8.8) (Sigma) and 50111 of 20% SDS (Bio-Rad). This solution was degassed 
for 15 minutes by applying a vacuum to a stoppered conical flask. In turn 500 
of ammonium persulphate (Bio-Rad) and 5p1 of N,N,N',N', 
tetramethylethylenediamine (TEMED, Bio-Rad) were added and the gel was 
poured between two glass plates. 100p,I of 0.1% sodium dodecyl sulphate 
(SDS, Bio-Rad) was added as an overlay to prevent evaporation of the gel 
contents. The gel was then allowed to polymerise for approximately 1 hour, 
during which time a 4.0% stacking gel was prepared. To 3.3 ml distilled water 
1.25 ml of 0.5 M Tris -HCI (pH 6.8), 25 pl of 20% SDS (Bio-Rad) and 670 pl of 
acrylamide/bis-acrylamide was added. The solution was again degassed and 
500 of APS and 5p1 TEMED added. The overlay was decanted from the 
separating gel and the stacking gel was added. The comb which forms the 
lanes to which the samples are loaded, was inserted. The stacking gel was 
allowed to polymerise for approximately 30 mins. 20 p.1 of lymph was mixed 
with 20 pl of 2 x SDS sample reducing buffer (2.0 ml 0.5 M Tris, pH 6.8, 1.6 ml 
glycerol (Bio-Rad), 3.2 ml of 10% SDS, 2-13-mercaptoethanol (Bio-Rad) and 
400 ml of 0.05% bromophenol blue (Bio-Rad) and the samples placed in boiling 
water for 5 minutes. Samples were microfuged at 12,000 rpm and placed on 
ice. The gel was placed into the cell, which contained approximately 600 ml of 
running buffer (1.8g Trizma base (Sigma), 8.64g glycine (Bio-Rad), 0.6g SDS 
(Bio-Rad) dissolved in 600 ml Milli-Q water) and samples (15 p. 1 ) loaded into 
specified lanes of the gel. 10 ml of pre-stained SDS-PAGE broad range marker 
(Bio-Rad), was also added to a lane in the gel. The Bio-Rad 200 power pack 
was used to apply current through the gel. Initially a 100 volt current was 
applied but when the sample began to run through the stacking gel the current 
was increased to 200 volts. When protein lined up on the separating gel the 
current was lowered to 90 volts. After the sample had finished running the gel 
was carefully removed from between the glass plates and the stacking gel 
removed from the separating gel. The gel was then western blotted to enable 
immunochemical probing for IL-10. 
2.11.2 	Western Blotting 
The SDS-PAGE gel was soaked for 15 minutes in Towbin transfer buffer 
which was prepared by the dissolving of 3.03g Trizma base (Sigma), 14.4 g 
glycine (Bio-Rad) and 200m1 of Methanol (BDH)in 11 of water. The gel was then 
placed on two sheets of filter paper and covered firstly by a nitrocellulose 
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membrane (Bio-Rad) and two further layers of filter paper. A cylinder was 
rolled over this sandwich to remove air bubbles, trapped between the different 
layers. This was placed into a mini trans-blot cell (Bio-Rad) containing Towbin 
transfer buffer and an ice pack. 30v of current from a Bio-Rad 200 power pack 
was applied through the cell overnight at 4°C. The apparatus was dismantled 
and the western membrane now containing protein transferred from the gel was 
washed twice by gently agitation for 10 minutes in TBS (2.425 g Tris (Sigma) + 
9g NaCI (BDH) dissolved in 1L Milli-Q water), pH 7.5. This was followed by a 
2 hour incubation of the membrane in blocking buffer (TBS + 5% BSA). 
Polyclonal rabbit anti-ovine IL-10 antibody was supplied by G. Barcham 
(Centre for Biotechnology, University of Melbourne, Australia) and was then 
added to give a final ratio of 1:100 polyclonal antibody to blocking buffer. This 
was incubated for a further hour at room temperature. The membrane was 
washed twice in TTBS (TBS+ 0.05% Tween-20) and once in TBS before being 
incubated for 1 hour in a solution containing a 1/1000 dilution of goat anti-
rabbit horseradish peroxidase conjugated antibodies (Silenus) in blocking 
buffer. After this incubation, the membrane was washed four times in TTBS, 
before being placed in a 10 ml buffered solution containing 3,3- 
diaminobenzidine (DAB) and urea peroxide. This was prepared 30 minutes 
prior to use by dissolving DAB and urea tablets in 10 ml of distilled water 
(Sigma). The membrane was left in the DAB (peroxidase substrate) for a 
sufficient time for clearly visible signal to developed. The reaction was halted 
by washing the membrane thoroughly in distilled water. 
2.12 IL-5 BIOASSAY 
This bioassay involved culturing the BAF cell line which has a 
requirement for IL-5 in order to proliferate. IL-5 was provided to keep the cells 
growing by the addition of 5% v/vol supernatant from the IL-5 producing X63 
cell line. Both cell lines were generously provided by Dr. D. Emery (CSIRO, 
Sydney, NSW) and used with permission of Dr. C Sanderson. BAF cells were 
cultured in culture media containing DMEM Hi-Glucose (HyClone), 2mM L-
glutamine (CSL), 1mM pyruvate (CSL), 100 mg/ml Penicillin/ 60 mg/ml 
streptomycin (CSL), 5x10 -6 M 2-mercaptoethanol (Sigma), 5% FCS (CSL) 
(DMEM + Supplements) with the addition of 5% X63 supernatant for two days. 
BAF cells were washed twice in an excess of medium only, and resuspend at a 
concentration of 106 cells/ml. 1000 of cell suspension was added to each well 
on a 96 well round bottom culture plate (Greiner). Test wells contained the BAF 
cells plus 50111 of sample and 500 of culture media. Wells also containing X63 
72 
supernatant, to give a final concentration of 5% constituted positive controls. 
1000 media only was added to BAF cells to serve as a negative control. Cells 
were incubated for 36 hours at 37°C/5% CO2 and pulsed with [ 3F1] thymidine 
(Amersham) over the last eight hours of culture. The cells were harvested on to 
glass filter paper (ICN Biomedicals) using a cell harvester (Skatron, Australia) 
and counted in 0.5 ml of scintillation fluid for one minute in a Rackbeta 
scintillation counter (LKB). The ability of samples to stimulate BAF cell growth 
was compared to the positive and negative controls. 
2.13 MISCELLANEOUS METHODS 
	
2.13.1 	Glassware 
All pipettes used for cell culture was soaked overnight in 2% extran. 
Pipettes were washed in tap water in a self-dumping pipette washer for at least 
4 hours. Pipettes were then rinsed in five changes of Milli-RO water followed 
by a further 3 Milli-Q rinses. After which cleaned pipettes were dried in a 50°C 
oven before being plugged with cotton wool and autoclaved at 121°C for 15 
mins in a copper canister. Then the pipettes were allowed to dry overnight in a 
50°C oven. All bottles were washed using a phosphate free detergent (Extran 
300, BDH) rinsed ten times with tap water followed by a further five rinses with 
Milli-Q water. All bottles were dried and then autoclaved at 121° for 15 
minutes. 
2.13.2 	Solutions and reagents 
Solutions which required sterilisation were sterilised either by filtration 
through a 0.2pm filter (Millipore) and transferred to a previously autoclaved 
500m1 bottle or by autoclaving at 121° for 30 mins. Deionised reagent grade 
water was use in all solutions (Milli-Q system, Millipore Corp. USA). 
2.13.3 	Preparation of Media 
A 10 litre powder pack of media (RPMI-1640 or DMEM) (HyClone, Logan, 
Utah USA) was added to 10 litres of Milli-Q water and dissolved by stirring. 
20g of Sodium Bicarbonate was also added bring the concentration to 2g/L and 
the media was left to stir for a minimum of 15 minutes. A peristaltic pump was 
used to pump media through a 0.2pm MediKap hollow fibre filter (Microgon, 
Laguna Hills, California, USA) into sterile bottles, this step being performed in a 
Class II BioHazard Cabinet. Filled and capped bottles were stored at 37°C for 
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several days to check for contamination. 	Media that was free from 
contamination was stored at 4°C in the dark until required. 
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CHAPTER 3 LANGERHANS CELL MIGRATION AFTER 
UV EXPOSURE 
3.1 INTRODUCTION 
The response of a T cell to an antigen is crucially dependant on its 
interaction with a dendritic cell (Ibrahim et al., 1995). In the cutaneous 
environment, the dendritic cells which play this role are the LC. These cells 
form a network in the epidermis where they are believed to fulfil a role in 
immunological surveillance (Janeway 1992, Ibrahim et al., 1995). LC can be 
activated by bacterial and viral products (Janeway et a/., 1992) or 
microenvironmental damage (Ibrahim et al., 1995), to process antigens and 
migrate to the draining lymph node. There they present antigen to T cells 
resulting in the generation of specific immune responses (Silberberg-Sinakin 
and Thorbecke, 1980). Any process which deleteriously alters the migration, 
survival or the ability of LC to present antigen to T cells will reduce cutaneous 
immunity. This in turn may adversely impact on the ability of the immune 
system to deal with the growth of neoplastic cells within the skin. 
UV light, especially UVB is able to penetrate the outer protective layers of 
the skin, damaging the underlying cells including LC (Aberer et al., 1981). UV 
light has been shown to cause cell death in the epidermal layers of the skin 
(Kerr etal., 1972, Olson and Everett, 1975). It has also been shown that the 
immune system is impaired in its ability to respond to antigens applied through 
UV damaged skin (Haniszko and Suskind, 1963, Greene etal., 1979, Toews et 
al., 1980, Morison et al., 1981a, Morison et al., 1981b, Noonan et at., 1981, De 
Fabo and Noonan, 1983, Elmets et al., 1985, Ullrich et al., 1986, Glass et al., 
1990). Morphological and ultrastructural changes have been seen in LC within 
the epidermis (Aberer et al., 1981, Obata and Tagami, 1985) and dendritic cells 
with UV specific damage, are found in the lymph nodes draining UV exposed 
skin (Sontag et al., 1995). These findings pose the question of whether LC 
depleted from the epidermis after UV exposure, migrate to the draining lymph 
node or die in situ. If these cells do not all die in situ they may in turn contribute 
to the aberrations observed in immune function. 
The sheep model is ideal for the investigation of migrating cell 
populations after UV exposure of the skin. Pseudoafferent lymphatic vessels 
were generated by the excision of the prefemoral lymph nodes and re- 
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anastomosis of the afferent lymphatics with what had been the efferent duct. 
Subsequent cannulation of pseudoafferent lymphatic vessels in this animal by 
the methods described by Hall and Morris (1965), allow the collection of large 
volumes of lymph and large cell numbers. This overcomes the problem of the 
small size and thus small lymph and cell output from true afferent lymphatic 
vessels draining the skin of small animals such as mice. The cell populations 
in pseudoafferent lymphatic vessels are similar to that of the true vessels and 
contains large numbers of dendritic cells, comprising 1-10% of the total 
population (Budjuso et al., 1989). The study of cells migrating from the skin in 
pseudoafferent lymphatic vessels as compared to lymph nodes, eliminates the 
presence of resident DC which occur in the DLN. However it must be 
emphasised that the cells found in the psuedoafferent lymph would be the cells 
that eventually reach the lymph node. The use of patent blue lymphography 
dye to define the area of skin drained by the pseudoafferent vessel also 
minimises contaminating DC from areas not affected by treatment. 
3.2 MATERIALS AND METHODS 
3.2.1 	Experimental Plan 
The aim of this series of experiments was to look at changes in cell 
population kinetics of pseudoafferent lymph after treatment of the skin with UV 
light. In particular, the effects on LC were closely monitored. 
After bilateral cannulation of pseudoafferent lymphatic vessels (Section 
2.2.2), lymph was collected in bottles using the protocols described in sections 
2.3.1 and 2.3.2. From each collection the volume of lymph flowing per hour 
was calculated and the cell concentration per millilitre was determined using a 
DN model coulter cell counter (Coulter Electronics Ltd., Harpenden, England). 
A surgical recovery period of usually 5-7 days was needed to ensure flow rate 
and cell concentration had stabilised. After this time, cells in the lymph were 
collected and stained using various monoclonal antibodies and 
immunofluorescent staining (Section 2.4). LC were identified by their forward 
and 90 0  scatter profiles and intensity of fluorescent staining with the SBU-T6 
mAb (anti-CD1w1) (see Fig 3.1). CD4 + T cells, CD8 + T cells and T19y T cells 
were identified using the mAbs SBU-T4, SBU-T8 and SBU-T19 respectively. 
Flow cytometric analysis was performed using an EPICS 741 flow cytometer 
(Coulter). The staining of cells was repeated at least four times to establish the 
"normal" pattern of migration prior to further treatment. The flank skin of the 
76 
Figure 3.1 
Two parameter flow cytometric analysis of CD1 (SBU-T6) staining of 
pseudoafferent lymph cells. Langerhans cells are defined as large (high 
forward scatter) green fluorescent (FITC positive) cells. Langerhans cells are 
the population of cells found within quadrant B2 of this histogram. In this 
particular sample 1.3% were CD1 + lymphocytes, 7.0% Langerhans Cells, 
87.1% lymphocytes and 4.6% CD1" dendritic cells. 
sheep was then treated with a single exposure UV fluorescent sunlamps as per 
section 2.3. The use of a single exposure avoids complications induced by 
multiple doses including epidermal thickening and melanogenesis (Kaidbey 
and Kligman, 1981), alterations in mediators involved in the production of 
erythema and pigmentation and thus optics of the skin (Kaidbey and Kligman, 
1979). Monitoring continued for a two week period after exposure as LC 
numbers within the skin are shown to recover during this period (Obata and 
Tagami, 1985). 
Various exposures were used ranging from a UVB dose of 2.7 kJ/m 2 to 
80.4 kJ/m2 (see table 2.1). The doses 2.7 kJ/m2, 8.1 kJ/m2 , 20.1 kJ/m2 and 40.2 
kJ/m2 UVB were examined in greater detail as they were found to be less 
damaging and better reflected "natural sunburning" doses in sheep. 
3.2.2 	Statistical Analysis 
The mean plus or minus two standard deviations of at least four pre-
treatment points, were used to establish a normal range of migration. Points 
lying outside this normal range were regarded as significantly different to 
normal migration data (Zar, 1984). 
3.2.3 	Presentation of Data 
The nature of the outbred sheep model, means that direct comparison 
between individual experiments is very difficult. The parameters monitored 
such as afferent lymph flow, cell numbers and the percentage of individual cell 
populations, varies greatly from individual to another, and even from one flank 
to the other flank on the same sheep. Although consistent trends can be 
observed by exposing different sheep to the same treatment regime these 
factors prevent pooling data from replicate experiments. It is therefore 
necessary to present results from a single representative experiment. All 
results shown for each dose are from the same animal and are representative 
of the trends observed from at least three experiments. A summary table has 
showing the trends observed for each individual experiment has also been 
included for each UVB dose used. The sustained changes in migration 
mentioned are when two or more data points fall outside the normal range. The 
normal range for each parameter is represented by the area within the dotted 
lines in Figures 3.3.1.1 - 3.3.5.6. It should be stressed that figures from result 
sections 3.3.4-3.3.5 are from a previous thesis (Gavin Clydesdale, 1993) and 
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are used to illustrate the effects of higher doses of UV light on lymph output 
and cell migration kinetics. 
3.3 RESULTS 
3.3.1 	Changes in Lymph Flow, Cell Kinetics and 
Composition after Exposure of Skin to 2.7 kJ/m 2 UVB 
3.3.1.1 	Effect on Total Cell Output and Lymph Flow 
Lymph flow stayed within the normal range for the duration of this 
experiment, apart from the final point which was seen to fall below the normal 
range (Fig. 3.3.1.1). Cell output remained within the normal range for the 
duration of this experiment (Fig. 3.3.1.2) 
3.3.1.2 	Effect on LC Migration 
Initially LC migration remained within the normal range, before a slight 
increase above the normal range at 58 hours. This was followed by a transient 
return to within the normal range (Fig. 3.3.1.3). This in turn was followed by a 
significant, sustained increase in LC migration between 83-96 hours post-
treatment. The 3.6 fold increase in LC at the 83 hour time point was the peak of 
LC migration. LC numbers then returned to within the normal range. After 
which there was a transient decrease below the normal range. A further 
sustained decrease below the normal range was seen between 168-191 hours 
post-treatment. This decrease was most significant at the 168 time point, 
representing a ten fold reduction in LC numbers. After this LC output was seen 
to increase, once again showing a sustained increase in LC numbers between 
225-312 hours post irradiation. This late increase in LC numbers peaked at 
273 hours post-treatment with a 2.6 fold increase in LC numbers. 
Sustained increases in the proportion of LC were observed between 83- 
96 and 225-312 hours post-treatment (Fig. 3.3.1.4). The timing of the peak 3.4 
fold increase in the percentage of LC, at 83 hours, corresponded to the peak 
increase seen in LC numbers (Fig. 3.3.1.3). The percentage of LC migrating 
between 168-191 hours was reduced. The largest reduction seen was at 168 
hours which corresponded to 0.2 % LC compared to the mean pre-treatment 
value of 2.3%. 
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Figure 3.3.1.1 Thp rate of lymph flow from skin treated with 
2.7 kJ/m2 UVB. Dashed lines indicate the 
normal range for this single representative 
experiment. 
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Figure 3.3.1.3 Numbers of Langerhans cells in lymph draining 
skin treated with 2.7 kJ/m 2 UVB. Dashed lines 
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Figure 3.3.1.4 Percentage of LC in lymph draining skin treated with 
2.7 kJ/m2 UVB treated skin. Dashed lines indicate 
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3.3.1.3. 	Effect on T Cell Migration 
The T19+ y5 T cell migration remained within the normal range until 58 
hours post-treatment when a slight increase above the normal range was 
observed. Immediately followed by a slight decrease below the normal range. 
A significant 1.8 fold increase occurred at 273 hours post-treatment (Fig. 
3.3.1.5) and was the only major point of T19 + y5 T cell migration for this 
experiment. CD8+ T cell migration showed a peak of near identical size at the 
same time (Fig. 3.3.1.6). CD4 + positive cells were seen at no time to increase 
above the normal range. A decrease in the migration of T19 + y5, CD4+ and 
CD8+ T cells was observed at 72 hours post-treatment (Fig. 3.3.1.5 and Fig. 
3.3.1.6). Further decreases below the normal range were evident only in the 
CD8+ cell population at 144 and 168 hours post-treatment, being just outside 
the normal range. 
Table 3.1 Summary of Effects after Exposure to 2.7 kJ/m 2 UVB 
3.3.1.4 	General 
The results for the representative sheep used to illustrate trends after this 
experiment are summarised in Table 3.1. Exposure of sheep to 2.7 kJ/m2 UVB, 
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Figure 3.3.1.5 Numbers of T19 +y5 T cells in lymph draining 
skin treated with 2.7 kJ/m2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
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Figure 3.3.1.6 	Numbers of CD4 and CD8 T cells in lymph draining 
skin treated with 2.7 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
output, as well as variable effects on the LC, T19 + y8 ,CD4+ and CD8+ T cell 
populations. A minority (one out of four sheep) showed sustained increases in 
lymph flow and total cell output. However, a majority (three out of four) showed 
a significant sustained increase in LC numbers, and all were approximately 
three fold in magnitude. However, only two out of four sheep were shown to 
have a corresponding increase in the percentage of LC in lymph. One out of 
the four sheep monitored showed a 1.8 fold increase in T19+ y5 T cell output. 
The same sheep also showed CD4+ and CD8+ T cells to be increased above 
normal, however increases in CD8+ cells were of lower magnitude. The 
observed increases in T cell populations in this sheep occurred in parallel with 
those of cellular output. 
3.3.2 	Changes in Lymph Flow, Cell Kinetics and 
Composition after Exposure of Skin to 8.1 kJ/m 2 UVB 
3.3.2.1 	Effect on Total Cell Output and Lymph Flow 
The exposure of the flank skin to 8.1 kJ/m 2 did not appear to cause any 
increase in the rate of lymph flow (Fig. 3.3.2.1). Lymph flow appeared to stay 
within the normal range at all times, with the exception being the final point. 
Similarly, cell output also remained within the normal range post-treatment (Fig. 
3.3.2.2). 
3.3.2.2 	Effect on LC Migration 
This treatment caused a sustained increase in the number of LC migrating 
in the pseudoafferent lymph from 25 hours to 148 hours post-irradiation (Fig. 
3.3.2.3). This sustained increased peaked at 49 hours at a level of 2.4 fold 
above normal. This was followed by a further sustained elevation between 187 
and 217 hours and further transient increases above normal at 240, 265, 290 
and 314 hours post irradiation. Transient decreases below that of the normal 
range were seen a 11, 170 and 305 hours, after treatment, although the 
number of LC generally increased after this treatment (Fig. 3.3.2.3). Broadly 
speaking increases in the percentage of LC migrating paralleled the increases 
observed in LC numbers (Fig. 3.3.2.4). However, the first initial increase in the 
proportion of LC migrating was only sustained between 49 and 121 hours post 
exposure which is a shorter duration than that of increased LC numbers. The 
second sustained increase was mirrored by similar transient increases in the 





























   
 
• • 
8.1 kJ/m2 UVB 
• 
4 - 
3 I 	 I 	• 	I 	• 	I 	• 	I 	 1 
-100 0 100 	200 	300 	400 
Time Post Treatment (Hours) 
Figure 3.3.2.1 The rate of lymph flow from skin treated with 
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Figure 3.3.2.3 	Numbers of Langerhans cells in lymph draining 
skin treated with 8.1 kJ/m 2 UVB. Dashed lines 
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Figure 3.3.2.4 	Percentage of LC in lymph draining skin treated with 
8.1 kJ/m2 UVB treated skin. Dashed lines indicate 
the normal range for this single representative 
experiment. 
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3.3.2.3. 	Effect on T Cell Migration 
The T19+ y5 T cell output remained within the normal range of migration 
throughout the duration of the experiment (Fig. 3.3.2.5) as did the CD4 + and 
CD8+ T cell populations (Fig. 3.3.2.6). There were relatively more CD4 + positive 
cells in this example than either T19 + y5 T cells or CD8+ positive cells. However, 
there were relatively similar numbers of T19 + y5 T cells and CD8+ positive cells. 
3.3.2.4 	General 
The results for the representative sheep used to illustrate trends observed 
after multiple experiments is summarised in Table 3.2. Lymph output showed a 
sustained increase above the normal range in one of four sheep. While two 
other sheep showed increases these were not sustained and tended to 
alternate above and below the normal range. Cell output was similarly affected 
by this dose of UVB as only one out of six sheep showed any increase above 
the normal range. LC migration was increased after treatment in all sheep. 
This increased migration of LC occurred within 24 hours of treatment in all 
cases. Two cases showed sustained increases for 240 and 315 hours post-
irradiation. The magnitude of increased LC numbers was approximately 2.4 
fold for all sheep. The proportion of LC in lymph was increased in all sheep. 
Only one sheep out of four showed a sustained increased migration of T19 + y5 
T cells after treatment with this dose, another sheep was seen to produce 
transient increases. The timing of these increases coincided with that of 
increases in total cell output. Only one sheep monitored showed any significant 
alterations CD4+ and CD8 + cells above the normal range. 
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Figure 3.3.3.5 Numbers of T19 +y8 T cells in lymph draining 
skin treated with 8.1 kJ/m2 UVB. Dashed lines 




















































0.0 I 	• 	I 
-100 0 100 	200 	300 	400 
Time Post Treatment (Hours) 
Figure 3.3.2.6 Numbers of CD4 and CD8 T cells in lymph draining 
skin treated with 8.1 kJ/m2 UVB. Dashed lines 
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Table 3.2 Summary of Effects after Exposure to 8.1 kJ/m 2 UVB 
3.3.3 	Changes in Lymph Flow, Cell Kinetics and 
Composition after Exposure of skin to 20.1 kJ/m 2 UVB 
3.3.3.1 	Effect on Total Cell Output and Lymph Flow 
It can be seen from Fig. 3.3.3.1 that lymph flow remained within the 
normal range throughout the duration of monitoring, with the exception of a 
period of elevated lymph flow between 24 and 80 hours post-treatment. 
However, this was only significantly above normal at 24 and 53 hours. 
Although it was observed that the other points between 24 and 80 hours fell 
within the in the high end of the normal range. A further increase was seen at 
321 hours post irradiation. Cell output which had a rather large normal range 
due to variation in background points showed no deviation outside the normal 
range, although from 100 hours onwards, the cell output remained in the lower 
half of the normal range (Fig. 3.3.3.2). 
3.3.3.2 	Effect on LC Migration 
From Fig. 3.3.3.3, it is clear that a sustained, dramatic increase in LC cell 
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Figure 3.3.3.1 The rate of lymph flow from skin treated with 
20.1 kJ/m2 UVB. Dashed lines indicate the 
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Figure 3.3.3.2 Total cell output in lymph draining skin treated 
with 20.1 kJ/m2 UVB. Dashed lines indicate 
the normal range for this single representative 
experiment. 
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Figure 3.3.3.3 Numbers of Langerhans cells in lymph draining 
skin treated with 20.1 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
irradiation, peaking at an approximately a 7.5 fold increase above the mean of 
normal values at 72 hours post-treatment. This was reflected in a similar 
percentage increase in migration of LC during the same time period (Fig. 
3.3.3.4). After this, LC numbers fell back to within the normal range. Apart from 
transient deviations above the normal range at 150, 217 321 and 336 hours 
post-treatment none of these increases in LC numbers were of the same 
magnitude as that observed earlier, however the increases in percentage of 
LC at 150, 264 and 336 hours were still quite dramatic and represented a 4.5, 
3.1 and 3.4 fold increases respectively (Fig. 3.3.3.4). 
3.3.3.3. 	Effect on T Cell Migration 
The T19+ y5 T cell numbers remained within the normal range throughout 
the duration of the experiment. However cell numbers were seen to mainly lie 
within the lower portion of the normal range after 81 hours post-treatment (Fig. 
3.3.3.5). No deviations outside the normal range were noted in either the CD4 + 
or CD8+ populations (Fig. 3.3.3.6). These cell populations also showed a 
general trend in the sense that the numbers of cells migrating fell towards the 
lower end of the normal range, parallelling the general trend observed in the 
total cell output (Fig. 3.3.3.2). 
3.3.3.4 	General 
Results for the representative sheep used to illustrate trends observed 
after multiple experiments is summarised in Table 3.3. Exposure to 20.1 kJ/m 2 
UVB only caused a sustained increase in lymph output in one of three sheep 
assessed. However, in this one case the increase consisted of only three 
points only one of which was substantially away from the upper limits of the 
normal range. Whilst the others had transient increases above normal, they 
generally remained within the normal range. Two out of the three sheep had 
sustained increases above the normal range for cell output. All sheep studied 
showed an increase in LC migration within the first 100 hours (7.5 fold, 3.3 fold, 
3.1 fold increases) after which one sheep showed a return to normal levels but 
the other still showed sustained levels of migration until 408 hours post-
treatment (one experiment was of shorter duration and such long term effects 
could not be assessed). These increases in LC numbers were mirrored by 
similar increases in the proportion of LC migrating in the lymph. T19 + yo T cell 
migration was found to stay within the normal range for two out of three sheep. 
However, one sheep as well as showing two transient increases above the 
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Figure 3.3.3.4 Percentage of LC in lymph draining skin treated with 
20.1 kJ/m2 UVB treated skin. Dashed lines indicate 
the normal range for this single representative 
experiment. 
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Figure 3.3.3.5 Numbers of T19 +yo T cells in lymph draining 
skin treated with 20.1 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
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with the majority of points after treatment falling below the normal range. One 
of the sheep whose T19+ 75 T cells stayed within the normal range, were at the 
lower end of the normal range for the duration of the experiment. CID4 + cells 
were increased in two out of three experiments and the increases seen 
followed those of increased cell output. The migration of CD8 + cells generally 
stayed within the normal range for all sheep, however some transient increases 
above normal were noted for one sheep. The same sheep that showed T19 + y5 
T cells decreasing towards the lower end of the normal range also 
demonstrated this for CD8 + cells. The timing of the transient but substantial 
points of increased migration of CD8 + cells seen in one sheep was unlike that 
of any other cell population. These included peaks of five fold in magnitude 
which were mirrored by a dramatic increase in the proportion of CD8+ cells in 
the lymph. 
Table 3.3 Summary of Effects after Exposure to 20.1 kJ/m 2 UVB 
3.3.4 	Changes in Lymph Flow, Cell Kinetics and 
Composition after Exposure of Skin to 40.2 kJ/m 2 
UVB 
84 
3.3.4.1 	Effect on Total Cell Output and Lymph Flow 
Fig. 3.3.4.1 shows that increases in lymph flow were seen after eight 
hours post-treatment and this increase was sustained until 70 hours post-
treatment. After a single transient decrease below the normal range at 94 
hours, was observed before the rate of lymph flow returned to within the normal 
range, where it remained for approximately 50 hours. A further transient 
increase above normal was seen at 157 hours, followed again, by return to the 
normal range for nearly 100 hours. Again this was followed by an increase 
above the normal range for three out of four of the remaining points. 
Cell output showed a dramatic increase above that of the normal range 
between 40 and 70 hours post-treatment, peaking at 60 hours with a 4.9 fold 
increase above the mean of the pre-treatment points (Fig. 3.3.4.2). After this 
time, the number of cells migrating from the treated site returned to the normal 
range apart from two transient increases at 157 and 335 hours which were 3.4 
and 2 fold above the mean pre-irradiation levels respectively. 
3.3.4.2 	Effect on LC Migration 
LC numbers showed sustained increases above normal between 40 and 
157 hours with, only a single return to the normal range at 133 hours. Two 
distinct peaks were seen; the first with a sustained increase peaking at 94 
hours with a 6 fold increase above mean pre-treatment levels and the second 
more transient peak 157 hours after irradiation at a level representing a 7 fold 
increase. After 285 hours, a further sustained increase in LC numbers outside 
the normal range was seen, however, this was smaller in magnitude than the 
earlier peaks. LC migration was greater in magnitude and longer duration than 
the increase in the total cell output. This was reflected by the sustained 
increase in the proportion of LC migrating in comparison to the total lymphoid 
cell numbers, throughout the monitoring period. The increased proportion of 
LC represented a 2 fold increase above the mean pre-treatment levels. A 
return to the normal range was seen between 166 and 239 hours. 
3.3.4.3. 	Effect on T Cell Migration 
T19+ y5 (Fig. 3.3.4.5), CD4 + and CD8+ (Fig. 3.3.4.6) all showed similar 
migration patterns to the total cell output (Fig. 3.3.4.2). However, the increase 
in CD4+ T cells was of a greater magnitude (6.4 fold) in comparison to that of 
the T19+ y5 or CD8+ T cell populations (4.5 and 1.9 fold increases respectively). 
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Figure 3.3.4.1 The rate of lymph flow from skin treated with 
40.2 kJ/m2 UVB. Dashed lines indicate the 
normal range for this single representative 
experiment. 
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Figure 3.3.4.2 Total cell output in lymph draining skin treated 
with 40.2 kJ/m2 UVB. Dashed lines indicate 
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Figure 3.3.4.3 	Numbers of Langerhans cells in lymph draining 
skin treated with 40.2 kJ/m2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
8 



















   
• 
  
-100 	0 	100 	200 	300 	400 
Time Post Treatment (Hours) 
Figure 3.3.4.4 	Percentage of LC in lymph draining skin treated with 
40.2 kJ/m2 UVB treated skin. Dashed lines indicate 
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Figure 3.3.4.5 	Numbers of T19 +y8 T cells in lymph draining 
skin treated with 40.2 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
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Figure 3.3.4.6 	Numbers of CD4 and CD8 T cells in lymph draining 
skin treated with 40.2 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
output (130%), whereas the increase in CD8 + was of much lower than the 
increase in cell output (40%). 
Table 3.4 Summary of Effects after Exposure to 40.2 kJ/m 2 UVB 
Lymph output 40 60 & 70 1.3 fold 40-70, 286-311 
Total cell output 40 60 4.9 40-70 
LC 40 157 7 fold 40-157 
% LC 40 286 2.4 fold 70-118,142-157, 
262-328 
T19+ 76 T cells 60 4.5 fold 40-94 
CD4+ T cells 40 60 6.4 fold 40-94 
CD8+ T cells 40 40 1.9 fold 40-70 
3.3.4.4 	General 
Three sheep were exposed to this dose. One experiment lasted 85 hours 
post-treatment yet showed sustained increases for all parameters (data not 
shown). Of the two experiments showing the full time course, both showed 
lymph flow to increase above the normal range. One however, consisted of 
only a transient increase (81 hours post-treatment) and the other showed a 
sustained increases up to 70 hours after treatment. A sustained increase was 
seen again after 157 hours and lasted for approximately 100 hours (See Fig. 
3.3.4.1). Cell output showed a sustained increases for all sheep between 81- 
96 hours (data not shown), 32-85 hours (data not shown) and 40-70 hours (see 
Fig. 3.3.4.2). All sheep showed substantial increase in the numbers of LC 
migrating which was reflected in increased proportion of LC in all cases. In 
both experiments of sustained duration, an initial peak was followed by return 
to normal and then a second peak. In one experiment the second peak was of 
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greater magnitude than in the first. In the other experiment the reverse was 
seen. Tl9 y T cells both showed increases above .the normal range. 
However, these occurred when cell output increased and increases in % T19 + 
y5 T cells were not seen in the lymph. CD4 + and CD8+ T cell migration were 
both observed to increase above the normal level but once again this reflected 
increases in total cell output rather than dramatic increase in these specific 
populations. 
3.3.5 	Changes in Lymph Flow, Cell Kinetics and 
Composition after Exposure of Skin to 80.4 kJ/m 2 
UVB 
3.3.5.1 	Effect on Total Cell Output and Lymph Flow 
Lymph flow showed an increase above the normal range ten hours after 
treatment. A transient return to within the normal range was then observed, 
followed by three further points of sustained lymph flow between 34 and 58 
hours post-treatment (Fig. 3.3.5.1). Two further transient increases above 
normal were seen at 130 and 275 hours. Lymph flow generally remained in the 
high end of the normal range after treatment. Cell output also showed a general 
increase after treatment, however, the majority of these points were above the 
normal range. The cell output peaked at 89 hours post-treatment (Fig. 3.3.5.2). 
Those points not lying above the normal range, were found at the high end of 
the normal range, apart from the points at 58 and 251-267 hours post-
treatment, which were towards the lower end of the normal range. 
3.3.5.2 	Effect on LC Migration 
LC numbers showed a dramatic increase above that of the normal range 
peaking at 34 hours with an 8.75 fold increase above the mean. The numbers 
of LC remained above normal, apart from a return to normal at 58 hours until 
hours post-treatment (Fig. 3.3.5.3). After this the LC numbers were seen to lie 
either above or slightly beneath the normal range. A decrease below the 
normal range was seen at 251 and 267 hours. This was followed by a further 
sustained increase in LC numbers above normal between 290 and 315 hours 
followed once again by fluctuations above and within the normal range. The 
percentage LC migrating generally reflected the initial changes seen in LC 
migration. A large increase was observed above the normal range followed by 
a return to with the normal range after 179 hours (Fig. 3.3.5.4). The % LC in the 
lymph peaked at 34 hours post-treatment, reflecting the peak seen in LC 
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Figure 3.3.5.1 The rate of lymph flow from skin treated with 
80.4 kJ/m2 UVB. Dashed lines indicate the 






















0.0  I 	• 	I 	• 	I 	I 	• 	I 	•1 
-100 0 100 	200 	300 	400 
_ 
Time Post Treatment (Hours) 
Figure 3.3.5.2 
	
Total cell output in lymph draining skin treated 
with 80.4 kJ/m2 UVB. Dashed lines indicate 
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Figure 3.3.5.3 
	
Numbers of Langerhans cells in lymph draining 
skin treated with 80.4 kJ/m 2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
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Figure 3.3.5.4 
	
Percentage of LC in lymph draining skin treated with 
80.4 kJ/m 2 UVB treated skin. Dashed lines indicate 
the normal range for this single representative 
experiment. 
numbers at this time. One further increase above normal was noted at 290 
hours post-treatment. 
3.3.5.3. 	Effect on T Cell Migration 
T19+ y5 cell numbers increased at 34 hours with a further increase, which 
was only just slightly outside the normal range, occurring between 83 and 98 
hours post-treatment (Fig. 3.3.5.5). Unlike other cell populations, no early 
sustained increases were seen. Furthermore, unlike other cell populations 
increases in T19+ 75 cell migration peaked after 217 hours and largely remained 
above normal with some following exceptions. The points at 251 and 267 were 
below the normal range and 338 hours was within the normal range. The 
increase of T19+ y5 cell migration peaked at 299 hours with a 3.3 fold increase 
above the mean. CD4 + T cell output pattern followed that seen by the total cell 
output (Fig. 3.3.5.2) but were increased above the normal range for four 
sustained periods between 11-48 and 83-131 and 170-243 and 275-346 
hours post-treatment (Fig. 3.3.5.6). CD4 + T cell numbers peaked at 83 hours 
with a 3.7 fold increase in CD4+ migration above the mean levels of pre-
treatment points. CD8 + cells followed similar migration patterns but, due to the 
fact that only two background points were able to be processed for this 
antibody means no valid normal range could be generated so results must be 
interpreted with care (Fig. 3.3.5.6). However CD8 + cell migration peaked at 314 
hours with and 6.2 fold increase above the mean of the two background points 
(Fig. 3.3.5.6). 
3.3.2.4 	General 
This high dose caused microscopic blistering and damage of the 
epidermis and was only repeated once, but due to high background variation 
this data was discarded. So no real trends can be established, however the 
changes that did occur in this single experiment, especially that of LC migration 
were significant in magnitude and perhaps the late increases in T19 + y8 T cell 
population are individually interesting. A summary of the observed changes 
after this single individual experiment is shown in Table 3.5. 
3.3.6 	Summary of Trends Observed in Pseudoafferent Lymph after 
Exposure of Sheep Skin to UV light 
Treatment of the flank skin of sheep with known dose of UVB was 
observed to produce inconsistencies in the parameters studied. Treatment of 
different sheep with the same dose was shown to have variable effect on the 
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Numbers of CD4 and CD8 T cells in lymph draining 
skin treated with 80.4 kJ/m2 UVB. Dashed lines 
indicate the normal range for this single 
representative experiment. 
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Period of sustained 
increases (hours) 
numbers of sheep showing sustained changes for each parameter and for each 
dose. 
• 	Lymph flow showed very few sustained increases for sheep treated with 
20.1 kJ/m2 and below. Lymph flow was generally seen to be elevated for 
sustained periods after treatment with two highest doses. Sustained increases 
in LC numbers were observed in the majority of sheep for all doses. The 
magnitude of these changes was seen to increase with increasing UVB dose 
(Fig. 3.6). Sustained increases in the proportion of LC migrating in the lymph 
when compared to other cell populations, were also seen for all sheep treated 
with doses greater than 8.1 kJ/m2. Sustained increases in T19 + y8 T cells were 
only observed in the majority of sheep treated with the two highest doses. Total 
cell output was increased all sheep treated with the two highest doses, as were 
CD4+ and CD8+ T cell numbers. Some sustained decreases below the normal 
range for cellular output, CD4 + and CD8+ and T19+ y5 T cells were observed for 
various doses, it must be noted that these were unusual and tended to occur 
towards the end of the monitoring period. These changes were more 
pronounced in the CD8+ and T19+ y8 T cells. 
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Table 3.6 Summary of the effects of increasing doses of UVB on multiple experiments 
LC Numbers  
Number of sheep: 
showing sustained 























































UV Dose Response of Langerhans Cells 
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Figure 3.6 
UV Dose kJ/m2 
The dose dependence of LC migration from 
skin treated with increasing doses of UV light. 
Each point represents the maximum sustained 
increase in LC migration for each individual sheep. 
3.4 DISCUSSION 
The study presented in this chapter looked at the time course of the 
migration of Langerhans cells and other cell populations from sheep skin after 
treatment with increasing doses of UV light. It demonstrated that the kinetics of 
cell migration are altered by exposure of the skin to UV light. These changes in 
migration patterns, especially of antigen presenting cells, have downstream 
ramifications including an alteration of immune responses occurring within the 
lymph node and therefore, in the whole organism. 
The minimum dose used in these studies (2.7 kJ/m 2) was suberythemal, 
with 8.1 kJ/m2 being the lowest dose which caused erythema. 2.7 kJ/m2 is 
equivalent to 8-9 MED in Caucasian humans (Cooper etal., 1992), suggesting 
that sheep appear relatively resistant to the inflammatory effects of UVB. In 
comparison, Negroes who have an MED 33 times greater than their Caucasian 
counter parts, are relatively resistant to the inflammatory effects of UVB (Olson 
et al., 1973). Given that sheep skin lacks obvious pigmentation, an alternate 
mechanism for the resistance to the inflammatory effects of UVB must exist. 
While small amounts of wool remain after close clipping and the undulating 
nature of sheep skin may contribute slightly to this resistance, it is unlikely this 
will have a significant effect. One noticeable difference between human and 
sheep skin is the secretion of lanolin and other wax esters from ovine 
sebaceous glands. Whether this contributes to the apparent erythemal 
resistance of sheep is not, as yet known. 
3.4.1 	The Migration of LC after UV Exposure 
After exposure of sheep skin to UVB, increases in the number of 
migrating LC (CD1w1 + dendritic cells) are observed in psuedoafferent 
lymphatic vessels draining the irradiated area of skin. The increase in the 
migration of viable LC is in accord with previous results obtained from studies 
in mice, where UV irradiation has been shown to result in an increase in 
dendritic cell numbers in the lymph node (Moodycliffe et al., 1992). Also 
observed in the mouse lymph node after irradiation is the presence of MHC II + 
thymine dimer+ cells, demonstrating that the cells have migrated from the skin 
after UV exposure. The increased migration of LC observed in the sheep 
model at least partially explains LC depletion from skin, which has been shown 
to occur in a variety of species, including human (Fan et a/., 1959, Zelickson 
and Mottaz, 1970, Aberer et al., 1981, Cooper etal., 1992), murine (Aberer et 
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al., 1981, Obata and Tagami, 1985), guinea pig (Lim etal., 1983, Hanua et al., 
1985) and sheep (Lyne and Chase, 1966). 
The increased migration of LC was shown to have a linear relationship 
with UVB dose (Fig. 3.6) as indicated by the regression coefficient of 0.8. 
However, previous studies have found that the relationship between LC 
depletion and UVB dose is a log-linear one (Obata and Tagami, 1985, Noonan 
et al., 1984). A similar relationship between UV dose and LC migration may 
have been obtained in this study by expanding the dose range to include 
higher and lower doses of UVB. 
While exposure to all doses used in this study caused an increase in LC 
numbers in pseudoafferent lymph 8.1 kJ/m 2 proved to be the lowest dose to 
consistently cause significant increases in the numbers of LC migrating. This 
change was caused by an increased proportion of LC in the lymph in 
comparison to minimal changes for other cell types and not just general 
increases in cell migration (Table 3.2). While it is difficult to compare the 
magnitude of LC migration to that seen in other models, one study performed 
showed a four fold increase in DC numbers in the DLN of mice after exposure 
to 1.44 kJ/m2 UVB (Moodycliffe etal., 1992). This dose is nearly half that of the 
lowest dose used in this study, 2.7 kJ/m2 , suggesting that sheep may be more 
resistant to the migratory and hence depletory effects observed in other 
experimental systems. This may be partially due to the relative erythemal 
resistance of sheep already mentioned. Increasing the dose above 8.1 kJ/m 2 
leads to increases in other cell types, as well as lymph and cellular outputs, 
reflecting the increased inflammatory insult to the skin. It should be noted, 
however that minor variations in the magnitude of increased LC numbers 
between individual sheep exposed to the same dose did occur. This probably 
reflects the outbred nature of the model. 
Although this study has shown an increase in the numbers of LC 
migrating from UV exposed skin, the magnitude is moderate when compared to 
the numbers of migrating LC seen after treatment of sheep skin with the 
chemical carcinogen DMBA (Dandie etal., 1994). Carcinogens such as DMBA, 
like UVB exposure, result in a depletion of LC from the epidermis (Woods et al., 
1996). While the sustained rate of increased LC migration observed after UV 
exposure may account for some of these differences, it is likely that there are 
other, non-mutually exclusive possibilities for the loss of Langerhans cells from 
the epidermis after UV exposure. These include both the loss of expression of 
the CD1 marker used to detect LC and LC cell death occurring in situ. LC 
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depletion from the skin after UV exposure was proposed by Aberer et al., 
(1981) to be due to the loss of LC specific markers such as ATPase and MHC 
II. Obata and Tagami (1985) found that this was due to cytotoxicity, with only a 
minority of LC showing loss of MHC II expression. Tang and Udey (1992) also 
found that the previously observed down-regulation of ICAM-1 on LC (Tang 
and Udey, 1991) was due to cytotoxicity. Neither CD1 or MHC ll have been 
observed to be down-regulated by in vitro UV exposure of epidermal cells 
(Czernlewski et al., 1984). This, in conjunction with the increased numbers of 
viable LC (CD1w1 + DC) observed to migrate from the skin in this study, 
suggests that loss of expression by LC is unlikely. 
In contrast, there is substantial evidence for LC death in the skin after 
exposure to UVB. LC undergoing changes, characteristic of apoptosis are 
observed in mouse skin after UVB exposure (Obata and Tagami, 1985). 
Ultrastructural evidence of LC death and its resulting debris have also been 
reported to occur in the skin (Mommas et al., 1993). The elimination of dead 
and dying cells by macrophages (Duvall et al., 1985) occurring in the skin, may 
account for the lack of increased cell death observed in lymph during flow 
cytometric analysis in this study. However, 48-96 hours after UVB exposure of 
sheep skin an increased number of hard white clots were repeatedly observed 
in the cannula. These clots could have formed from dead cells or debris 
flushed from the skin by increased lymph flow. Further, DC with UV specific 
DNA damage has been found in the DLN of mice after UVB exposure of the 
skin (Sontag et al., 1995). While the increased migration of viable LC was 
observed in this study, the presence UV induced DNA damage within these 
cells cannot be ruled out. The use of thymine dimers in the ovine system may 
make it possible to distinguish whether the increased numbers of LC observed 
migrating from the skin are a resident population (thymidine dimer positive) or a 
population of recent emigrants (thymine dimer negative). Initial studies to 
clarify this by looking for the presence of thymine dimer + dendritic cells in 
psuedoafferent lymph after UV exposure of the skin are currently being 
undertaken. 
The monoclonal antibody used in these studies to identify LC (SBU-T6), 
recently has been reclassified as CD1w1 (Nassens et a/., 1997) and was 
previously thought to be a pan CD1 marker (Dutia and Hopkins, 1991). It is 
therefore possible it was detecting not only LC but the sheep equivalent of 
dermal DC, which express CD1b in humans (Richters at, 1995). Richters et 
al., (1996) argues that the number of LC migrating from skin, is reduced after 
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UV exposure. However, examination of their studies which utilised skin 
explants, reveal that, while the proportion of CD1a + DC (LC) was decreased, 
these cells still greatly outnumber CD1b + and CD14+ cells. Therefore the 
majority of ovine CD1w1+ DC observed in this study are still likely to be LC. 
The continuing development of ovine specific reagents, may enable LC to be 
distinguished from dermal DC cell in the future, although this will probably 
involve multi-parameter flow cytometric analysis. Further, the use of in vitro 
systems, such as explants, eliminates input from other areas such as the 
circulatory and nervous systems. It can be strongly argued that the sheep 
model, which studies cells collected ex vivo from wholly intact skin after UV 
exposure, is much more likely to represent the "normal" response of LC to this 
physical insult. 
The SBU-T6 mAb used in this study, as well as possibly reacting with 
dermal DC has been shown to react with some ovine tissue macrophages 
(Dutia and Hopkins et al., 1991), as well as ovine macrophages produced by 
culturing PBMC (Gorrell etal., 1992). Macrophages are one of the cell types 
shown to infiltrate the skin after UV exposure (Cooper et al., 1992) and migrate 
from skin explants after UV exposure (Richters et al., 1996). Further cells with 
a macrophage-like phenotype are seen in the DLN of mice after UV exposure 
(Moodycliffe et al., 1992). It may therefore be possible that the mAb used may 
be reacting with migrating macrophages. Evidence is presented in chapter 4 
showing that this it is unlikely, although it cannot be eliminated entirely. 
Nonetheless, macrophages remain the major candidate other than UV altered 
LC, for down-regulation of antigen specific immune function detected after UV 
light exposure of the skin. 
Other studies examining LC migration from sheep skin have been 
performed in this department, and it is interesting to compare the timing, 
magnitude and duration of these studies using skin exposure to chemicals with 
data obtained in this current study investigation UV light exposure of the skin. 
The contact sensitiser TNCB has been shown to cause increased LC migration 
in the sheep model, as have the complete chemical carcinogens DMBA 
(Dandie et al., 1992, Dandie et al., 1994) and BP as well as the tumour 
promoter, TPA (Ragg etal., 1994). All of these chemicals have been shown to 
deplete LC from the epidermis of mice (Halliday et al., 1987b, Muller et al., 
1985, Woods et al., 1993, Woods et al., 1996). In the sheep model, LC 
migration was shown to be increased immediately after application of TNCB 
(Dandie et al., 1992, Dandie et al., 1994) , BP, TPA (Ragg et al., 1994) or 
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DMBA (Dandie etal., 1992, Dandie etal., 1994). Similarly UV irradiation of the 
skin caused increased migration, usually observed to begin within the first 24 
hours. The magnitude of this initial increase in LC migration after cutaneous 
exposure to BP, TPA and DMBA, was approximately 5-10 fold, suggesting 
antigen induced migration as it was of similar timing and magnitude to that 
induced by TNCB (Dandie et al., 1992, Dandie etal., 1994). The magnitude of 
LC migration in this study, to the highest doses of UVB was also of a similar 
size. 
Increased LC migration following UVB exposure of skin is likely to be a 
response to inflammatory stimuli proposed by Ibrahim eta!, (1995) causing DC 
to migrate, rather than a response to UV induced antigens. It is likely to involve 
UV specific alterations such as alterations in the local cytokine milieu in the 
skin (reviewed by Granstein, 1996 and Takishima and Bergstresser, 1996), cis-
UCA production (Moodycliffe etal., 1992, Kurimoto and Streilein, 1992) or DNA 
damage (LeVee et al., 1988). The migration of LC in response to UVB appears 
to be sustained for a much longer period than that of any chemical exposure of 
the skin. 
3.4.2 	Lymph Output and Total Cell Output after UV 
Exposure of the Skin 
The treatment of skin with UV light causes vascular changes, including 
vasodilatation, which in turn leads to fluid accumulation in the skin which has 
been shown to occur for at least 24 hours after UV exposure (Gilchrest et al., 
1981). Exposure of the skin to large doses of UV causes oedema or blistering. 
However, only microscopic blistering was evident in the skin of sheep treated 
with the highest dose used in this study, 80.4 kJ/m 2 (unpublished 
observations). Despite the lack of obvious erythema, transient increases in 
lymph flow was observed in 3/5 sheep treated with 2.7 kJ/m 2 suggesting that 
erythema may have been present to some extent and that measurement more 
precise than visual estimation of erythema are required. However for this dose 
sustained increases above the normal range were only observed in one sheep. 
Transient increases were common in the first 48 hours after exposure to all 
doses of UVB assessed and sustained increases in lymph flow are seen for all 
sheep treated with doses higher than 20.1 kJ/m2. This possibly reflects 
increased fluid accumulation at the inflammatory site. The increased rate of 
lymph flow observed after UV exposure of the skin may account for some of the 
94 
increases in cellular output as increased fluid flow may have had a flushing 
effect. 
Increased cellularity of the lymph was observed after the flank skin was 
exposed to UV light in the majority of sheep treated with 20.1 kJ/m 2 UVB and 
above. It should be noted that, sustained increases were observed only in one 
out of four sheep after treatment with the 8.1 kJ/m 2 UVB. The increased 
cellularity of the lymph is due to a combination of two factors, the migration of 
resident cells from the skin and/or the migration of infiltrating cells. The latter is 
in agreement with Cooper et al., (1993), who found that exposure of BALB/c 
mice to 3.12 kJ/m2 caused the epidermis to be extensively infiltrated with 
neutrophils, macrophages and monocytic cells. Gilchrest et al., (1981) also 
found some lymphocytes infiltrate the skin after UV exposure. It should be 
noted that the origin of the infiltrating macrophage\monocyte cells is a subject 
of debate and may originate from within the skin (Meunier et al., 1995). 
Increased inflammatory cell infiltrate of sheep skin due to ecto-parasite 
infection, is also associated with increased cell output from cannulated 
pseudoafferent lymphatic vessels, the magnitude being similar (2-4 fold) to that 
observed after UVB exposure of the skin (Egan et al., 1996.) 
However for those sheep treated with UV light that did not show an 
increased number of cells in the lymph it may mean that the UV dose was too 
low to stimulate cells to be recruited into the skin or alternatively these cells 
andlor resident cells did not emigrate to the DLN in significant numbers. 
Increased cellularity was not due to the increased migration of LC, as this cell 
type was still relatively minor in number, even when significant increases in LC 
numbers were observed. 
3.4.3 	Migration of T cell Subsets after UV Exposure of the 
Skin 
There is very little data on the migration of lymphocytes into or out of the 
skin after UV exposure. However, it has been shown that a slight lymphocytic 
influx occurs in human skin 24-72 hours after exposure with UV (Gilchrest et 
at, 1981). The data shown in this current study indicates that treatment of the 
skin with UV causes a general increase in the migration of lymphocytes to the 
draining lymph node, which included CD4+ T cells and, to a lesser extent, T19 + 
yo T cells and CD8 + T cells. Lymphocytes in this study appear to be less 
sensitive to these changes than LC which are the most sensitive to the effects 
of UVB light. 
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CD4+ positive lymphocytes comprised the largest individual population of 
cells in the lymph after UVB. CD4 + cells consistently made up the majority of T 
cells in the lymph, followed by T19 + y5 T cells and CD8+ T cells. The proportion 
of CD4 to CD8 T cells approximately reflected the ratio previously found in 
psuedoafferent lymph of 3.5 to 1 (Mackay et al., 1988), albeit the numbers of 
T19+ y5 T cells appeared to vary between sheep some being close to the 
numbers of CD4+ T cells, while others were similar in number to the CD8 + T 
cells. T19" y5 T cells were not assessed as anti TCR1 antibodies were not used 
in this study, although the number of these cells is small (Mackay and Hein, 
1989, Hein and Mackay, 1991). Accordingly it was concluded that UV exposure 
of the skin caused an increase in the migratio' n of T cells and CD4 T cells were 
increased in all sheep showing increased cellular output. It should be noted 
that T cell sub-populations, especially CD8+ T cells, did not appear to be as 
sensitive to the migratory effects of UV light as that of LC, perhaps indicating 
that LC are much more susceptible to the effects of UV light. It also illustrates 
the function of DC, which readily migrate in response to inflammation and cell 
damage (Ibrahim et al., 1995). 
It is known that inflammatory endothelium preferentially extracts T cells of 
the memory phenotype (Mackay et al., 1992). These cells traffic through the 
inflamed tissue back to the draining lymph node (Mackay et al., 1990). 
E-selectin is up-regulated on endothelial cells after exposure to 2 MED UVB 
after 6 hours, peaking at 24 hours (Norris et al., 1991). This correlated with 
increased accumulation of inflammatory cells. Human studies show E-selectin 
preferentially attracts a sub-population of skin homing memory T cells 
expressing the cutaneous lymphocyte associated antigen (CLA) (Picker et al., 
1993). While an equivalent antigen is yet to be determined in sheep, the 
observed increases in migrating lymphatic CD4 + T cells, CD8+ T cells and T19+ 
y6 T cells may be memory cells that have responded to changes in the vascular 
endothelium by trafficking through the UV inflamed skin. 
Further evidence for the attraction of memory T cells into ovine skin 
comes from another model of a cutaneous inflammation using Lucila cuprina, 
an ectoparasite (Egan etal., 1996), where the authors found that the increased 
cellularity of the lymph was primarily due to the migration of CD4 + T cells and y5 
T cells both of a memory phenotype. The same cell types also predominate in 
the inflammatory lesion. It should be noted that this model did not cause 
significant increases in the migration of LC, which the authors suggest was due 
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to the production of different cytokines in comparison to those produced in the 
skin after UV light exposure. 
Likewise, infiltration of CD4 + T cells and CD8 + T cells has been observed 
to occur in ovine skin using Trypansoma congolese (Mwangi et al., 1990), and 
was paralleled by increases in these specific cell populations in bovine 
pseudoafferent lymph studies (Flynn et al., 1994). No infiltration of y5 T cells 
was observed and these were few in lymph draining the infected site. This 
indicates that specific cell types observed to infiltrate the skin after a specific 
inflammatory stimulus, subsequently results in similar cell migration to the DLN. 
Extrapolating this to the present study, CD4 + T cells, CD8 + T cells and T19+ y5 T 
cells all show an increased migratory response to UV light, reflecting the 
phenotype of cells infiltrating the skin. In support of this increased numbers of 
these T cell subsets have been observed in the dermis of chronically UV 
exposed sheep skin (Gorrell etal., 1995). 
T19+ y5 T cells are proposed to represent mature y5 T cells (Mackay 
1989). Gorrell et al, (1995) and Hein and Mackay (1991) have both shown that 
the immature y5 T cells (T19 y T cells) preferentially home to epithelia in 
sheep, and thus are more likely to represent the equivalent population to the 
DETC seen in mouse skin. Depletion of resident y5 T cells in response to UV 
light in mouse skin has been demonstrated (Aberer et a/., 1986 and Alcalay et 
al., 1989). However, the fate of these cells is unknown as y8 T cells (including 
DETC), are not found within the DLN with UV specific damage (Sontag et al., 
1995). This suggests that they either migrate from the epidermis and are 
retained in the dermis; or undergo apoptotic cell death prior to reaching the 
node; or are not susceptible to UV induced damage. 
A separate analysis of large, possibly dendritic, T19 + y5 T cells has been 
investigated in conjunction with the study presented in this chapter (Dandle et 
al., in preparation). This revealed that while migration of dendritic T19 + y5 T 
cells is increased after UV exposure, this event was not dose related. DETC 
have been proposed as mediators of some of the suppressive effects of UV 
light especially in rodent models where a network of DETC is observed 
(Okamoto and Kripke, 1987). However, the human equivalent DETC 
population is not normally present in the epidermis (Bergstresser et a/., 1993). 
Furthermore, DETC have not been demonstrated in either the epidermal or 
dermal layers in the sheep in normal skin or chronically UV exposed skin 
(Gorrell etal., 1995). In the current study only a small proportion of T19 + y5 T 
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cells are dendritic. These cells may be large granular lymphocytes, rather than 
true DC. 
In sheep skin CD8+ T cells outnumber T19+ 1,6 T cells (Gorrell et al., 1995), 
yet in lymph draining normal and UV treated skin CD8+ T cells were only rarely 
observed to outnumber T19+ y8 T cells despite increases in their migration. 
Gorrell et al., (1995), also found that CD8+ T cells were less likely to be found 
next to superficial vessels were T19 + y6 T cells predominate and suggested that 
T19+ yE• T cells represent a more transient population within ovine skin. CD8 + T 
cells are the most numerous T cell sub-population in ovine skin, yet they were 
the sub-population least sensitive to UV light, in terms of observed migration 
patterns. The migration of resident T cell populations, such as the epidermal 
CD8+ T cells after UV exposure could be masked by the influx and migration of 
T cells responding to the inflammatory stimulus. The use of thymine dimers 
would appear to be the most useful technique for elucidating what proportion of 
CD4+ T cells, CD8 + T cells and T19+ y6 T cells migrating were resident in the 
skin at the time of irradiation. 
Gorrell etal., (1995) also observed that in sheep skin chronic exposure to 
UV light resulted in an increased number of CD4 + T cells in the epidermis, while 
in the dermis T lymphocytes of all subtypes were increased, but especially 
CD4+ T cells with the positioning of these cells near blood vessels indicating 
immigration rather than replication. Therefore as well as CD4 + T cells migrating 
to the DLN which has been demonstrated in this chapter, after chronic 
exposure to UV light they and other subtypes return to the skin. 
3.5 SUMMARY 
The migration kinetics of Langerhans cells and other cell populations has 
been investigated after UV exposure of the flank skin in sheep. These studies 
show that, in the ovine model UVB doses of 8.1 kJ/m 2 and greater cause 
increased LC migration. Consistent increases in general cell output were 
observed at higher doses and this reflected the migration of lymphocytes, 
including CD4+ T cells, T19+ y5 T cells, and to a lesser extent CD8+ positive T 
cells. It was found that these cell types were much less sensitive to UV 
irradiation than LC which are resident in the skin. Evidence presented in this 
study supports the idea that LC migration to the draining lymph node is 
increased after UV exposure of the skin, in a dose dependant manner. This 
conclusion partially explains the depletion of LC from the epidermis which has 
been previously demonstrated in other models. 
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CHAPTER 4: PHENOTYPE OF AFFERENT LYMPHATIC 
DC AND MACROPHAGES 
4.1 INTRODUCTION 
Exposure of skin to UVB draws inflammatory cells into the skin as well as 
affecting the resident DC. These inflammatory cells include neutrophils (Logan 
and Wilhelm, 1963, Hawk et al., 1988, Cooper et al., 1992), lymphocytes 
(Gilchrest et al., 1981) and macrophages (Cooper et al, 1992). The induction 
of tolerance by epicutaneous immunisation 2-14 days after UV exposure, 
coincides with the timing of the influx of macrophages into the epidermis 
(Cooper et al., 1985b). Separation of DC and macrophages is difficult given 
that they share many markers, perhaps reflecting their close relationship 
(Peters et al., 1996). This problem is exacerbated in the ovine system where a 
more limited range of reagents against leucocyte antigens are currently 
available. In this chapter experiments will be described which have used a 
number of the relevant mAb's which are available to specifically identify any 
macrophages, which may be present in pseudoafferent lymph draining normal 
or UV exposed skin. Macrophages obtained from alveolar lavage fluid have 
been used as a readily identifiable population of ovine macrophages for the 
purpose of mAb testing and comparison in flow cytometric studies. 
The exposure of the skin to UVB while drawing other cell populations into 
the skin appears to crucially affect the ability of LC to induce Th1 responses. 
The alteration of MHC II, adhesion molecules and co-stimulatory molecules on 
UV irradiated LC has been a topic of considerable debate. A crucial group of 
co-stimulatory molecules are the B7 family, CTLA-4 ligands. These have been 
previously noted in ovine pseudoafferent lymph DC (Ragg et al., 1997). This 
chapter will further investigate the affect of UV exposure on the expression of 
CTLA-4 ligands on migrating ovine afferent lymph DC. 
The use in this chapter of the more modern FACSCAN TM (BD) and 
ELITE."' (Coulter) flow cytometers in comparison to the EPICS V flow cytometer 
used in chapter 3. These cytometers allow precise gating and have capabilities 
for greater multi-parameter analysis, permitting the phenotype of cells to be 
studied in greater detail, thus enabling a more thorough search for 
macrophages in pseudoafferent lymph and a more accurate analysis of the 
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expression of B7 molecules on migrating LC, before and after cutaneous UV 
exposure. 
4.2 MATERIALS AND METHODS 
4.2.1 	Experimental Plan 
4.2.1.1 	Isolation of Pseudoafferent Lymph DC and Alveolar 
Macrophages 
The study of migrating DC was performed using cells from the ovine 
pseudoafferent lymphatic model as described previously (Sections 2.2-2.5), 
while the isolation of isolation of alveolar macrophages (AM) is described in 
Section 2.10. 
4.2.1.2 	Detection of Macrophages 
Large cells consisting of either macrophages from alveolar lavage fluid or 
DC from pseudoafferent lymph, were identified by forward and 90° scatter 
profiles (see Fig. 4.1). These cells were gated and analysed separately to 
ensure the populations of DC and AM were relatively pure. The levels of MHC 
I and MHC II expression were measured using mAbs SBU-I (41.19) and SBU-II 
(49.1). Antibodies against various cell markers, were also used, including SBU-
16 (20.27) which is an anti-CD1w1 mAb (Naessens etal., 1997), which reacting 
with ovine LC in the skin and with migrating LC in pseudoafferent lymph 
(Dandie etal., 1992). To identify CD4 + T cells, CD8+ T cells and T19+ 78 T cells 
the mAbs SBU-T4(44.38+44.97), SBU-T8 (38.65) and SBU-T19 (19.19) were 
used respectively. °Mt 0M2 and 0M3, which have been shown to stain 
macrophages and macrophage sub-populations but not pseudoafferent 
lymphatic DC, were used in an attempt to identify macrophages (Pepin et al., 
1992). 0M1 has been recently reclassified as a marker of CD11c (Nassens et 
al., 1997). The mAb CC-G33, which was raised against bovine CD14 (Sopp et 
al., 1996), cross reacts with ovine CD14 (reviewed by Nassens et al., 1997) 
and was used as a specific marker of macrophages. Directly conjugated 
isotype controls for IgG1 and IgGa (BD), were used to assess non-specific 
binding. For lavage fluid samples 25,000 cells and for lymph samples 10,000 
cells were analysed for each phenotypic marker. The immunofluorescent data 
from each sample were stored as list mode files using the EPICS ELITE flow 
cytometer (Coulter) and were analysed using Elite software (Coulter). The 
staining patterns of the various mAb were used to compare the profiles of the 
two distinct cell types, alveolar macrophages and pseudoafferent lymph DC, to 
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determine if macrophages could be identified in pseudoafferent lymph under 
normal conditions, or after UV induced inflammation of the skin. 
4.2.1.3 	CTLA-4 Ligand Expression by DC 
CTLA-4 is a molecule expressed on T Cells which has been shown to be 
a receptor for the B7 (Lindsey et al., 1991) family of co-stimulators. Previous 
use of the CTLA-4 marker against ovine DC showed that it reacted with 68 -'-I-
7% of ovine DC (Ragg et al., 1997). Although the CTLA-4 fusion protein is a 
construct made from the human CTLA-4 receptor this molecule has been 
shown to be conserved across species (>70% homology) (Lindston et a/., 
1993). MCD40 was used as the control for the CTLA-4 construct protein. Two 
colour immunofluorescence was used to detect the expression of CTLA-4 
ligands on LC (CD1w1 + DC). The second layer used to detect the mAbs in this 
case contained phycoerytherin (PE) conjugated anti-mouse F(ab') 2 fragment 
(Silenus) to detect CD1w1 expression and FITC conjugated anti human F(ab')2 
(Silenus) to detect CTLA-4 ligand expression. These samples were processed 
using the FACSCAN flow cytometer (Becton-Dickenson), generously made 
available by the Red Cross Blood Bank, (Hobart) . Once pre-treatment levels 
were stabilised, the region of flank skin to be irradiated was shorn and exposed 
to UVB light (see Section 2.4) and monitoring continued. Doses of 2.7 kJ/m 2 , 
8.1 kJ/m2 and 20.1 kJ/m 2 UVB were administered to shorn flank skin (Section 
2.4). Care was taken to ensure that the conditions for each staining were kept 
as similar as possible. Samples were stored in FACS FIX (see Section 2.5), 
until the time course was finished. Samples were then analysed on the same 
day using the same cytometer settings to reduce possible variation. 
4.2.2 	Presentation of Data 
For each phenotypic marker an example of the staining profile of AM and 
psuedoafferent lymphatic DC draining normal skin, is depicted in a histogram 
showing log FITC staining for each cell population. The findings are 
summarised in Table 4.1 showing the mean percentage of positive cells in both 
the DC and AM populations and the mean fluorescence intensity for each 
marker. 
The CLTA-4\SBU-T6 staining's are presented as intensity of staining of 
LC (CD1w1 + DC) with the CTLA-4 fusion protein. This is shown as a time 
course after UV exposure. Because of the variability observed two 
representative graphs are used to illustrate the trends observed for each dose. 
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4.3 RESULTS 
4.3.1 	Phenotype of Afferent Lymphatic DC and Alveolar 
Macrophages 
4.3.1.1 	Flow Cytometric Characteristics of Afferent Lymph DC and 
Alveolar Macrophages 
It can be seen from Fig. 4.1a that macrophages (large granular cells) 
appear to make up approximately 67% of cells isolated from lavage fluid. 
Small-lymphocyte like cells compose between 7-22% of the cells isolated from 
lavage fluids. The remaining cells are likely to be dead cells or debri and were 
exlcluded from the anlysis. Cells with the characteristic FSC vs SSC profile of 
DC are a minor cell population of pseudoafferent lymph as illustrated by Fig. 
4.1b where they comprised 11.6% of the total afferent lymph cells. To assess 
the phenotype of dendritic cells and macrophages these specific cell 
populations were gated and separately analysed as "macrophages" or "DC". 
4.3.1.2 	Controls 
The use of isotype controls containing two directly conjugated isotypes, 
IgG1 (FITC) and IgG2a (PE) revealed that very few cells were positive. It 
should be noted that macrophages appeared to have a higher intensity of 
staining with IgG1 (Fig. 4.2a) than did DC (Fig. 4.2b). Controls containing the 
second layer, anti-mouse FITC conjugated F(ab') 2 fragments (Silenus), only 
showed a higher fluorescence intensity than those of the isotype controls. 
Therefore this control was used to set which cells could be regarded as 
"positive" or "negative" for both macrophages and DC , and is represented by 
the red lines in the Figs. 4.3-4.11. 
4.3.1.3 	Major Histocompatability Complex 
Macrophages and DC expressed MHC I, with 98.3% (Fig. 4.3a) and 
96.4% (Fig. 4.3b) respectively being positive. The level of expression was 
similar, with positive cells for both populations generally found within the third 
decade (log 102  andlog 103) of immunofluorescence. 
Both, macrophages and DC were also found to express MHC II to varying 
degrees, with 91% (Fig. 4.4a) and 98.4% (Fig. 4.4b) respectively being MHC II 
positive. 	However, it appeared that a minority of cells lying within the 
macrophage gate macrophages were negative. 	Further, the levels of 
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Dot plot representation of flow cytometric analysis of forward 
scatter (FSC) and side scatter (90) of cells comprising (a) 
alveolar lavage fluid and (b) psuedoafferent lymph, showing the 
gating used for analysis purposes and the % of cells lying within 
the gate for this representative example 
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Figure 4.3 MHC I 
a) Macrophages 
	 b) Dendritic Cells 
Flow cytometric staining profile of the anti-MHC I monoclonal antibody (SBU I - 
41.19) showing the percentage of postive cells from gated macrophages from 
alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent lymph (b) 
in comparison to cells from control samples (red). 
Figure 4.4 	MHC II 
a) Macrophages 	 b) Dendritic Cells 
Flow cytometric staining profile of the anti-MHC II monoclonal antibody (SBU II 
- 49.1) showing the percentage of postive cells from gated macrophages from 
alveolar lavage fluid (a) and dendritic cells from pseudoafferent lymph (b) in 
comparison to cells from control samples (red). 
having a continuum from negative through weakly positive to quite intensely 
positive. The immunofluorescent levels of the majority of positive macrophages 
lay within the third decade, while the majority of DC lay within the upper third 
and fourth decades. 
	
4.3.1.4 	T Cell Markers 
Staining with the SBU-T6 mAb revealed that, in general, AM were 
negative for this marker (Fig. 4.5a), whereas a majority of DC, 61.4% in the 
example shown (Fig. 4.5b) were positive. Fig. 4.6a shows that macrophages 
were negative for CD4 whereas a minority of cells lying within the DC gate 
were positive, in this case, 7.7% (Fig. 4.6b). The expression of this T cell 
marker was quite variable on DC, but its expression was consistently observed. 
The fluorescence intensity of CD4 staining was relatively low lying within the 
upper second decade. Macrophages were observed to be CD8 negative (Fig. 
4.7a). However a small number of pseudoafferent lymph DC were positive 
(Fig. 4.7b). The percentage of CD8 positive cells were consistently smaller 
than that of CD4 positive cells and the fluorescence intensity of these cells was 
very low. Very few T19 + yo T cells were found in either the macrophage gate 
(0.1%) or within the DC gate, (2.0%) (Fig. 4.8). 
4.3.1.5 	Macrophage Markers 
Macrophages were found to express CD11c (0M1) (Fig. 4.9a) as were 
the majority of DC (Fig. 4.9b), 89.7% and 65.1% respectively. However, 
approximately one third of DC did not express this marker. Similarly 0M2 was 
expressed on 94.3% of cells within the macrophage gate (Fig. 4.10a), whereas 
only a minority of cells within the DC gate, 35.8%, expressed this marker (Fig. 
4.10b). 0M3 was not expressed significantly by either AM or DC; and only 
1.5% and 0.9% of AM and DC, respectively were weakly positive (Fig. 4.11). 
CD14 was expressed by 87.7% of macrophages (Fig. 4.12a) but only by 0.9% 
of cells lying within the DC cell gate (Fig. 4.12b). 
4.3.1.6 	Summary 
Table 4.1 summarises the percentage of cells observed to express the 
various markers examined. While macrophages express MHC II, the intensity 
of expression was lower than that of DC. It was also consistently found that a 
minor population of DC expressed the T cell marker, CD4. Two other 
differences were the expression of CD1w1 by the majority of dendritic cells and 
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Flow cytometric staining profile of the anti-CD1w 1 monoclonal antibody (SBU 
T6 - 20.27) showing the percentage of postive cells from gated macrophages 
from alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent 
lymph (b) in comparison to cells from control samples (red). 
Figure 4.6 CD4 
a) Macrophages  b) Dendritic Cells 
Flow cytometric staining profile of the anti-CD4 monoclonal antibodies (SBU 
T4 -44.38+44.97) showing the percentage of postive cells from gated 
macrophages from alveolar lavage fluid (a) and gated dendritic cells from 
pseudoafferent lymph (b) in comparison to cells from control samples (red). 
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Figure 47 CD8 
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b) Dendritic Cells 
Flow cytometric staining profile of the anti-CD8 monoclonal antibody (SBU 
T8 - 38.65) showing the percentage of postive cells from gated macrophages 
from alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent 
lymph (b) in comparison to cells from control samples (red). 
Figure 4.8 T19 yö T cells 
Flow cytometric staining profile of the anti-T19 monoclonal antibody (SBU 
T19 - 19.19) showing the percentage of postive cells from gated macrophages 
from alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent 
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Flow cytometric staining profile of the anti-CD11 c monoclonal antibody 
((WI) showing the percentage of postive cells from gated macrophages from 
alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent lymph 
(b) in comparison to cells from control samples (red). 
Figure 4.10 0M2 
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Flow cytometric staining profile of the anti-0M2 monoclonal antibody showing 
the percentage of postive cells from gated macrophages from alveolar lavage 
fluid (a) and gated dendritic cells from pseudoafferent lymph (b) in 
comparison to cells from control samples (red). 
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Flow cytometric staining profile of the anti-0M3 monoclonal antibody 
showing the percentage of postive cells from gated macrophages from 
alveolar lavage fluid (a) and gated dendritic cells from pseudoafferent 
lymph (b) in comparison to cells from control samples (red). 
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Flow cytometric staining profile of the anti-CD14 monoclonal antibody 
(CC-G33) showing the percentage of postive cells from gated 
macrophages from alveolar lavage fluid (a) and gated dendritic cells from 
pseudoafferent lymph (b) in comparison to cells from control samples 
(red). 
The crucial finding was that the CD14 surface molecule was not expressed by 
pseudoafferent lymph DC. These findings provided a critical base to assess 
macrophages migrating after skin exposure to UVB. 
Table 4.1 Expression of Phenotypic Markers by Alveolar Macrophages 
and Psuedoafferent lymphatic Dendritic Cells 

















MHC I 99.3 (0.4) 21.3 97.1 ( 3.7) 39.1 
MHC II 95.7 (3.9) 82.4 71.4 (27.5) 20.1 
CD1w1 58.7 (10.9) 4.5 2.4 (1.5) 7.0 
CD4 29.1 (10.4) 3.1 3.1 (1.5) 9.6 
CD8 6.8 (2.8) 3.9 1.8 (1.1) 5.8 
T19 y5 T cells 2.4 (0.7) 4.2 1.6 (1.3) 5.5 
0M1 60.8 (8.2) 3.9 91.6 (3.5) 12.9 
0M2 27.7 (8.6) 3.8 94.6 (1.3) 21.3 
0M3 0.9 (1.0) 3.8 3.9 (1.6) 8.2 
CD14 2.9 (1.6) 2.4 88.4 (7.2) 10.7 
4.3.2 	Migration of CD14+ DC after UV Exposure 
The flank skin of three cannulated sheep was exposed to 20.1 kJ/m 2 UVB 
and the proportion of migrating CD14 + cells occurring within the DC gate was 
monitored to determine if macrophages were being induced to migrate. From 
Fig. 4.13 can be seen that there was a sustained increase in the percentage of 
large granular cells expressing the CD14 molecule. This peaked 24 hours after 
exposure, with an approximate 4 fold increase above the mean pre-UVB 
exposure levels. The proportion of CD14 cells within the DC gate remained 
elevated until 96 hours were they returned to within the normal range. This 
change was transient and was immediately followed by another increase above 
the normal range which was followed by subsequent decrease between 120 
and 132 hours post treatment. Following this a gradual increase in the 
proportion of CD14 positive DC occurred, peaking at 192 hours, after which the 
percentage of CD14 returned to the normal range apart from a transient 
increase above the normal range at 264 hours. 
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Figure 4.13 Migration of CD14+ cells after Exposure of 
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Dotted lines indicate the normal range for 
this single representative experiment. 
Increases in the percentage of CD14+  DC were seen for two other sheep 
both peaking within the first 24 hours. The up tempo migration CD14 + DC was 
observed to last for 168 and 216 hours for these two replicate experiments 
Thus it appears that after UV exposure of the skin CD14 + cells with the FSC 
and SSC characteristics of both DC and macrophages were induced to migrate 
to the draining lymphatics. 
4.3.3 	Expression of B7 molecules by Afferent lymph DC 
after UV exposure of the skin 
4.3.3.1 	Expression of CTLA-4 Ligands by Pseudoafferent DC 
Fig. 4.14 illustrates how the expression of CTLA-4 ligands by LC (CD1w1 + 
DC) was assessed. The conjugate only control was used so negative cells 
could be excluded from the analysis (Fig. 4.14a). The construct MCD40 (Fig. 
4.14b) was used as an isotype control for the CTLA-4 construct (Fig. 4.14c) 
and cells lying within this region were excluded by logical gating from the 
histogram analysis of the levels of CTLA-4 ligand expression (Fig. 4.14d). 
4.3.3.2 	Expression of CTLA-4 Ligands by Pseudoafferent DC after 
Skin Exposure to 2.7 kJ/m2 UVB 
There was a variable response in the level of B7 expression on CD1w1 + 
DC observed after UV exposure of skin to 2.7 kJ/m 2 . It can be seen from Fig. 
4.15 that the fluorescence intensity did not deviate from the normal range after 
exposure of the skin to 2.7 kJ/m 2. However, Fig. 4.16 shows that in a different 
experimental subject the intensity of fluorescence, was first observed to 
increase 22 hours after treatment but subsequently returned to within normal 
levels. Between 48 and 72 hours the intensity of fluorescence was again 
observed to be above the normal range. After this the level of 67 expression 
by DC returned to normal levels apart from subsequent increases above the 
normal range at 176 and 298 hours. It should be noted that the increases in B7 
expression were not very dramatic for the one experimental subject which 
showed increases above the normal range. So typically it was found that only 
small increases, if any, in the levels of B7 expression were observed after 
exposure of sheep flank skin to 2.7 kJ/m2 . 
4.3.3.3 	Expression of CTLA-4 Ligands by Pseudoafferent DC after 
Skin Exposure to 8.1 kJ/m2 UVB 
When sheep skin was exposed to higher doses of UVB, similar results 
were noted. Figs. 4.17 and Fig. 4.18 illustrate that after treatment of the skin 
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FIGURE 4.14 ANALYSIS OF CTLA-4 LIGANDS ON 
MIGRATING LC (CD1w1+ DC) 
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	 b) MCD40 + SBU-T6 
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Figure 4.14a, b & c are dot plot representations of dendritic cells labelled with (a) 
directly conjugated FITC and PE second layer F(ab')2 only, (b) with the MCD40 control 
construct and the SBU-T6 mAb and (c) with the CTLA-4 construct and SBU-T6. 
Regions are shown in colors (R1 = Red and R2 =Green. Figure 4.14d is histogram gated 
on region G3 showing intensity of CTLA-4 staining on CD1w1+ dendritic cells 
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Fluorescence intensity of CTLA-4 ligand expression 
on migrating CD1w1 + DC after exposure of the skin 
to 2.7 kJ/m2 UVB. Dashed lines represent the normal 
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Figure 4.16 B7 expression after 2.7 kJ/m 2 
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Fluorescence intensity of CTLA-4 ligand expression 
on migrating CD1w1 + DC after exposure of the skin 
to 2.7 kJ/m 2 UVB. Dotted lines represent the normal 
range for this representative experiment. 
with 8.1 kJ/m2 UVB, the intensity of expression of CTLA-4 ligands were 
substantially unchanged. The exceptions were two transient increases just 
above the normal range at 218 and 305 hours and a transient decrease below 
the normal range at 96 hours after UV exposure (Fig. 4.17). It should be noted 
that the pre-treatment level of B7 expression were quite variable, between 
experimental subjects and ranged from a mean fluorescence channel of 
120-220 (Fig. 4.18). 
4.3.3.4 	Expression of CTLA-4 Ligands by Pseudoafferent DC after 
Skin Exposure to 20.1 kJ/m 2 UVB 
Exposure of sheep skin to 20.1 kJ/m 2 had variable effects on the 
expression of CTLA-4 ligands. This is illustrated by Fig. 4.19 and Fig. 4.20. 
Fig. 4.19 shows that a sustained decrease in the intensity of CTLA-4 ligand 
expression occurred within the first 24 hours after UV exposure. While a 
transient return to within the normal range, the substantial decrease in the 
expression of CTLA-4 ligands was sustained throughout the duration of the 
monitoring period. In contrast, data from another experimental subject (Fig. 
4.20) shows a sustained increase in the expression of CTLA-4 ligands, initially 
between 80-120 hours after exposure and then between 240-312 hours 
following exposure. 
Exposure of two further sheep to this dose revealed no decreases in the 
levels of intensity of CTLA-4 expression but increases in the intensity of CTLA-
4 ligand expression were observed at 48 hours and between 96-120 hours 
respectively. Therefore, levels of B7 expression on migrating DC after 
exposure of the skin to 20.1 kJ/m2 were generally observed to be elevated in 
expression in the majority of experimental subjects (3/4). 
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Figure 4.18 B7 expression after 8.1 kJ/m 2 UVB 
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Fluorescence intensity of CTLA-4 ligand expression 
on migrating CD1w1 + DC after exposure of the skin 
to 8.1 kJ/m 2 UVB. Dashed lines represent the normal 
range for this representative experiment. 
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Fluorescence intensity of CTLA-4 ligand expression 
on migrating CD1w1 + DC after exposure of the skin 
to 20.1 kJ/m2 UVB. Dashed lines represent the normal 
range for this representative experiment. 
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Fluorescence intensity of CTLA-4 ligand expression 
on migrating CD1w1 + DC after exposure of the skin 
to 20.1 kJ/m2 UVB. Dashed lines represent the normal 
range for this representative experiment. 
4.4 DISCUSSION 
The previous chapter used the EPICS V, flow cytometer to assess the 
migration of various cell types, including DC in pseudoafferent lymph. The use 
of the FACSCAN and ELITE flow cytometers allows a more accurate analysis 
to be performed, as these cytometers are capable of more precise gating of 
individual cell populations. This, combined with the multi-parameter capacity of 
FACSCAN and ELITE cytometers, allows a more detailed analysis of individual 
cell phenotypes. The two objectives of experiments reported in this chapter 
were to see if a population of migrating macrophages could be detected in 
pseudoafferent lymph after UV exposure and secondly, to see if the exposure 
of skin to UVB altered the expression of B7 molecules on migrating DC. 
4.4.1 	Macrophage Migration Induced by UV Exposure of 
the Skin 
The expression of MHC I by both AM and DC was expected, and therefore 
used mainly as a positive control. While the majority of AM expressed MHC II, 
the intensity of expression was highly variable but generally much lower than 
that of pseudoafferent DC. The high levels of MHC II expression on DC shown 
here is in agreement with previous reports of high levels of MHC ll in sheep 
afferent lymph DC (Budjuso et al., 1989). 
The lack of CD1w1 expression by alveolar macrophages was unexpected 
as some ovine tissue macrophages (Dutia et al., 1991) and macrophages 
generated from culture of ovine PBMC (Gorrell et al., 1992) have been shown 
to express this marker. This suggests that the expression of this molecule by 
macrophages may be dependent on the tissue of origin and that perhaps the 
microenvironment of the lung is not conducive to its expression. This lack of 
expression by macrophages supports the use of the SBU-T6 monoclonal 
antibody to specifically identify migrating LC in this study. 
A T cell marker found to be expressed by a sub-population of DC in 
pseudoafferent lymph is CD4, which has been shown to be expressed by LC in 
human skin (Wood et al., 1983). However, the expression of CD4 by ovine DC 
is less well characterised but has been noted on 50% of dendritic 
"macrophages" in pseudoafferent lymph (Mackay et al., 1988b). In contrast to 
this finding the expression of CD4 has since been shown not to occur on ovine 
macrophages from tissue, blood and culture experiments (Gorrell et a/., 1988a, 
107 
Gorrell eta!, 1988b, Gorrell etal., 1992), suggesting that Mackay etal., (1988), 
were in fact observing CD4 expression on DC, possibly migrating LC. 
CD8 expression by the DC population was restricted to a minor group of 
cells in the DC fraction. AM were not found to express this marker. While DC 
have been shown to express CD8 in the thymus and spleen of mice, this has 
not been previously demonstrated in lymph. While it is possible this antigen is 
expressed on DC, it is more likely this result represents contaminating CD8 
positive lymphocytes attached to DC as they are examined. The lack of 
expression of the T19 marker of mature y6 T cells (Mackay etal., 1989) by both 
DC and AM was not surprising. The lack of expression by migrating DC 
supports the previous findings of Gorrell (1995) and Hein and Mackay, 1991), 
that it is unlikely that sheep possess the equivalent of the mouse DETC. 
This study showed that °Mt which was recently classified as equivalent 
to CD11c (Gupta etal., 1995), reacted with a majority of cells lying within the 
DC gate. The reactivity of 0M1 with afferent lymph DC was noted previously by 
Gupta et al., (1995). Gupta's study led to the characterisation of 0M1 as an 
antibody directed against ovine CD11c. Panfilis et al., (1989) found the 
expression of CD11c on resting human LC, which agrees with the findings from 
DC from other species (Steinman et al., 1991). The reason for the lack of 
expression of 0M1 on LC reported by Pepin et al., (1992) is unknown. It may 
be due to differences in the strain of sheep used or methods employed to 
detect CD11c expression. However, it confirms the results of both Pepin etal., 
(1992) and by Gupta etal., (1995) which show that, CD11c is expressed on the 
majority of alveolar macrophages. The percentage of DC expressing either 
CD1w1 or 0M1 suggests that some overlap in the expression of these 
molecules occurs. Future studies using two colour immunofluorescence may 
reveal co-expression of these molecules on migrating ovine DC. 
0M2 was shown to react with a smaller portion of the DC fraction whereas 
nearly all AM were found to be 0M2 positive. The reactivity with AM is in 
agreement with Pepin et al., (1992). However, 0M3 was not observed to stain 
either alveolar macrophages or DC. This contrasts with Pepin's study were 
0M3 was observed to react with "nearly all" ovine AM. This lack of expression 
by sheep AM in the current study may reflect differences in the age and sheep 
strain used, which in Pepin's study were 3 month old Prealpes du Sud lambs. 
One major aim of this part of the current study was to identify a marker 
which could be used to distinguish migrating macrophages from DC. This was 
108 
viewed as being of particular importance as after UV exposure macrophages 
are noted to enter the human epidermis (Cooper et al., 1985, Cooper et al., 
1992), and are increased in the lymph node of mice (Muller etal., 1994) after 
UV exposure. These cells are thought to play a down-regulatory role in the 
subsequent immune responses occurring in the skin (Baadsgaard et a/., 1988, 
Baadsgaard 1990, Kang et al., 1994). This migration of macrophages appears 
to also occur in the ovine system, as very few CD14 + cells were detected in 
ovine lymph under normal circumstances, but a dramatic increase in the 
percentage of CD14 +  large granular cells appeared after exposure of the skin 
to 20.1 kJ/m2 UVB. 
The migration of macrophages was observed to be maximal 24 hours after 
UVB exposure, with increased migration occurring for up to two weeks after 
irradiation. This early increase in the percentage of CD14 + macrophages 
migrating from UV exposed skin is in accordance with the findings of Richters 
et al., (1996), who observed macrophage migration from skin explants to be 
increased 24 and 48 hours after UV exposure. However, as the maximal 
migration of macrophages into the skin occurs 48-72 hours after exposure 
(Baadsgaard et al., 1987), the initial efflux of macrophages from the skin may 
represent the migration of dermal macrophages. The increased macrophage 
migration at later time points may be composed of macrophages migrating from 
the epidermis. Vink et al., (1995) demonstrated that cells with UV damage 
were found in the dermis, thus providing evidence that macrophages in the 
dermis might be directly affected by UV light exposure leading to their 
migration. However, the migrating macrophages appear to be only a minor 
population when compared with the proportion of LC in the pseudoafferent 
lymph. This agrees with evidence from the mouse model (Muller et al., 1994) 
and human skin explant studies (Richters et a/., 1995), where the number of 
cells expressing characteristic macrophage markers is increased but is still a 
relatively minor population in comparison those expressing DC markers such 
as CD1 or MHC II 
It might be argued that the expression of CD14 by alveolar cells may not 
necessarily be related to the expression of CD14 by macrophages in the lymph 
after UV exposure. However, UV induced epidermal macrophages have been 
proposed to originate from the spleen (Jun et al., 1989) and the dermis 
(Meiuner et al., 1995), while normally characterised by their expression of 
CD11b (Cooper et al., 1993), they have been shown to co-express CD14 in 
both spleen (Buckley etal., 1991) and skin (Cooper etal., 1986, Sonthiemer et 
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a/., 1989), whereas LC do not express CD14 (Davis etal., 1988). This strongly 
suggests that the CD14+ cells detected in the ovine lymph were the same UV 
induced macrophages proposed by Cooper et al., (1993), and were migrating 
from skin to the draining lymph node via the afferent lymphatics. This agrees 
with current theory that inflammatory macrophages migrate from inflammatory 
sites to the draining lymph node in vivo (Belligan etal., 1996). 
The phenotypic characteristics of the infiltrating macrophages also include 
the expression of CD11 b (Cooper etal., 1993), which has also been shown to 
be expressed by some LC in human skin (Panfilis et al., 1989). However, 
Duraiswamy etal., (1994) by combining the expression of MHC II, CD11 b and 
Ly6c (monocyte/endothelial antigen) have been able to distinguish between 
macrophages and LC. While macrophages were found to express MHC II, 
CD11 b and are Ly6c+ LC were found to be weakly CD11b + and Ly6c". The dual 
expression of CD11 b and CD14 by migrating ovine macrophages after UV light 
would perhaps be a more definitive study, than looking at the expression of a 
single marker. However, it was not possible during the duration of this 
investigation to obtain access to a mAb specific to CD11 b, albeit a number of 
these are available (Naessens et al., 1997). The expression of non-specific 
esterase is also used to characterise macrophages. But this is expressed by 
freshly isolated ovine LC (M Sandeman, personal communication) and so ruled 
out its use as a histochemical marker of macrophages to compliment the flow 
cytometric studies. 
While previous studies have shown that the migration of cells with 
macrophage characteristics occurs after UV exposure of the skin (Cooper et al., 
1993, Muller etal., 1994, Richters etal., 1995), due to the limitations of these 
models, a time course over an extended period has not been able to be 
performed. The study presented in this chapter extends the previous studies in 
other species and shows that that the migration of macrophages occurs for an 
extended time following UV exposure of the skin. This event perhaps 
contributes to the alteration of the cutaneous immune response for extended 
periods, due to the infiltrating macrophages ability to both induce tolerance in 
vivo (Hammerberg et al., 1994) and produce the cytokine IL-10 (Karig et al., 
1994). However, it should be noted that while the percentage of CD14 + DC 
increased, LC (CD1w1 + DC) were still the major migrating dendritic cell 
population. 
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4.4.2 	Expression of CTLA-4 Ligands by Migrating LC after 
UV exposure of the Skin 
The study presented in this section utilised the multi-parameter 
capabilities of the FACSCAN flow cytometer (Becton-Dickenson) to examine 
the expression of CTLA-4 ligands on migrating LC (CD1w1 + DC). The CTLA-4 
ligands include all members of the B7 family of co-stimulatory molecules. The 
B7 family of co-stimulators includes two molecules expressed on mature LC, 
B7-1 and B7-2 (Symington et al., 1993), which are crucial for T cell stimulation 
(reviewed by Lenschow et al., 1996). In this study exposure to 2.7 kJ/m 2 and 
8.1 kJ/m2 did not cause sustained decreases in B7 expression. Although, the 
occasional transient decrease was observed in some subjects such changes 
were not observed in repeat experiments. Similarly, some sustained increases 
were observed after exposure to 2.7 kJ/m 2 but not in other experiments. While 
three sheep clearly showed increases in B7 expression after exposure of the 
skin to 20.1 kJ/m2, a clear decrease in B7 expression by migrating LC was 
observed in one sheep. While care was taken to ensure that cytometer 
settings and staining conditions were kept constant, these apparent 
inconsistencies may have been due to the outbred nature of the model. 
Nonetheless these studies suggest B7 expression appears not to be down-
regulated for either the 2.7 kJ/m2 or 8.1 kJ/m2 doses and was up-regulated for 
the majority of sheep exposed to the 20.1 kJ/m2 dose. 
The maturation stage of DC influences the expression of B7 on DC, such 
that, in human skin CTLA-4 ligands are expressed only weakly or not at all by 
LC freshly isolated from the skin (Symington etal., 1993, Weiss etal., 1995). 
After fresh LC are cultured for 48 hours the expression of B7-1 and B7-2 is 
dramatically up-regulated (Weiss et al., 1995). Culturing is proposed to 
represent the maturation of LC, to lymph node DC (Romani et al., 1989, 
Teunissen et al., 1990) and the increased expression of B7-1 and B7-2 
parallels this theory. The current study examined LC freshly isolated from 
afferent lymph which appear to express an intermediate level of B7 molecule in 
comparison with cultured human LC (Weiss et al., 1995). This intermediate 
expression may reflect an intermediate stage of maturation associated with 
ovine LC migrating from the skin or may reflect a species difference. Weiss et 
al., (1995) also found that the up-regulation of B7-1 and B7-2 was inhibited 
when LC were irradiated in vitro, prior to culture. This lead Weiss etal., (1995) 
to propose that the loss of expression of B7 molecules on UV irradiated LC may 
be responsible for the lack of stimulation and induction of anergy in Th1 cells. 
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A more recent study by Laihia and Jansen, (1997) has shown that in vivo 
exposure of human skin to erythemal levels of UV light resulted in increased 
levels of B7-1 and B7-2 expression on LC within the skin, which was maximum 
between 12-24 hours after exposure. The levels of expression returned to 
normal at 48 hours before being elevated again at 72 hours. This in agreement 
with the present study, which also showed some up-regulation especially after 
exposure to the 20.1 kJ/m2 dose, although generally this occurred after the time 
points observed by Laihia and Jansen, (1997). The delay in the increased 
levels of B7 expression may represent the time taken for LC to migrate from the 
epidermis to the dermis via the draining lymphatics. 
The expression of B7 molecules is up-regulated by cytokines such as 
IFNy, IL-4 and the CD40/CD4OL pathway (reviewed by Lenschow et a/., 1996). 
However, no evidence for the up-regulation of either cytokine has been 
observed within the skin after UV irradiation (Takashima and Bergstresser, 
1996). The involvement of CD40 or its ligand in the cutaneous UV immune 
response at this time is unknown. Conversely IL-10 has been shown to 
specifically down-regulate the expression of B7-2 on the surface of peripheral 
blood DC, resulting in the inhibition of allogeneic T cell proliferation (Buelens et 
a/., 1995). However as the CTLA-4 immunoglobulin fusion protein detects both 
B7-1 and B7-2 specific changes in either co-stimulatory molecules cannot be 
detected in the current study. In contrast to the changes reported by Buelens 
et al., (1995), IL-10 has also been shown to inhibit both B7-1 and B7-2 up-
regulation on peritoneal macrophages (Willems et a/., 1994). The effects of IL-
10 on migrating LC have not yet been studied, so whether this effect is 
restricted to B7-2 on this cell type is unknown. Sustained down-regulation was 
apparent in only one of the experimental subjects used in the present study. 
However, if the migrating LC had been cultured for extended periods, a lack of 
up-regulation may have been observed, which in turn may result in the 
reduction of T cell proliferation in response to antigens presented by LC. 
While the expression or lack of expression of 67-1 or B7-2 on migrating 
LC may be important to the resulting immune response, equally important is the 
expression of the counter receptors CD28 or CTLA-4 on T cells. The 
interaction of B7 molecules with CD28 appears to costimulate T cells and 
prevent the induction of anergy and apoptosis. Conversely the interaction with 
CTLA-4 appears to cause down-regulation of the immune response either by 
competing with CD28 for its ligands or by the induction of apoptosis (reviewed 
by Lenschow et al., 1996). While it was observed in a previous chapter that T 
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cell migration from UV exposed skin was altered, the lack of reagents specific 
for the CD28 or CTLA-4 receptors in the ovine system means that any 
alterations in the expression of these molecules on migrating T cells is 
unknown. 
4.5 	Summary 
This chapter describes a series of experiments designed to investigate 
the expression of a variety of surface molecules on migrating ovine 
psuedoafferent lymph DC after UV exposure of the skin. The study included an 
investigation of the expression of the B7 family of co-stimulators on migrating 
LC and the identification of migrating macrophages from UV exposed skin. The 
expression of CD14 by 'alveolar macrophages and not DC, was used to 
distinguish macrophages migrating in pseudoafferent lymph. A sub-population 
of large granular cells that were CD14+ showed substantially increased 
migration after UV exposure of the skin. While the migration was maximal at 24 
hours it was sustained for extended periods after exposure, thereby possibly 
identifying, migrating macrophages which have been shown to infiltrate the 
epidermis after UV exposure in other species. The expression of B7 molecules 
on LC migrating from the skin was found to generally remain within or above 
,normal levels after exposure to 2.7, 8.1 and 20.1 kJ/m2 UVB. The timing and 
extent of these changes varied between experimental subjects and in one case 
a substantial sustained decrease in the expression of 67 was observed. These 
findings agree with and extend recent findings that B7 expression appears to 
increased on human LC residing in the skin after cutaneous UV exposure. 
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CHAPTER 5: EFFECTS OF UVB ON THE FUNCTION 
OF MIGRATING ANTIGEN PRESENTING 
CELLS 
5.1 INTRODUCTION 
LC initially function as a sentinel in the epidermis; when stimulated to 
migrate, they carry antigen to the draining lymph node (DLN). In the DLN, LC 
function changes from antigen uptake to one of antigen presentation. They 
present antigen to T cells, thereby initiating an immune response (as reviewed 
by Ibrahim et al., 1995). During this maturation into interdigitating cells, LC 
undergo dramatic phenotypic changes including up-regulation of MHC I, MHC II 
and adhesion molecules (Romani et al., 1989, Teunissen et a/., 1990), as well 
as the appearance of the important co-stimulatory molecules B7-1 and B7-2 
(Yokozeki et al., 1996). LC become functionally unable to phagocytose 
(Sousa et a/., 1993) or process soluble antigens (Steinman et al., 1991). These 
changes reflect the maturation of LC from a sentinel, to antigen presenting cell 
(Ibrahim et a/., 1995). It is this transformation which enables LCs to become 
"the most potent stimulators Of naive T cells that have been identified" (Udey, 
1997). LCs are critical for the initiation of anti-tumour responses in the 
cutaneous environment (Muller and Halliday, 1991). Furthermore, LCs have 
been shown to present tumour associated antigens in both the initiation and 
elicitation phases of the anti-tumour response (Grabbe et al., 1991, Grabbe et 
al., 1992). 
Following UV exposure of the skin, the role of LC in tumour responses 
becomes crucial. Mutations which occur in the DNA of exposed cells, together 
with the altered microenvironment of the skin and the suppression of the 
immune system have been well documented. These factors undoubtedly 
contribute to the generation of tumours within the skin. Evidence presented in 
Chapter 3 demonstrated that following UV exposure, the number of LC 
(CD1w1 +  DC) migrating from exposed skin increased. This poses the question, 
whether these cells migrating from the skin function normally. That is, are the 
LC able to process and present tumour associated antigens that may arise at 
this time. This chapter describes experiments, which assessed the functional 
capacity of DC post UVB exposure, exploiting the unique properties of the 
sheep pseudoafferent lymphatic model. 
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5.2 MATERIALS AND METHODS 
5.2.1 	Experimental Plan 
5.2.1.1 	Assessment of Antigen Presenting Cell Function 
Sheep were immunised twice over a 48 hour period with a 2 mg/m1 
suspension of alum precipitated ovalbumin (OVA) (see section 2.7.1). This 
immunisation protocol was repeated 4 weeks later and serum antibody levels 
were assessed by haemagglutination two weeks after this (see section 2.6). If 
it was found that titres were low sheep were re-immunised and titres re-
assessed. Bilateral pre-femoral lymphatic cannulation was carried out on 
lymphadenectomised immune sheep (section 2.2). A post-operative recovery 
period of 5-7 days was allowed for stabilisation of lymphatic output. Sterile 
collections of pseudoafferent lymph then commenced (see section 2.3.2) as did 
collection of blood for use in a proliferation assay. This assay assessed the 
ability of DC to process and present OVA to responding cells contained in the 
PBMC fraction. Briefly, DC were enriched using discontinuous metrizamide 
gradient (14.5% + 15% FCS) centrifugation. Similarly, PBMC were enriched by. 
centrifugation over a discontinuous histopaque gradient (density 1.077). The 
DC were pulsed with OVA then treated with mitomycin C, which inhibited DNA 
synthesis and thus cell division. The DC were then co-cultured with autologous 
PBMC for 5 days and pulsed with [3 F1] thymidine over the last 16 hours, as a 
measure of proliferation. Control wells were used to assess the proliferation of 
DC alone and PBMC alone. This procedure was adapted from the method of 
Bujdoso et al., (1989) by Ragg et al., (1995) and is presented in greater detail 
in Section 2.7 
Once a sufficient number of background points had been used to 
establish the normal range of stimulation indices, the sheep were treated with 
8.1 kJ/m2 UVB. The dose (8.1 kJ/m 2 UVB) was used on the basis of the 
previous finding that exposure of ovine skin to this dose caused consistent 
increases in LC migration with minimal increases in other cell populations and 
minimal erythemal changes. This minimised the overwhelming inflammatory 
effects that would be evident with higher doses. These experiments were 
repeated three times to ascertain if the observed trends were consistent. 
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5.2.1.2 	Assessment of PBMC function 
Full body UVB exposure has also been shown to result in suppression of 
lymphocyte function (Morison et a/., 1979). Where possible, contralateral 
sheep flanks were used as controls in order to distinguish any systemic effects 
of UVB. However, due to shortage of successful bilateral cannulations, it was 
decided also to test lymphocyte function with mitogen stimulation, using 
phytohaemagglutin (PHA). PBMC remaining from the antigen presentation 
assays were cultured in triplicate for three days in dilutions of PHA. The cells 
were pulsed with [ 3H] thymidine during the last 16 hours of culture and uptake 
of the radioactive label was used as a measure of proliferation. 
5.2.2 	Presentation of data 
5.2.2.1 	Antigen Presenting Assay 
The ability of DC to present antigen to PBMC is presented as a 
stimulation index (SI), calculated at a ratio of 1 DC :16 PBMC. The method for 
calculation of the SI is detailed below. 
SI = Mean CPM OVA pulsed DC: PBMC co-cultures 
Mean CPM CONTROL DC: PBMC co-cultures 
The mean of at least four pre-treatment points +/- two standard deviations 
from this mean were used as the normal range ( >90% confidence limits Zar, 
1984) SI. The limits of this normal range were shown as dotted lines (see Fig. 
5.2). SI outside these lines are considered to be significantly different. The 
post treatment samples, are shown as the mean SI +/- the error accumulated 
by the division of CPM of quadruplicate samples of PBMC cultured with antigen 
pulsed DC by mean CPM values of quadruplicate samples of PBMC cultured 
with unpulsed DC. The data presented is from a representative experiment, 
illustrating the trends observed. SI generally represented a 5-8 fold greater 
stimulation of T cells by the OVA pulsed DC than that of control DC. 
5.2.2.2 	PHA cultures 
Data obtained from triplicate cultures as CPM were averaged for each 
concentration of PHA. The above statistical method was used to calculate the 
normal range of CPM expected for a given PHA concentration prior to 
treatment with UVB. Similarly, the data is from another single representative 
experiment, illustrating the trends observed. 
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5.3 RESULTS 
5.3.1 	Effects of UVB Exposure of Flank Skin on DC 
Function 
The exposure of ovine flank skin to UVB was observed to result in the 
changes previously outlined in Chapter 3. These include transient but 
substantial increases in lymph flow during the first 24-48 hours post exposure, 
increases in the number of migrating DC and the presence of hard white clots 
within the cannula. A reduced number of DC were also found to survive the 
mitomycin C step in the antigen presentation assay after UVB irradiation. 
Therefore, occasionally insufficient DC were obtained to allow the assay to 
performed for each lymph collection. 
5.3.2 	Exposure of flank skin to 8.1 kJ/m 2 
5.3.2.1 	Assessment of DC Function 
The exposure of the flank skin to a dose of 8.1 kJ/m 2 UVB has previously 
been shown to result in the increased numbers of DC migrating from the skin. 
These experiments assess the functional ability of UVB induced migrating DC 
to process and present OVA to T cells within the PBMC fraction. From Fig. 5.1 
the optimal ratio of DC to responder cells was 1:16. 
Monitoring the ability of DC to induce responder cell proliferation at this 
ratio revealed that the functional capacity of DC was reduced (Fig. 5.2). As 
detailed in this representative experiment, DC function was impaired within 48 
hours of UVB irradiation. While the mean pre-UV exposure SI was 4.98, the 
loss of antigen presenting cell activity between 60-168 hours after exposure led 
to a substantially decreased SI (range 1.65 - 0.98). Following this period of 
time, the SI returned to a level within the normal range. It remained within the 
normal range until the final two collection points at 336 and 480 hours, which 
were significantly below normal. 
5.3.2.3 	Assessment of Responder Cell Function 
The optimal concentration of PHA required to stimulate proliferation was 
found to be 12.5 pg/m1 (Fig. 5.3) This concentration was therefore used to 
asses the ability of PBMC to proliferate after the flank skin was exposed to 8.1 
kJ/m2 UVB. The proliferation of the responder cells was decreased between 24 
and 72 hours after UVB exposure of the flank skin (Fig. 5.4). The reduction in 
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Figure 5.1 Functional Ability of Antigen Pulsed DC 
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Figure shows the stimulation indicies after culturing105 PBMC with 
doubling dilutions of DC for 5 days. Stimulation indicies are calculated 
by dividing PBMC proliferation incubated with OVA pulsed DC by PBMC 
proliferation after incubation with non-pulsed DC. Proliferation was 










Figure 5.2 Functional Ability of Migrating Antigen Pulsed 
DC to Stimulate the Proliferation of PBMC 
after Exposure of Flank Skin to 8.1 kJ/m 2 UVB 
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Stimulation index (Y axis) represents the ability of pulsed DC divided 
non-pulsed DC to stimulate PBMC proliferation. Norm represents the 
the mean stimulation index (+/- 2 standard deviations) of four pre-
treatment points, the normal range of which is indicated by dotted lines 
Error bars for other time points represent the cumulative error accrued 
from the division of quadruplicate samples of pulsed/unplused DC. 
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Proliferation of 10 5 PBMC after 3 days culture in 
various concentrations of phytohaemagglutin (PHA). 
Proliferation was measured by thymidine uptake over 
the last 16 hours of culture 
Figure 5.4 PHA Induced Proliferation of PBMC 
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Time after UVB treatment (hours) 
PBMC proliferation induced by 72 hours culture in 12.54/m1 PHA. 
Normal sample (Norm )represents the mean CPM +1- 2 standard deviations 
of at least four pre-treatment points used to set the normal range (dotted 
lines). Error bars for other time points represent the calculated 
standard deviation. Maximal Control CPM was 2132 for this experiment. 
proliferation was maximal at 72 hours and represented a 63% reduction in CPM 
in comparison to mean pre-treatment levels. Two repeat experiments were 
performed and showed a similar loss of mitogen induced proliferation between 
24 and 72 hours post irradiation. One experimental subject was sham UV 
irradiated (Fig. 5.5) in parallel to the experiment shown in Fig 5.4 and no loss of 
PHA induced responder cell proliferation was observed in this control 
experiment. 
5.3.2.2 General 
Two repeat experiments were performed examining the APC function of 
migrating DC after exposure of ovine flank skin to 8.1 kJ/m 2. These 
subsequent experiments showed a similar loss of functional ability to that 
shown in Fig 5.2. However the timing of these effects varied between 
individual experimental subjects. The two repeat experiments showed the 
initial loss of function occurred at 24 hours after UV exposure and the return to 
normal function also varied and occurred at 144 and 192 hours, respectively 
after UV exposure. The shorter duration of the two repeat experiments did not 
allow the assessment of the later loss of function observed in Fig 5.2. A 
systemic loss of DC function was observed between 24-72 hours after UV 
exposure, for one experiment using a bilaterally cannulated sheep. However 
this sheep was exposed to a slightly lower dose due to the failure of 2 UV 
lamps. Further bilateral cannulations of sheep which lasted the duration of the 
experiment were unsuccessful. 
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Figure 5.5 PHA Induced Proliferation of PBMC 
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5.4 DISCUSSION 
The ovine model allows direct investigation of the functional ability of DC 
that under normal circumstances, would reach the DLN after UV exposure. It 
has been demonstrated that the ability of antigen pulsed DC to stimulate the 
proliferation of PBMC responder cells was seriously inhibited after exposure of 
skin to 8.1 kJ/m2. Previous investigations were limited to the study of cells from 
within UV exposed skin or alternatively the cells found in the DLN in response 
to UV exposure and a fluorescent contact sensitiser, FITC. The former 
involves traumatic removal of tissue from the animal and includes cells which 
may be incapable of reaching the lymph node to present antigen, while the 
latter has large numbers of contaminating DC, not fluoresceinated and 
therefore potentially not exposed to UV light. The ovine model allows the 
investigation of the function of ex vivo migrating DC after UV exposure of intact 
skin. It does not require the application of an external agent (which may add 
confounding factors to the experiment). These migrating cells are likely to 
stimulate an immunologic or tolerogenic response to antigens arising in the 
skin after UVB exposure. 
The experiments described in this chapter have examined the ability of 
DC to cause proliferation of PBMC responder cells in an in vitro assay system. 
A similar assay system was used by Stingl et al., (1980) using in vitro irradiation 
of murine epidermal cells (EC). These cells were pulsed with antigen and then 
washed. Their ability to stimulate purified T cells was shown to weaken in 
response to UVB in a dose dependant manner. Similarly the ovine system has 
shown that the DC migrating from UV exposed skin have a reduced ability to 
stimulate T Cells. Further, the return of normal function was not observed until 
144-192 hours post exposure. Accordingly, the capacity of the skin immune 
system to deal with infection or tumour cells arising in the skin during this 
period would be seriously compromised. While this series of experiments 
concentrated on the function of antigen presenting cells migrating from the 
skin, previous investigations have concentrated on the function of LC within the 
skin. For example, it has been shown that LC from normal murine skin were 
able to stimulate T cells (Green et a/., 1980), while Toews et al., (1980) 
observed that mice exposed to low doses of UV light failed to induce CHS, 
which was associated with a loss of LC and the generation of suppressor cells. 
Later experiments have also demonstrated that epidermal cells isolated from 
UV exposed skin had a reduced capacity to stimulate both allogeneic or 
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antigen specific T cells in vitro (Lynch et al., 1983, Cooper et al., 1985 and El-
Ghorr etal., 1994) and this was at least partially due to alteration in the antigen 
presenting activity of LC. Cruz et al., (1990) found that purified MHC II + cells 
which were irradiated and conjugated to hapten in vitro, then subsequently 
injected into mice resulted in the failure of the mice to develop CHS to the 
specific hapten. This was due to induced tolerance, as a subsequent 
application of the same hapten failed to induce CHS. 
LC purified from the skin and then UV irradiated in vitro retain their ability 
to stimulate Th2 cells but are unable to stimulate Th1 clones (Simon et al., 
1990). Due to UV irradiated LC inducing anergy in the Th1 clones (Simon et 
al., 1991). The failure of migrating ovine DC in this study to cause proliferation 
of PBMC after UV exposure of the skin may reflect the failure of the OVA 
specific Th1 cells to respond to UV altered DC. It should be noted that this 
antigen has been shown to preferentially induce Th1 responses at high and 
intermediate doses (reviewed by Constant and Bottomly, 1997). Saijo et al., 
(1997) found that that lymph node DC from UV irradiated mice induced less T 
cell proliferation than non-irradiated controls, a result supported by the current 
study. Further, the cytokine profile of the cells in Sajio's experiments suggest 
that this was not limited specifically to Th1 cells, but also included Th2 cells. 
Sajio's etal., (1997) study also illustrates the differences that may be observed 
between in vivo and in vitro experiments. Thus the experiments using Th 
clones such as those performed by Simon et al., (1990) may be an 
oversimplification of what occurs in vivo. While the antigen presentation assay 
used in this chapter took place under in vitro culture conditions, the dendritic 
cells were irradiated in vivo and the responder cells did not solely comprise 
specific clones, thus being more representative of the heterogenous population 
of T cells in vivo. 
Failure to take up antigen due to physical alteration of the LC is another 
possible reason for this loss of function, as UV light has been previously shown 
to physically alter LC. DC migrating after UV exposure used in the functional 
assay, appeared to have normal morphological characteristics under the light 
microscope. Alterations in LC morphology in the skin have been observed in 
previous studies (Aberer et al., 1981, Obata and Tagami, 1985), and there is 
evidence of LC death (Mommas et al., 1993). In addition, modification of the 
LC cytoskeleton by vinblastine, which alters microtubules, causes similar 
morphological changes to those induced by UVB exposure and also reduces 
CHS (Bacci etal., 1996). This suggests that physical damage of LC may play a 
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role in this loss of function (Bacci etal., 1996), as the characteristic ruffles and 
projections on the LC membrane are crucial for antigen uptake (Steinman and 
Swanson, 1995). As the DC used in the assay system are capable of migration 
from the skin, they would appear to be relatively intact as the integrity of the 
cytoskeleton is crucial for cell shape, motility and migration (Ingber et al., 
1994). Physical damage of the LC may contribute to the apparent loss of 
function of DC migrating from skin by causing the premature death of these 
cells during 5 days culture. While DC were initially viable, it has been 
previously reported by Pretell et a/., (1984) that the reduced viability of in vitro 
UV exposed adherent cells, is not apparent until 48 hours after culture. The 
impairment of APC function may be mediated in part by DNA damage (Vink et 
al., 1996) and UVB exposure is known to lead to the induction of delayed 
apoptosis (Godar et a/., 1995). This is unlikely to account for the long term 
alterations in migrating DC function (6-8 days), as this effect on DC viability 
would appear to be limited to within the first two days after UVB exposure 
(Godar et al., 1996) 
One unexpected result found in the current study was the reduction of 
mitogen induced proliferation of PBMC for 72 hours after UV exposure of the 
flank skin. This systemic loss of proliferation was confirmed in one experiment 
which found reduced stimulation of PBMC in response to antigen pulsed DC 
migrating from the flank contra-lateral to the exposed flank. Likewise, a 
reduction in mitogen induced proliferation of PBMC has been observed in 
humans after whole body irradiation (Morison etal., 1979). The current study 
indicates that irradiation of a small area of the body (200 cm 2) is sufficient to 
alter the function of circulating cells. This suggests the responder cell 
population in the antigen presentation assay may have been directly affected 
by UV irradiation. The ability of APC to stimulate T cell proliferation was 
reduced for up to 192 hour post treatment, while the reduction in the ability of 
PBMC to proliferate in response to mitogen lasted only 72 hours post exposure. 
Thus it appears these are two separate affects of UV exposure. Systemic 
effects were noted in one experiment on the contra-lateral side which confirmed 
the systemic effects of UV exposure using the mitogen and supported the 
finding that the systemic loss of function lasted for between 24-72 hours being 
identical to that observed in the assay utilising mitogen induced proliferation. 
This similarity in the observed time courses supports the systemic loss of 
function being due to the loss of responder cells ability to proliferate. However, 
a systemic loss of APC activity has been reported after UV irradiation possibly 
mediated by cis-UCA (Noonan et al., 1988) or IL-10 (Ullrich et al., 1994) and it 
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cannot be ruled out that this also occurred. Another effect of UVB exposure 
that may have a bearing on the experiments conducted is the phenotype of T 
cells in the blood, with a reduction in the numbers of CD4 + circulating T cells 
the most commonly observed effect (reviewed Hersey et a/., 1995) although 
this occurred after whole body exposure to sunlight. It is possible that the loss 
of CD4 cells from the responder cell population would account for a portion of 
the loss of function observed. One way to manage this effect in the future, 
would be to isolate and store responder cells prior to commencement of the 
experiment, which could then be used after irradiation. This would eliminate 
any effects that UV exposure has on the responder cell population. There are 
two distinct possibilities for the systemic loss of function of mononuclear cells, 
either the direct irradiation of cells passing through the circulatory system in 
skin is occurring at the time of irradiation or alternatively a cytokine or soluble 
factor may being produced which systemically alters PBMC function. The latter 
hypothesis is examined in chapter 6. The failure to detect thymine dimers in 
PBMC from mice which had their dorsal surface UVB irradiated would seem to 
reduce the possibility of the former occurring (Sontag et a/., 1995). 
5.5 SUMMARY 
The ability of DC induced to migrate from UV exposed ovine skin to take 
up and present antigen to autologous T cells in culture was examined. After 
exposure of the skin to 8.1 kJ/m 2 (approximately 1 MED UVB) the ability of 
antigen pulsed DC to stimulate immune responder cells was reduced. This 
effect was found to last as long as 192 hours post irradiation. While this may 
have been initially due to the reduced ability of PBMC to proliferate, it is 
apparent that LC migrating from UV exposed skin are unable to fulfil their role 
as sentinels of the skin and their ability to induce an effective immune response 
is seriously impaired. The lowering of immunosurveillance in UV exposed skin 
and the systemic nature of the observed UV effects may thus facilitate the 
escape of neoplastic cells that otherwise would be eliminated. 
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CHAPTER 6: ALTERATION OF CYTOKINES AND 
SOLUBLE FACTORS AFTER UV 
EXPOSURE OF OVINE SKIN 
6.1 INTRODUCTION 
Cells of the skin immune system produce many soluble factors that are 
required for the growth, activation and differentiation of immunocompetent 
cells. Keratinocytes are the major producers of many cytokines in the 
cutaneous micro-environment (Matsue et a/., 1992). LC are also a source of 
cytokine secretion and are the major, if not only source, of the T cell stimulating 
cytokines IL-113 (Matsue et al., 1992, Enk et al., 1993a) and IL-12 (Kong et at, 
1996) in normal epidermis. However, levels of cytokines in normal skin are 
generally below detectable levels and it requires an exogenous stimulus, such 
as that provided by UV exposure, to significantly induce the secretion of a vast 
array of cytokines (Reviewed by Luger et al., 1997). Such changes in the 
skin's microenvironment undoubtedly affect the LC resident in the skin and may 
in turn, alter those which subsequently migrate to the DLN. This, in turn would, 
alter the interaction between migrating LC and T cells, perhaps changing the 
range of cytokines produced by the T cells. Accordingly, it was an important 
part of this study to examine alterations in cytokine and soluble factor 
production in both lymph draining the skin and in DC:PBMC co-cultures, to 
determine if there were any changes which might result in altered immunity 
after UV exposure. 
The aberrant antigen presenting function of DC migrating from UV 
exposed skin discussed in chapter 5 may be due to the lack of a co-stimulatory 
cytokine such as IL-10. This cytokine is regarded as the typical T cell 
stimulatory cytokine and has been shown to be essential for the growth of some 
T cell clones (Weaver and Unanue, 1990). Experiments have since 
determined that LC are a source of IL-113 in the epidermis (Matsue et al., 1992, 
Enk and Katz, 1992). Further, LC express the IL-1 converting enzyme (ICE), 
which is essential for IL-113 secretion (Ariizumi, et al., 1995).. The secretion of 
IL-10 by LC has been demonstrated to be essential for the initiation of primary 
immune responses occurring in the skin (Enk et al., 1993a). Any reduction in 
secretion of IL-113 by DC migrating from UV exposed skin may reduce antigen 
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specific T cell proliferation. Thus an investigation of the quantities of IL-1f3 in 
DC:PBMC co-cultures as part of these studies was deemed to be essential. 
The loss of antigen presenting function by LC may also be due to 
presence of inhibitory soluble factors, such as the cytokine IL-10 or the 
secretion of prostaglandins by cells affected by UV exposure. IL-10 has been 
shown to be a cytokine crucial to both UV induced immunosuppression 
(Ferguson et al., 1994, Navarro et al., 1994, Rivas and Ullrich, 1994) and 
apparent reduction in LC function (Enk et al., 1993b, Peguet-Navarro et al., 
1994). As this cytokine is produced both by cells in the skin and systemically 
after UV irradiation (Rivas and Ullrich, 1992), IL-10 was assayed in DC:PBMC 
cell co-cultures and lymph draining UV irradiated skin. Prostaglandins such as 
PGE2 are up-regulated in the skin after UV light exposure (Imokawa and 
Tejima, 1989) and appear able to inhibit cutaneous immune responses (Chung 
et a/., 1986, Jun et al., 1988). As LC are one source of PGE2 synthesis 
(Teunissen etal., 1991, Rosenbach etal., 1990), so the amount of PGE 2 was 
assayed in DC:PBMC co-culture supernatants after UV exposure to determine 
if the level of production was altered. 
Another cytokine known to influence LC function is GM-CSF, which is 
secreted by resting keratinocytes in the skin (Kupper et al., 1986) and most T 
cell subtypes (reviewed by Mosmann and Sad, 1996). It is an important 
regulatory factor required for differentiation of LC into potent immunoregulatory 
cells (Heufler et al., 1988). GM-CSF has also been shown to stimulate LC 
migration in vitro (Rupec et al., 1996). Further, increased GM-CSF production 
has been noted in the skin after UV irradiation (Schwarz and Luger, 1989). 
The investigation of the presence of this cytokine in both lymph and DC:PBMC 
culture supernatants was therefore undertaken as part of this study. 
The interaction between a DC and a T cell may induce apoptosis, anergy 
or activation of T cells capable of responding to that antigen. Further, the 
activation of T cells may cause cells to become further differentiated into the 
Th1 or Th2 subtypes. These subtypes lead to the production of different 
cytokine profiles, which in the case of Th1 cells are IFNy, TNFI3 and IL-2 , while 
Th2 cells secrete IL-4, IL-5 and 1L-10 (reviewed by Mosmann and Sad, 1996). 
Evidence suggests that the ability of UV exposed LC to induce a Th1 response 
is reduced (Simon et al., 1990) and may preferentially induce anergy in these 
cells (Simon etal., 1991). Conversely the ability to stimulate a Th2 response 
appears unaltered (Simon etal., 1990). These changes may lead to alterations 
in the balance of Th1 and Th2 cytokines in DC:PBMC co-cultures. This study 
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therefore investigated the levels of IFNy and IL-5, cytokines which are 
produced by Th1 and Th2 cells, respectively. 
6.2 METHODS AND MATERIALS 
	
6.2.1 	Experimental Plan 
Sterile lymph collections were made as described previously (Section 
2.3.2) and following centrifugation to collect the migrating cells, 10 ml of lymph 
supernatant was collected and stored at -80°C until required. The DC:PBMC 
co-cultures were set up in parallel to the functional assays discussed in chapter 
5. Briefly, afferent lymph DC migrating from normal and UV exposed skin were 
collected and enriched by centrifugation over metrizamide. The DC were 
pulsed with antigen (OVA) and treated with mitomycin C to inhibit proliferation. 
Autologous PBMC was collected by venipuncture and enriched by 
centrifugation over Ficoll. After this 10 5 DC were co-cultured with 105 PBMC for 
72 hours at 37°C/5% CO2 (See Section 2.7). Following this, culture medium 
was collected from the cultures, placed in 1.5 ml tubes (Eppendorf) and 
microfuged at 12,000 rpm in to remove cells and debris, after which the 
supernatant was removed and placed in a second tube and stored at -80°C 
until analysed. All procedures for the isolation of lymph and cell culture 
supernatant were performed aseptic techniques. 
6.2.2 	Cytokine Assays 
The assays and procedures for the detection and quantification of the 
cytokines GM-CSF, IL-10, IL-5, IL-10, IFNy and the soluble factor PGE 2 are 
presented in detail in Chapter 2, sections 2.9 -2.11. It should be noted that the 
three experiments which are presented examining cytokine levels in DC: PBMC 
co-culture supernatants, all used the same three experimental subjects. The 
normal range of cytokine secretion was calculated using the previously 
described method (Section 2.8). 
6.3 RESULTS 
6.3.1 	GM-CSF in lymph and Culture Supernatants 
The levels of GM-CSF in both lymph and cultures of afferent lymph DC 
were assayed by ELISA and quantified against the GM-CSF standard provided 
(Fig. 6.1). The assay proved not to be as sensitive as previously reported 
(Entrician et al., 1996) and was only able to detect 1900 pg/ml of the 
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Figure 6.1 GM-CSF Standard Curve 
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recombinant GM-CSF standard (Fig. 6.1). The ELISA was repeated and, 
despite increasing incubation times and the addition of further wash steps, no 
improvement in sensitivity was observed. No detectable levels of GM-CSF 
were found in any samples of either lymph or culture supernatants examined. 
6.3.2 	IL-1fl Detection 
The levels of IL-1(3 in DC:PBMC co-cultures and supernatants from the 
macrophage inhibition assays were detected using a sandwich ELISA and 
compared to IL-10 standards (Fig. 6.2). The lower limit of IL-113 detection was 
0.156 ng/ml (Fig. 6.2). 
6.3.2.1 	IL-113 Detection in Lymph and DC-PBMC Co-Cultures 
IL-1r3 was detected in all supernatants from afferent lymph DC and PBMC 
(Table 6.1). The results presented are the mean (and standard deviations) 
from three separate experiments. IL-1 13  concentrations for pre-treatment 
samples ranged between 0.3 ng/ml and 0.81 ng/ml, while the range of all post 
treatment samples was between 0.24 ng/ml and 0.99 ng/ml. There appeared to 
be little difference in the quantity of IL-113 present in all of the samples taken 
before and after exposure of ovine flank skin to 8.1 kJ/m 2 UVB (Table 6.1). 
6.3.3 	IL-10-like activity in Lymph after 2.7 10/m 2 UVB 
Lymph samples from two experimental subjects were assayed for IL-10- 
like activity before and after exposure of the flank skin to 2.7 kJ/m 2 UVB. Fig. 
6.3 shows some variations in pre-treatment lymph levels of IL-10-like activity in 
samples from the two different experiments. 24 hours after UV exposure lymph 
sample from one sheep had decreased IL-10-like activity in comparison to pre-
treatment levels (Fig. 6.3a). This experiment also showed sustained IL-10-like 
activity between 60 and 216 hours, peaking at 108 hours post-UV exposure, 
broken only by a transient return to pre-treatment levels at 132 hours. In the 
other experiment transient increases in IL-10-like activity were observed at 12, 
48 and 192 hours post-UV exposure. Increased IL-10 like activity was 
observed at 48 hours and a further sustained increase between 120-144 hours 
post UV exposure (Fig. 6.3b). In both experiments IL-10-like activity was 
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Table 6.1 IL-113 in Supernatants from Afferent Lymph DC:PBMC Co-
Cultures after Exposure to 8.1kJ/m 2 UVB 
* Only 1 Experiment lasted to this timepoint 
Figure 6.3 Lymph IL-10 Assessed by Inhibition of Macrophage 
IL-13 Production from Two Individual Experiments 
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6.3.4 	IL-10-like activity after 8.1 kJ/m 2 UVB 
6.3.4.1 	IL-10-like activity in Lymph 
Lymph samples were assayed for IL-10 like activity after exposure of the 
flank skin to 8.1 kJ/m2. Again some variation in the pre-treatment levels of IL-
10-like activity were between experimental subjects (Fig. 6.4). Increased 
like activity was detected in lymph collected after UVB exposure from two 
experimental subjects, occurring at 48-96, 192 (Fig. 6.4a) and 24 (Fig. 6.4b) 
hours respectively. 	While similar decreases were observed in the final 
experiment at 24 and 192 hours post UV exposure. While the final experiment 
was not observed to vary outside the normal range, possibly to greater level of 
variation in pre-treament samples. However, the general trend observed was 
that sustained increases in IL-10-like activity occurred in lymph after exposure 
of the skin to 8.1 kJ/m2 UVB. 
6.3.4.2 	IL-10-like activity in Culture Supernatants 
Since functional studies were performed on DC migrating from UV 
exposed skin, IL-10-like activity in supernatants from DC:PBMC co-cultures 
was also assessed using the macrophage inhibition assay. Generally, 
supernatants from pre-treatment cultures displayed IL-10-like activity in 
comparison to control samples though the extent of this varied between 
individual experiments (Fig. 6.5). In one experiment (Fig. 6.5a) the IL-10-like 
. activity was decreased below that of the controls containing only LPS at 12, 84 
and 192 hours post treatment. While in one experiment the trend was a later 
decrease in the IL-10-like activity in culture supernatants (Fig. 6.5b). While 
from Fig. 6.5c it can be observed that from this experimental subject there was 
no variation outside the normally range. Reduced or unchanged IL-10-like 
activity was generally observed in DC:PBMC culture supernatants after UV 
exposure of flank skin to 8.1 kJ/m 2 . 
6.3.5 	IL-10-like activity in Lymph after 20.1 kJ/m 2 UVB 
The IL-10 like activity contained in lymph from skin exposed to 20.1 kJ/m 2 
was examined. Again, the levels of IL-10-like activity present in pre-treatment 
samples appeared to vary when individual experiments were compared. 
Unusually, one experimental was observed to have lymph that appeared to 
stimulate the secretion of IL-1(3 from macrophages. A definite trend of 
gradually increasing levels of IL-10-like activity was observed in two 




































Figure 6.4 Lymph IL-10 Assessed by Inhibition of Macrophage 
IL-113 Production from Three Individual Experiments 
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Figure 6.5 IL-10 Detected by Macrophage Inhibition of L-10 
synthesis by DC:PMBC Co-Cultures from Three 
Individual Experiments after Exposure of Ovine 






























     
   
   
 
. 
6 	50 	100 150 200 250 360 
Time after UV exposure (hours) 
Dashed lines represent the range of IL-10 
like activity from two pre-treatment samples. 
 
' 50 	100 	150 	200 	250 
























































Figure 6.6 Lymph IL-10 Assessed by Inhibition of Macrophage 
IL-10 Production from Three Individual Experiments 
after Exposure of Ovine Flank Skin to 20.1 kJ/m 2 UVB 
Time after UV exposure (hours) 
Dashed lines represent the normal range of IL-10 
like activity from two pre-treatment samples. 
observed in the other experiment for all time points 24 hours after UV 
exposure, apart from a return to the normal range at 84 hours post-UV 
exposure and one dip below pre-treatment levels, at 144 hours post treatment 
(Fig. 6.6c). This third experiment was of shorter duration thus trend towards 
the increased IL-10-like activity was observed towards the end of the time 
course in lymph from other experimental subjects could not be assessed for 
this experiment. However, it is apparent that lymph which drained skin 
exposed to 20.1 kJ/m2 UVB contained a sustained level of IL-10-like activity. 
	
6.3.6 	Detection of IL-10 Protein in Lymph after UV 
Exposure 
Western blotting was used to detect the presence of IL-10 protein in the 
lymph samples, which were shown to be positive for IL-10 like activity in the 
macrophage inhibition assay. Figs. 6.7, 6.8 and 6.9 show lanes from western 
blots performed on lymph samples from 2.7 kJ/m 2, 8.1 kJ/2 and 20.1 kJ/m 2 
respectively. IL-10 protein was detected using an anti-ovine-IL-10 polyclonal 
antibody and was found to have an apparent molecular weight of approximately 
20 kD. While some of the bands on the gels appear to be of a slightly lower 
molecular weight, this was most likely an artefact of the western process, as the 
samples which were nearest the molecular weight markers were observed to be 
slightly distorted. Despite changing many variables it was not possible to 
overcome this problem without degradation of the molecular weight markers. 
While it can be seen that there were faint bands in normal (pre-exposure 
samples) from both the 8.1 kJ/m2 (Fig. 6.8) and the 20.1 kJ/m2 (Fig. 6.9), the 
normal sample from 2.7 kJ/m2 (Fig. 6.7) had a quite intense band. Further, 
samples which were previously found to have inhibitory effects on IL-113 
secretion by macrophages had intense bands. The detection of this protein 
was reduced 144 hours after UV exposure in the 2.7 kJ/m 2 and 20.1 kJ/m2 
doses (Figs. 6.7 and 6.9 respectively), however, it was still apparent in the 
lymph draining skin exposed to 8.1 kJ/m2 (Fig. 6.8). It should be noted that no 
band was detected in the control samples which contained culture media only 
(RPMI+Supplements). Accordingly it is concluded that IL-10 is found in lymph 
draining from both normal skin and UV irradiated skin, although the quantity of 
IL-10 protein appears to be elevated after UV exposure. 
6.3.7 	Prostaglandin E2 in Lymph and Culture Supernatants 
The levels of secretion of PGE2 in DC:PBMC co-cultures were assayed by 
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PGE2 standards (Fig. 6.10). PGE 2 was detected in pre-treatment samples of 
three experimental subjects at levels ranging from 345 pg/ml to 889 pg/ml (Fig. 
6.11). The levels of PGE 2 were dramatically increased to 3980 pg/ml and 7227 
pg/ml respectively for two of the experiments 24 hours after exposure (Fig. 
6.11a & b) while the remaining experiment (Fig. 6.11c) showed an increase to 
1220 pg/ml at the same time point. These increases represent six, ten and two 
fold increases respectively above the mean background levels of PGE2 for 
each of the three experiments. After 24 hours the levels of PGE 2 returned to 
approximately pre-treatment levels where they remained for the duration of two 
experiments (Fig. 6.11a&b). The remaining experiment (Fig. 6.11c) showed 
increased PGE 2 levels towards the end of the time course, peaking at 264 
hours with PGE 2 concentration of 3220 pg/ml. 
6.3.8 	IFNy in Culture Supernatants 
IFNy levels in DC:PBMC co-culture supernatants were measured in 
comparison to recombinant bovine IFNy standards (Fig. 6.12). The range of 
IFNy in the DC:PBMC co-cultures prior to UV exposure of the skin to 8.1 kJ/m 2 
was between 0-21 pg/ml (Fig. 6.13a,b&c). However, in co-cultures set up using 
DC collected after UV exposure of the skin of the skin, substantial increases in 
IFNy levels were detected in all experimental subjects. This increase in IFNy 
secretion occurred within 48 hours of exposure were observed for two out of 
three sheep. Differences in the timing and magnitude of these increases were 
noted. In one experiment there was a transient peak at 24 hours of 391 pg/ml 
(Fig. 6.13b) while the other experiment showed a longer duration of effect and 
while IFNy production was increased at 24 hours, it did not peak until 36-48 
hours after exposure (Fig. 6.13c). Sustained detectable levels of IFNy were 
present for these two sheep for an extended period after UV exposure (Fig. 
6.13b&c). One experimental subject showed a more substantial peak in IFNy 
levels to 226 pg/ml at the end of the time course. However, an increase in IFNy 
concentration to 41 pg/ml was evident in lymph samples 24 hours after UV 
exposure (Fig. 6.13a). Smaller increases occurred at 96, 168 and 216 hours 
while the final collection point at 240 hours was found to contain 96 pg/ml of 
IFNy. In general increased IFNy production in DC:PBMC co-cultures occurs 
primarily within the first 24-48 hours after UV exposure. It should be noted that 
the experimental subject which did not show substantial increases initially in 
IFNy concentration was not the same experimental subject in which a relatively 














Figure 6.10 PGE 2 Standard Curve 
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Figure 6.12 IFN7 Standard Curve 
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Figure 6.13 IFNy in DC : PMBC co-cultures from Three 
Individual Experiments after Exposure 
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6.3.9 	IL-5 in lymph and DC-PBMC Co-Cultures 
The levels of IL-5 in samples was assessed by a bioassay in which 
proliferation of the BAF cell line is IL-5 dependent. Supernatant from the X63 
cell line was used a source of IL-5 for the initial growth of the BAF cell line and 
was also used as a positive control. Substantial proliferation of BAF cells was 
observed when incubated with 5% X63 supernatant as a positive control giving 
a mean [3H]thymidine uptake of 28,500 CPM for the positive controls for one 
experiment. Little proliferation was observed in the negative control sample 
(355 CPM). In a separate experiment, incubation of the cell line with the 
mitogen PHA, produced a mean of 192 CPM. The majority of test samples, 
either lymph or culture supernatants caused similar rates of BAF proliferation to 
that of the negative controls. Some samples were observed to cause BAF cells 
to proliferate but this was inconsistent and bore no apparent relationship with 
UV exposure of the skin or other parameters controlled by these experiments 
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6.4 DISCUSSION 
UV irradiation of skin and the subsequent production of cytokines and 
soluble factors by its constituent cells has been the subject of intense study 
(reviewed by Granstein,1996, Bergstresser and Takashima, 1996). The current 
investigation expands these studies by exploiting the properties of the ovine 
pseudoafferent system to examine the effects of UV exposure on skin cytokine 
production. Specifically, tests were conducted to identify the presence of 
cytokines after UV exposure of skin, in lymph fluid draining the skin and from 
cultures containing DC migrating from skin. The exposure of DC to cytokines, 
prior to their interaction with T cells can influence the nature of subsequent 
immune response generated (Cua et al., 1996, Dai and Streilein, 1995, 
Steinbrink et al., 1997). Thus DC migrating from UV exposed skin will be 
influenced by the cytokines present not only within the skin but also those in 
the lymph in which they migrate. In turn, the result of interaction between 
migrating DC and T cells in the DLN is influenced by a number of factors, 
including cytokines and soluble factors present in the local micro-environment. 
In the culture system used, it is likely that DC are a major source of cytokines 
which influence the development of T cell immune responses. The culture 
supernatants were harvested after three days, a time period previously shown 
to allow detection of immunoregulatory cytokines in DC:T cell co-cultures 
(Teunissen et al., 1991, Schrieber et al., 1992). The method used in the 
gathering and storage of supernatants was identical to that used by Ragg et al., 
(1997) to assess IL-1 i3 levels after carcinogen treatment of ovine skin. 
6.4.1 	GM-CSF 
While no GM-CSF was detected in either lymph or culture supernatants 
before or after UV exposure of skin, this result may be inconclusive. The 
ELISA used to detect the cytokine was much less sensitive than previously 
reported. Entrician et al., (1996) indicated that the assay was sensitive to 100 
pg/ml GM-CSF, however the present study found the assay only sensitive to 
1900 pg/ml. The loss of sensitivity may have occurred in transit or during 
storage prior to use. Since GM-CSF has been shown to be present in lymph 
draining normal human skin, as have cells secreting the cytokine (Yawalker et 
al., 1996b). The lack of detection may therefore be solely due to the 
insensitivity of the assay system used in this study, although species 
differences in the patterns of cytokine production between humans and sheep 
cannot be excluded. 
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	6.4.2 	IL-113 Production 
The majority of IL-113 in the skin is produced by LC (Shevach et al., 1992, 
Heufler et al., 1992) and this cytokine plays a crucial role in the initiation of 
immune responses occurring within the skin (Enk et aL, 1993a). It has 
previously been shown in the sheep model that IL-1(3 is secreted by migrating 
DC cultured with PBMC (Ragg et al., 1997). IL-10 is produced by activated DC 
as part of an antigen recognition process (Enk and Katz, 1992, Enk et al., 
1993). This activation process may be partially dependent on T cells, as XS52 
a LC-like cell line requires interaction with T cells and, more specifically 
interaction through B7 or MHC II to produce IL-113 (Kitajima et al., 1995). In the 
antigen presenting assay from which the supernatants were isolated, it appears 
that antigen is also crucial to this process as IL-10 production was not detected 
unless DC were pulsed with OVA prior to incubation (Ragg, unpublished 
observations). Macrophages are another possible source of IL-10 in the 
DC:PBMC cultures supernatants as ovine macrophages also produce IL-10 
(Egan and Nash, 1996). From evidence already presented in this thesis, it 
appears that even after exposure to higher doses of UV, the proportion of 
migrating DC is greater than macrophages suggesting migrating DC are likely 
to be the main source of this cytokine, both before and after UV exposure of the 
skin. 
The levels of IL-10 secreted by DC migrating from normal skin in this 
study were slightly lower in magnitude than the normal values reported 
previously by Ragg et al., (1997). Ragg et al., (1997) found that the loss of 
antigen presenting function observed in migrating ovine DC after cutaneous 
exposure to carcinogens (DMBA and BP) was closely associated with loss of 
IL-113 secretion. Initially, it was considered that the loss of antigen presenting 
activity of ovine DC migrating from UV exposed skin may have been similarly 
associated with a loss of IL-113 production. However, IL-10 was consistently 
present in supernatants from DC:PBMC after exposure to 8.1 kJ/m 2. Thus it is 
concluded that IL-10 secretion by migrating DC is unaffected by UV exposure. 
Secondly it provides evidence that migrating DC were viable after UV 
exposure, as they were still able to secrete the cytokine. 
6.4.3 	IL-10 production 
This study attempted to detect IL-10 in lymph and in DC:PBMC co-
cultures before and after cutaneous UV exposure. It is stressed that the 
macrophage inhibition assay could only detect IL-10-like activity as measured 
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by the inhibition of IL-1 3 synthesis by LPS exposed macrophages. This study 
also used an anti-ovine IL-10 polyclonal antibody to detect a protein having the 
expected molecular weight of ovine IL-10 (20 kD as found by Martin et al., 
1995). However the lack of a positive control (ovine IL-10) during the time of 
these experiments means that some small element of doubt may be associated 
with this data. While it is highly likely that the protein in lymph is IL-10, it remain 
possible that the activity and protein observed may be due to another unrelated 
cytokine or soluble factor having a similar molecular weight. 
Generally lymph appears to suppress the ability of LPS stimulated 
macrophages to produce IL-113. This may be due to inhibitory properties of 
cytokines which are normally present in ovine lymph, or may be due to the 
nutritive properties of lymph in comparison to culture media. In one case, 
lymph appeared to stimulate the production of inflammatory cytokines again 
illustrating the inherent variability of the outbred sheep model. The levels of IL-
10-like activity increase in lymph samples after UV exposure to 2.7 kJ/m 2, 8.1 
kJ/m2 and 20.1 kJ/m2 . While the presence of an IL-10-like protein was detected 
in lymph samples prior to UV exposure of the skin, it would appear that 
cutaneous UV exposure was associated with increased levels of this protein. 
Low levels of IL-10 have previously been demonstrated in normal lymph 
draining human skin and have been shown to be up-regulated in after 
elicitation of a primary allergic reaction such as the elicitation of allergic contact 
dermatitis.(Brand et al., 1997). UV exposure of the skin has been shown to 
cause dramatic up-regulation in IL-10 levels in the skin and serum (Rivas and 
Ullrich, 1992), thus it is not unexpected that IL-10-like activity was detected in 
ovine lymph. The source of cutaneous and hence lymphatic IL-10 appears to 
be due to the secretion by macrophages (Kang et al., 1994) and/or 
keratinocytes (Rivas and Ullrich, 1992, Enk etal., 1995). 
No increases in IL-10-like activity after UV exposure were observed in 
DC:PBMC co-cultures after exposure of the skin to 8.1kJ/m 2 UVB. In fact, it 
was more common for the loss of this activity to occur. This suggests that the 
cells within the DC or PBMC populations have not been induced to secrete 
increased levels IL-10 after UV exposure. This result ties in with the finding 
that IL-113 secretion in the DC:PBMC co-cultures was not inhibited after UV 
exposure of the skin. Thus it appears that DC migrating from UV exposed skin 
do not cause increased IL-10 production. It would therefore appear that the IL-
10 detected in these experiments was produced in the skin or by non-dendritic 
cells in the lymph 
133 
6.4.4 	Prostaglandin E2 Production 
This investigation found there were detectable levels of PGE2 secreted in 
DC:PBMC co-cultures under normal conditions which ranged from 345 pg/ml to 
889 pg/ml. PGE 2 has been shown to be secreted from organ cultured guinea 
pig skin at levels of approximately 4 ng/ml (Imokawa et al., 1989). Therefore, 
the finding of PGE2 in pre-treatment cultures was not surprising. This cytokine 
is likely to be derived from dendritic cells which have migrated from the skin as 
LC produce this soluble factor (Ruzicka and Aubock, 1987, Rosenbach et al., 
1990, Teunissen et al., 1991). The finding that PGE 2 is present in normal 
DC:PBMC co-cultures provides a possible explanation for the lack of detection 
of IFNy as discussed in the next section, as PGE 2 is known to inhibit IFNy 
production by T cells (Hasler et al., 1983). Further, exposure of T cell clones to 
10 -8 M PGE2 reduces the production of IL-2 and IFNy by Th1 and THO clones 
but not IL-4 and IL-5 production by Th2 and Th0 clones (Betz and Fox, 1991, 
Snijdewint et al., 1993). While the molarity of PGE 2 found normally in the 
cultures was slightly lower at approximately 2x1 0 9 M, it might be possible that 
this amount may be sufficient to shift T cells towards the Th2 subtype and 
reduce IFNy production to undetectable levels. This may reflect 
microenvironmental differences in vitro in comparison to in vivo conditions, 
where the presentation of antigen takes place in the lymph node. 
24 hours after UV exposure of skin, the amount of PGE 2 present in 
DC:PBMC co-cultures increased by two, six and ten fold for the three 
experiments after exposure. As culture conditions were identical for the three 
experiments, the source of variation may be due to the outbred nature of the 
ovine model. Increased production of prostaglandins in the skin following UV 
exposure is a well established phenomena (Black et al., 1978a, Black et al., 
1978b) and was found to reach its maximum at the same time point in the 
current study (24 hours). It should be noted that normally, the major 
arachidonic acid metabolite secreted by LC is PGD 2 (Ruzicka and A0bock, 
1987, Rosenbach, 1990), however the ratio of PGD 2 to PGE2 is reversed after 
UV irradiation of the skin (Ruzicka et al., 1983). Thus suggesting that the 
cycloxygenase pathway after UV exposure appears to favour PGE 2 production. 
Extensive studies have shown that inhibitors of PG synthesis, such as 
indomethacin and aspirin reduce the erythemal response to UV light (Miller et 
al., 1967, Greenberg etal., 1975, Synder et al., 1975, Black et al., 1978b, Lim 
et al., 1983). Thus it appears the nature and timing of the increase in PGE2 
observed in DC:PBMC co-cultures reflects acute inflammatory events. The 
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short duration of this increase probably rules out increased PGE 2 levels in 
DC:PBMC co-cultures playing a role in the reduction of DC or PBMC function. 
The increase in PGE2 levels to >10 43 M observed 24 hours after UV exposure of 
the skin observed for 2/3 experiments, would be sufficient to skew cytokine 
secretion by T cells towards that of the Th2 subtype (Betz and Fox, 1991, 
Snijdewint et al., 1993). 
6.4.5 	IFNy 
This study attempted to ascertain whether DC migrating from UV exposed 
skin caused alterations in the production IFNy by responding T cells. Little or 
no IFNy production was observed prior to UV exposure of the skin, suggesting 
that, under normal circumstances OVA pulsed ovine DC, do not appear to 
stimulate IFNy production by responding T cells. However, increased 
production was observed following UV exposure. This is contrary to previous 
findings, which after cutaneous UV exposure followed by FITC sensitisation, 
showed that DLN cells produced less IFNy (Sajio et al., 1996). However, with 
Sajio's study the FITC sensitisation took place three days after irradiation and 
the DLN were not isolated until a further 18 hours. In the present study the 
increased IFNy production occurred between 24-48 hours after UV exposure, 
this would have occurred prior to the sensitisation of the skin in Sajio's 
investigation and so would not have been detected. However, the lack of IFNy 
production prior to UV exposure may represent differences between the ovine 
and murine models. In the ovine system the production of IFNy by PBMC in 
response to OVA is crucially dependent on the adjuvant in which the protein is 
inoculated (Emery etal., 1990). The use of alum as an adjuvant did not induce 
production of IFNy by PBMC from immune sheep (Emery et al., 1990), whether 
this is due to a Th2 immune response is unknown. 
Variations in the time course of production IFNy were noted between 
individual experimental subjects. This may be due to the outbred nature of the 
sheep used. Major increases in IFNy production occurred within the short time 
period after treatment (24-48 hours), perhaps reflecting a response to the acute 
inflammatory effects of UV exposure. IFNy has been shown to be primarily 
produced by activated Th1 cells, and is thought to skew T cells towards the 
production of Th1 cytokines. Further, it has been shown to promote 
macrophage production of cytocycidal soluble factors TNFa, Nitric oxide and 
reactive oxygen intermediates (reviewed by Farrar and Schrieber, 1993). This 
suggests a possible role for IFNy in the elimination of damaged cells. IFNy and 
LPS induction of NOS synthetase activity in murine DC was found to be closely 
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associated with DC apoptosis and sub-optimal T cell proliferation. (Lu et al., 
1996). Additional studies would be required to further elucidate if any the role 
of IFNy in apoptotic cell death after UV exposure. However, the unchanged 
production of IL-1(3 would appear to reduce the possibility that DC are 
prematurely undergoing apoptosis. 
6.4.6 	IL-5 
This study utilised a recently developed bioassay to detect the secretion 
of IL-5 in DC:PBMC co-cultures before and after UV exposure of the skin. The 
BAF cell line has been manipulated so it requires IL-5 to proliferate (D Emery, 
personal communication). This study revealed that there appeared to be no IL-
5 production in the co-cultures, suggesting under normal circumstances this 
cytokine is not secreted in amounts detectable using the above bioassay. 
Further, samples from DC:PBMC co-cultures after UV irradiation also did not 
contain detectable levels of the cytokine. While Simon et al., (1990) found that 
UV irradiated LC preferentially activated Th2 cell clones in comparison to Th1 
cell clones, he did not find increased stimulation of Th2 clones. In subsequent 
studies it was found that while restimulated hapten primed lymph node cells 
had a reduced Th1 response, no detectable Th2 response was generated 
(Simon et al., 1994). This is supported by the present studies and so far in the 
ovine model IL-5 production has been only found in parasitised and DNA 
vaccinated sheep (D. Emery, personal communication). Sajio etal., 1996, were 
able to show that loss of T cell proliferation after UV exposure, was due to a 
defect in antigen presentation and was associated in vivo with a down-
regulation of both Th1 and Th2 cytokines, IL-4 and IL-10, respectively. IL-4 is 
perhaps the most well characterised Th2 cytokine but as yet no specific 
bioassay or ELISA has been developed for its detection in the ovine system. 
The development of such an assay would help to clarify the Th1/Th2 status of 
ovine immune responses. The results presented in this chapter suggest that 
DC migrating from UV exposed skin do not stimulate increased levels of Th2 
cytokines by primed T cells (IL-5 and IL-10). 
6.5 SUMMARY 
This chapter describes investigations of alterations in the secretion of 
cytokines after UV exposure of ovine skin. Attempts to detect GM-CSF and IL-
5 were unsuccessful using the assays available. IL-1(3, an important T cell co-
stimulatory factor produced by migrating ovine DC was found to be unaltered 
after cutaneous UV exposure. Normally IFNy was undetectable or found in low 
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levels in cultures containing antigen pulsed DC and primed T cells. However, 
after UV exposure of the skin short term increases in the levels of IFNy were 
noted in the culture supernatants. Similar short term increases in PGE2 
production were also found in culture supernatants after UV exposure of the 
skin. However, in contrast to IFNy, PGE2 was detected in supernatants from 
unexposed skin and the suppressive activity of this soluble factor may provide 
a reason for the lack of IFNy production under normal circumstances. The 
detection of increased IL-10-like activity and an increase in IL-10 protein in 
lymph draining UV exposed skin, suggests that increased IL-10 production was 
occurring in the skin. No increased production of IL-10 was observed in culture 
supernatants, suggesting that preferential stimulation of Th2 response was not 
occurring in vitro. These changes may have important ramifications for the 
immunological reactions occurring after UV exposure of the skin which are 
discussed further in Chapter 7. 
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CHAPTER 7: GENERAL DISCUSSION 
Ultraviolet rays within the solar spectrum are arguably the most ubiquitous 
carcinogen to which humans regularly are exposed. Substantial evidence from 
animal models shows that UVB portion of sunlight fulfils the three steps of 
carcinogenesis, initiation, promotion and progression (reviewed by Kraus, 
1996) The crucial role of the immune system in inhibiting tumour growth is 
highlighted by the findings that patients on immunosuppressive therapy have 
increased incidence of skin tumours (Marshall ) 1974). Similarly loss of 
immunity has been shown after UV exposure, as UVB irradiated mice fail to 
reject highly immunogenic tumours, which were rejected by non-irradiated 
littermates (Fisher and Kripke, 1978, Kripke et al., 1990). UVB exposure also 
down-regulates 0TH responses in mice and humans (Toews et al., 1980, 
Cooper et al., 1992). Further the induction of long lasting antigen specific 
unresponsiveness occurs when antigen is applied through UV irradiated skin 
due to the formation of suppressor cells (Fisher and Kripke, 1978, Okamoto 
and Kripke, 1987) 
One mechanism by which UV light alters immune function in the skin is via 
the modulation of LC, the local antigen presenting cells of the skin. LC are 
known to be depleted by exposure of the skin to UV irradiation, including LC in 
the ovine skin (Lyne and Chase, 1966). The experiments presented in this 
thesis have utilised an ovine model, where cannulated lymphatic vessels 
allowed the investigation of migration kinetics and function of ex vivo migrating 
DC, draining a defined area of UV exposed skin. The key findings of these 
studies were that UV exposure of the skin caused; increased migration of 
functionally aberrant LC, the appearance of macrophages in lymph and a 
reduction in the proliferative capacity of circulating cells. Investigations 
revealed that the loss of normal function of migrating DC was not related to B7 
expression or the in vitro production of a number of cytokines. However, the 
increased in vivo production of the suppressive cytokine IL-10 was found. 
The UV exposure of ovine flank skin triggered enhanced migration of LC 
(CD1w1 + DC). This effect was noted for a range of doses between 2.7 and 
80.4 kJ/m2, in a dose dependent manner. The migrating LC were viable, thus 
eliminating the possibility that they were dead cells flushed from the skin in a 
non specific manner. These findings confirm previous observations in the 
murine system where increased numbers of DC were present in the lymph 
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nodes draining UV areas of skin (Moodycliffe et al., 1992). The increase in the 
number of lymph node DC detected in those experiments where similar in 
magnitude to the increase in LC migration observed in these experiments. 
However, the increased migration of ovine LC contrasts with the findings of 
Richters etal., (1996) and Kremer etal., (1997) who used a human skin explant 
model. It can be argued that the migration of LC found in ovine pseudoafferent 
lymph more accurately reflects what occurs in vivo than an explant model wher 
a number of factors are abnormal such as the complete disruption of neural 
input. This may be particularly relevant as recent data has shown that the 
nervous system plays a role in UV induced LC depletion (Niizeki et aL, 1997). 
While LC were readily stimulated to migrate by low doses of UV light, 
higher doses of UVB 20.1 kJ/m 2) led to non-specific increases in the 
migration of other cell populations including T lymphocytes and CD14 + cells. 
The increased migration of CD4, T19 and to a lesser extent CD8 T cell subsets 
may reflect the increased cellular traffic of these cells through UV inflamed 
skin. Similar effects have been observed in other ruminant models of 
cutaneous inflammation (Egan et al., 1996, Mwangi et al., 1990, Flynn et al., 
1994). This is most likely due to the up-regulation of adhesion molecules such 
as E-Selectin, on vascular endothelial cells which are directly affected by UV 
exposure (Strickland et al., 1997). It has been shown in this thesis that 
migrating ovine DC do not express the CD14 surface molecule, which is 
expressed by macrophages migrating from UV exposed skin (Richters et al., 
1996). After exposure of ovine flank skin to UVB increased migration of CD14+ 
cells occurred, supporting the findings that macrophages, like LC, migrate from 
UV irradiated skin (Muller et a/., 1994, Richters et al., 1996). However, 
migration of macrophages extended out to 168-264 hours after UVB exposure, 
a much longer period than that previously reported by Richters et al., (1996) 
which may again indicate the limitations of the skin explant system. However, it 
should be noted that the CD14+ cell population was minor in comparison to 
migrating DC, only comprising 13% of the DC fraction in the pseudoafferent 
lymph during its maximum migratory efflux. Hence, T cell interactions occurring 
within the lymph node are still likely to be dominated by migrating DC. 
The subsequent reclassification of established monoclonal antibodies 
used to assess DC and macrophage migration has affected the interpretation of 
studies in this thesis (0M1, SBU-T6 & CC-G33). The recent reclassification of 
the SBU-T6 mAb which is a marker for LC in ovine skin (Mackay et al., 1985 
and thought to be equivalent to the human CD1c marker (Ragg etal., 1994) is 
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now classified as CD1w1 (a workshop definition) and its reaction with a specific 
equivalent human CD1 subtype is now uncertain (Naessens et a/., 1997). 
However, as the SBU-T6 mAb undoubtedly reacts with ovine LC in the skin 
(Mackay etal., 1985) and DC in the draining lymph, where CD1a and CD1c are 
both expressed (reviewed by Romani et a/., 1991, Hart etal., 1997), it seems 
likely that SBU-T6 is reacting with an equivalent ovine surface molecule or 
molecules. During the course of these studies, the mAb (CC-G33) used to 
detect CD14 molecules on macrophages was accepted as a marker in the 
ovine/bovine system (Sopp etal., 1996, Berthon and Hopkins, 1996, Naessens 
etal., 1997). These ongoing changes in the development and classification of 
ovine reagents should make the future study ovine cell populations more easy 
to relate to the phenotype of cells in other species. 
This study has shown enhanced migration of LC to the lymph node still 
occurs after cutaneous UV exposure and evidence exists that the functional 
ability of LC within the skin is reduced (Stingl et a/., 1981). It was therefore 
hypothesised that the functional ability of the migrating ovine DC would also be 
reduced. The capacity of migrating ovine DC to present antigen to primed T 
cells was evaluated after cutaneous exposure to 8.1 kJ/m 2 UVB. This dose was 
chosen in an attempt to minimise the gross inflammatory effects observed at 
higher doses, as it was the lowest dose to consistently cause an increased 
proportion of LC in the draining lymph. The functional capacity of the migrating 
DC was found to be reduced after UV exposure of the skin. The assay used in 
this study required active antigen uptake, processing and presentation by DC 
to the primed T cells. Not all these steps are required for allostimulation which 
appears unaffected by UV light exposure (Lappin et al., 1996, Kremer et a/., 
1997). Functionally, DC migrating from UV exposed skin are capable of 
inducing specific suppressor cells (Okamoto and Kripke, 1987). The DC 
studied in this thesis and by others have a reduced capacity to stimulate T cells 
(Dai and Streilein, 1995, Sajio et a/., 1996). How the suppressor cells are 
generated still remains a subject of debate. The cells are generally thought to 
be of the CD4 Th2 subtype (Yagi et al., 1996) or CD8 equivalent (Tc2) 
(Schwarz etal., 1998) and act via a suppression of Th1 responses. Evidence is 
not yet available which relates UV induced down-regulation of Th1 response to 
tumour formation. It is proposed that neoantigens arising in UV exposed skin 
when APC function is aberrant, may result in the activation of neoantigen 
specific suppressor T cells. Such events may reduce the immune response 
against the transformed cells and so would allow tumours to evade elimination 
by the immune system (reviewed by Nishigori etal., 1996). 
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Experimental evidence from bilateral cannulations indicated that the loss 
of function was a systemic effect of UVB exposure. To investigate if this was 
due to alterations of DC or the responding primed T cells, mitogen stimulation 
of PBMC was used as an indicator of the proliferative capacity of the responder 
cells in the functional assay. Exposure of ovine skin to 8.1 kJ/m 2 reduced the 
proliferative ability of PBMC for 72 hours. While the loss of responder cell 
function illustrated the serious nature of the alterations in immune response 
observed after UV exposure, it also generated a degree of uncertainty about 
any perceived loss of DC function occurring during the first 72 hours post-
exposure. However, since one experimental subject did not show a loss of the 
functional capacity of DC until 48 hours after UV exposure of the skin this 
suggests that the immediate loss of function may be due to the loss of the 
proliferative capacity of PBMC. Evidence from murine studies also 
demonstrates a delay of 3 days is required before painting UV exposed skin 
with hapten leading to the induction of tolerance and generation of suppressor 
cells (Howie et al., 1986). The loss of DC function in the antigen presentation 
assay lasted between 24-192 hours after exposure, much longer than the 
reduced proliferative ability of PBMC which was detected for only 72 hours. 
The difference in time course of these two effects indicates that the aberrant 
DC function and temporary loss of mitogen induced proliferation are two 
separate effects occurring after UV exposure of the skin. 
It was decided to investigate possible mediators that may play a role in 
the loss of antigen presenting cell function by migrating ovine DC. Possibilities 
include the loss of the expression of co-stimulatory molecules on the surface of 
migrating LC, the production of an inhibitory cytokine(s) or the lack of 
production of stimulatory cytokine(s). No loss of expression of B7 molecules 
occurred on migrating ovine DC after UV exposure of the skin, in fact it was 
common for increases in the expression of B7 molecules to occur. Recent 
evidence agrees with the findings of this study. Lappin et aL, (1996) has 
shown that the expression of B7-2 molecule is increased on migrating DC and 
B7 molecule expression also appeared to be up-regulated within the skin after 
UV exposure (Laihia and Jansen, 1997). However, the expression of B7 
molecules by migrating CD1w1 + DC was generally stable after exposure of the 
flank skin to 8.1 kJ/m 2 UVB, the same dose shown to cause inhibition of DC 
antigen presenting function. It therefore seems unlikely that loss of the APC 
function after UV irradiation of the skin is caused by alterations in B7 
expression. This observation lead to changes in the production and secretion 
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of various cytokines and their role in aberrant DC becoming a more important 
focus of this thesis. 
The production of the prototype costimulatory cytokine IL113 by LC is 
crucial for the initiation of immune responses in the skin (Enk et al., 1993). The 
production of this cytokine was investigated in DC:PBMC co-cultures, which 
were set up in parallel with cultures used for the APC assay. These 
experiments revealed that migrating DC were still capable of in vitro production 
of this cytokine after UV exposure. Thus, any loss of DC antigen presenting 
function after UV exposure of the skin, unlike chemical carcinogens (Ragg et 
a/., 1997), appears not to be associated with a loss of IL-113 production. 
Further soluble factors were investigated in DC:PBMC co-cultures after UV 
exposure with the only changes detected being a temporary up-regulation of 
IFNy and PGE2. PGE2 is known to be produced by cells in the skin, including 
LC (Teunissen et al., 1991, Rosenbach et al., 1990) and is up-regulated in the 
skin after UV exposure (lmokawa and Tejima, 1989) contributing to some 
immunosuppressive events (Jun et al., 1988). The up-regulation observed in 
cultures containing DC and primed T cells may be due to the increased PGE2 
synthesis by migrating LC in response to the acute inflammatory effects of UV 
exposure. This in turn may be an attempt to reduce the production of 
inflammatory cytokines, such as TNFa and IL-6 by activated macrophages, 
which has been shown to be linked with IL-10 production (Strassman et a/., 
1994). Both PGE 2 and IL-10 have been shown to influence the ability of 
immature DC to induce Th1 or Th2 responses (Kalinski et al., 1997). It is 
apparent from these studies that the magnitude of temporary increases in 
production and/or secretion of PGE 2 may be sufficient for this to occur (Betz 
and Fox, 1991, Snijdewint etal., 1993). This effect may also be mediated by 
the lack of IL-12 production as sufficient PGE 2 was found in pre-treatment 
samples (10 -9 M) to inhibit IL-12 production by DC in vitro (Kalinski etal., 1997) 
and this is likely to be exacerbated with the increased PGE 2 levels after UV 
exposure of the skin. Further, Kalinski et al., (1997) showed the loss of IL-12 
production by DC was stable even after the withdrawal of PGE 2 from culture 
and this was associated with IL-10 secretion by DC. It may be hypothesised 
that PGE2 production after UV exposure could affect the capacity of LC in vivo 
to produce IL-12 for a sustained period, thus leading to the observed loss of 
ovine APC function in vitro. However, in this study the in vitro expression of 
PGE2 did not correlate with a loss of APC function. So PGE2 could not be 
directly related to the functional changes observed. 
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A further effect of the exposure of immature DC to PGE 2  is a reduction in 
expression of the CD1 surface molecule while increasing CD14 expression 
(Kalinski et a/., 1997). This requires exposure to PGE 2 at levels greater than 
10-9  M, which were observed to occur after UV exposure. Both markers were 
used in this study to investigate DC and macrophage migration respectively. It 
might be hypothesised that increased PGE 2 and IL-10 levels may alter DC 
maturation, leading to the development of a more macrophage-like cell. This 
theory may warrant future investigation, as it suggests that PGE 2 cultured DC 
may be useful for immunotherapy where the induction of a Th2 response is 
desirable. 
A temporary increase in IFNy was detected in DC:PBMC co-cultures set 
up with cells collected within 24 hours of UVB exposure of the skin. This 
finding was unexpected as it has not been demonstrated in responses studied 
in the DLN, where the loss of this cytokine is commonly associated with UV 
irradiation (Simon et al., 1994, Sajio et a/., 1996). However, a novel form of T 
cell activation has been noted in vitro associated with macrophages in UV 
irradiated skin. This involved up-regulation of IFNy mRNA and deficient IL-2ra 
expression by responding T cells (Stevens et a/., 1995). Circumstantial 
evidence exists in the ovine model which supports this observation as the initial 
increase in migration of macrophages from ovine skin occurs at a similar time 
point as the temporary production of IFNy in vitro. IFNy and PGE 2 would 
appear to have opposing effects on the immune response, with these soluble 
factors known to skew immunity towards a Th1 or Th2 response respectively. 
The production of both cytokines simultaneously in vitro illustrates the level of 
complexity associated with the generation of an immune response. 
A bioassay was used to assess IL-10-like activity. This assay measured 
the inhibition of IL-113 by LPS stimulated macrophages after the addition of 
lymph or DC:PBMC co-culture supernatant. Lymph samples and co-culture 
supernatants taken before UV of the skin were compared with those derived at 
various time points after irradiation. This revealed that there was little or no 
increase in IL-10-like activity in supernatants from DC: T cell co-cultures after 
cutaneous exposure to 8.1 kJ/m 2 UVB. The lack of any increase in IL-10-like 
activity in the DC:PBMC co-cultures suggested that the DC migrating from UV 
exposed skin did not stimulate primed T cells to produce detectable levels of 
this cytokine. So the increased IL-10 secretion may be limited to in vivo 
production within the skin after UV exposure, where likely sources of IL-10 
include macrophages (Kang et al., 1994) and keratinocytes (Ullrich etal., 1994, 
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Enk et al., 1995, Grewe et al., 1995). The apparent lack of increased IL-10-like 
activity in DC:PBMC co-cultures, despite the increased migration of CD14 + 
macrophages from UV exposed sheep skin, suggests these cells were not 
producing this cytokine in vitro. This indicates that the activity may be 
restricted to macrophages and keratinocytes within the environment of the skin. 
Therefore this study has been unable to find a suppressive factor within 
DC:PBMC culture supernatants, which directly correlates to the loss of APC 
function observed. 
Because of the lack of in vitro changes in IL-10 production corresponding 
to the functional changes, it was decided to investigate the in vivo production of 
IL-10 in ovine lymph draining the UV irradiated sheep skin. The detection of IL-
10 protein by western blotting of lymph samples was undertaken using specific 
polyclonal anti-IL-10 antibodies. This technique detected the presence of 
protein with the approximate molecular weight of ovine IL-10 (20 kD). This was 
detected in lymph draining from both normal and skin exposed to 2.7, 8.1 and 
20.1 kJ/m2 UVB. While IL-10 protein was barely detectable in pre-exposure 
samples, increases in the intensity of the bands were observed after UV 
exposure of the skin. Hence the quantity of IL-10 protein in lymph draining UV 
exposed skin was increased. This was further supported by increased IL-10- 
like activity in lymph draining UV exposed skin. IL-10 has been shown to affect 
the APC function of LC which lose their ability to present antigen to Th1 cells 
but not Th2 cells (Enk et al:, 1993). Further, the systemic effects of UV 
immunosuppression on antigen presenting cell function are blocked by the 
administration of IL-10 neutralising mAb's (Ullrich et al., 1994) and DC exposed 
to IL-10 in vitro induce tolerance rather than immunity by inducing antigen 
specific anergy (Steinbrink etal., 1997). The induction of anergy in T cells may 
account for the sustained loss in ability of migrating ovine DC from UV exposed 
skin to stimulate primed T cells in vitro. The importance of IL-10 in UV induced 
immunosuppression is highlighted by studies which have shown that IL-10 
knockout mice are completely resistant to the immunosuppressive effects of UV 
exposure (Beissert et al., 1996). Further, IL-10 has been found to reduce the 
presentation of tumour associated antigens by LC (Beissert et al., 1995), thus 
allowing transformed cells to evade a protective cellular immune response in 
vivo and develop into a tumour. 
From the results presented in this thesis, the most likely explanation for 
the UV induced loss of APC function by migrating DC would appear to be the 
exposure to IL-10 and possibly PGE2 while present in the skin and lymph. This 
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in turn may lead to a lack of IL-12 production by antigen presenting cells. IL-12 
production by migrating ovine DC after UV exposure of the skin was not 
investigated due to a lack of ovine reagents specific for this cytokine. However, 
IL-12 is undoubtedly important in the induction of cellular immune (Th1) 
responses (Seder et al., 1993) and the addition of IL-12 after UV irradiation 
may overcome the induction of UV induced suppression and the activity of UV 
induced suppressor cells (Schmitt et a/., 1995, Schwarz et al., 1996). This 
suggests a pivotal role for the inhibition of IL-12 production in UV induced 
immunosuppression. This lack of IL-12 may occur for a sustained period, due 
to an increased production of IL-10 and PGE2 (Kalinski etal., 1997). 
These studies have shown the effects UV light has on the migration and 
functional capacity of ovine pseudoafferent lymph DC and provides some 
insights into mediators of these effects. However some questions remain 
unanswered. For instance the photoreceptor mediating these effects is still 
unknown. Loss of APC may be due to DNA damage, cis-UCA production or a 
combination of both. The availability of liposomes containing the excision 
repair enzyme T4 endonuclease V (T4N5) (Yarosh et al., 1990) and antibody 
against cis-UCA (El-Ghorr and Norval, 1995) would readily allow these 
parameters to be assessed. Investigations of the stage at which the loss of 
APC function occurs, whether in antigen uptake, processing or presentation are 
currently being undertaken and should provide valuable insights into the 
stage(s) at which UV irradiation effects APC function. The increasing 
availability of ovine reagents will allow detailed investigation into the role of IL-
10 and IL-12 in the loss of APC function demonstrated here. While this thesis 
and many previous investigations have concentrated on the cellular mechanism 
of UV immunosuppression, little is known about the molecular mechanisms 




This study has shown that cutaneous UVB exposure results in a dose 
dependant increase in LC migration from exposed skin for sustained periods 
after UV exposure. Increasing the level of UV exposure also increased the 
numbers of migrating T cell subsets and cells expressing the CD14+ surface 
molecule characteristic of macrophages. Like LC, the enhanced migration of 
these cells lasted for a sustained period of time but these cells were only a 
relatively minor population when compared to migrating DC. The functional 
capability of migrating DC was investigated and found to be aberrant, as they 
failed to present exogenous antigen and induce the proliferation of autologous 
primed T cells. This loss of functional activity lasted for 6-8 days after UV 
exposure. Further, direct effects on circulating cells were found, with the 
mitogen induced proliferation of PBMC reduced for 72 hours after exposure. 
The cause of APC functional loss was investigated but did not correspond to 
any reduction in B7 molecule expression on migrating DC. While no sustained 
production of inhibitory cytokines was detected in the culture supernatants, 
which corresponded to the loss of APC function, immediate transient increases 
in the levels IFNy and PGE2 were observed. The detection of increased IL-10- 
like activity and IL-10 protein was found in lymph draining UV exposed skin. In 
vivo production of this cytokine in the skin and lymph may be responsible for 
the failure of the migrating DC to present antigen through possible down-
regulation of IL-12 production. These alterations of LC from UV exposed skin 
have serious consequences for cutaneous immunity, as LC play a crucial role 
in immunosurveillance and their subsequent loss of antigen presenting activity 
upon migration may lead to reduced cellular immunity, resulting in the 
increased potential for viral and microbial infections. Further, LC migrating 
from UV exposed skin may be incapable of presenting tumour antigens which 
arise in UV exposed skin. This, in turn, may lead to tumours evading immune 
responses and progressing to malignancy. These findings add to and expand 
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